data_2k7g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k7g _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 CA-C-O 120.368 -0.129 . . . . 0.0 112.817 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.622 HG13 HG21 ' A' ' 4' ' ' ILE . 4.4 t -80.42 124.21 82.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.75 52.67 4.4 Favored 'Trans proline' 0 CA--C 1.527 0.158 0 C-N-CA 122.709 2.272 . . . . 0.0 114.181 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.622 HG21 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -89.96 8.06 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.994 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 3.7 m -88.81 -36.01 16.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.109 0.481 . . . . 0.0 109.78 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.59 29.57 74.08 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.027 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 35.2 mt-10 -113.36 144.81 42.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.614 0.245 . . . . 0.0 110.604 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.4 p -91.22 129.19 37.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.332 -0.394 . . . . 0.0 109.939 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.449 ' O ' ' HD1' ' A' ' 23' ' ' TRP . 44.5 t -89.76 20.35 4.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.541 0.686 . . . . 0.0 109.661 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -58.93 -39.25 81.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.275 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.26 6.83 47.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.892 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.402 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 61.58 46.02 95.13 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.892 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 80.3 m -156.72 133.99 10.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.852 0.326 . . . . 0.0 111.152 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.8 m -126.4 136.77 53.1 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -88.34 -27.22 21.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.697 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.4 m -77.21 103.24 7.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.126 0.488 . . . . 0.0 110.753 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.35 122.93 13.73 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.334 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.94 -17.2 22.66 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.79 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 96.1 m -87.92 135.95 33.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.86 0.362 . . . . 0.0 110.378 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -88.28 143.6 26.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.826 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 t -87.61 81.54 7.69 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 m -89.97 76.5 7.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 26.9 t90 -34.89 127.07 0.52 Allowed Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 124.066 0.854 . . . . 0.0 112.382 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.1 Cg_endo -99.96 35.67 7.2 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.19 -1.171 . . . . 0.0 114.082 0.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.89 141.14 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.468 0.651 . . . . 0.0 112.445 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 93.0 m -88.52 116.16 26.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.1 p -121.98 132.61 54.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.003 0.43 . . . . 0.0 111.253 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 32.0 ttt85 -89.11 112.94 24.03 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 C--N 1.328 -0.368 0 O-C-N 123.564 0.54 . . . . 0.0 110.014 -178.82 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.505 0 N-CA-C 112.783 -0.127 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.885 HG11 HG21 ' A' ' 4' ' ' ILE . 3.3 t -81.59 119.15 74.79 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.94 0.4 . . . . 0.0 110.599 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.6 Cg_exo -79.33 51.49 3.89 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.118 2.545 . . . . 0.0 114.134 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.885 HG21 HG11 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.29 17.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.153 0.501 . . . . 0.0 110.617 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.2 m -89.45 -34.77 16.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.192 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.65 34.96 79.57 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.394 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -128.71 143.02 50.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.881 0.372 . . . . 0.0 111.34 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.4 p -97.19 127.11 42.86 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 7.6 t -99.74 35.66 1.96 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.977 0.418 . . . . 0.0 110.701 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -34.84 74.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.8 mt -98.44 14.23 28.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.416 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 63.44 49.33 70.88 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.918 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.2 m -155.68 134.96 12.29 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.667 -0.313 . . . . 0.0 111.062 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.5 m -137.45 135.02 36.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.87 -26.2 21.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.913 0.387 . . . . 0.0 110.306 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.425 HG22 ' SG ' ' A' ' 19' ' ' CYS . 5.3 m -73.25 97.33 2.42 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.23 0.538 . . . . 0.0 110.883 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.84 127.92 30.76 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.14 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.94 -16.11 39.74 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.075 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.425 ' SG ' HG22 ' A' ' 16' ' ' THR . 72.2 m -88.63 134.96 33.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.077 0.465 . . . . 0.0 110.808 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -88.49 155.31 19.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.099 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.0 t -87.99 84.63 6.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.071 0.462 . . . . 0.0 111.692 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 m -90.5 67.25 6.51 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 14.2 t90 -32.31 125.97 0.37 Allowed Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 124.461 1.101 . . . . 0.0 112.734 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.6 Cg_endo -99.44 36.33 6.87 Favored 'Cis proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.102 -1.207 . . . . 0.0 113.937 0.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.58 142.74 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 121.754 -0.591 . . . . 0.0 112.152 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 53.9 m -88.84 123.4 33.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.9 p -125.87 133.66 51.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.201 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -88.8 107.97 19.25 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.331 -179.019 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 112.758 -0.137 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.846 HG13 HG21 ' A' ' 4' ' ' ILE . 3.7 t -86.0 120.69 72.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.028 0.414 . . . . 0.0 110.391 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HG3' HG23 ' A' ' 27' ' ' THR . 6.2 Cg_exo -78.41 52.29 4.07 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.946 2.431 . . . . 0.0 114.202 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.846 HG21 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -92.46 20.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.049 0.452 . . . . 0.0 110.911 178.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 10.9 m -89.11 -29.66 19.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.006 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.79 32.5 74.12 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.355 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.64 143.81 51.11 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.845 0.355 . . . . 0.0 110.997 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -97.93 129.2 44.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 8.8 t -98.5 34.39 2.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.036 0.446 . . . . 0.0 110.419 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -34.94 75.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.859 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.95 11.99 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.887 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.464 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 62.97 46.58 93.25 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.912 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 58.0 m -156.39 135.57 12.08 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.659 -0.318 . . . . 0.0 111.079 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 m -132.35 135.87 46.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -88.76 -25.51 22.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.75 0.31 . . . . 0.0 110.444 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.426 HG21 ' SG ' ' A' ' 19' ' ' CYS . 8.4 m -72.86 97.63 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.147 0.498 . . . . 0.0 110.672 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.7 126.35 23.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.794 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.77 -16.81 33.46 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.94 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' HG21 ' A' ' 16' ' ' THR . 99.2 m -88.96 132.25 34.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.022 0.439 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -89.2 157.73 18.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.776 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.7 t -89.05 129.8 35.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.292 0.568 . . . . 0.0 111.424 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -138.53 68.63 1.39 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.2 t90 -31.68 126.03 0.33 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.931 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.2 Cg_endo -99.94 34.23 8.28 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.144 -1.19 . . . . 0.0 113.883 0.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.46 146.22 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.743 -0.598 . . . . 0.0 111.936 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.5 m -89.26 126.09 35.36 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.475 HG23 ' HG3' ' A' ' 3' ' ' PRO . 77.2 p -117.97 131.22 56.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.206 0.527 . . . . 0.0 111.596 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.552 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 35.4 ttt85 -92.56 108.21 19.8 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.926 -178.506 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 112.688 -0.165 . . . . 0.0 112.688 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.531 HG11 HG21 ' A' ' 4' ' ' ILE . 17.4 t -90.13 117.94 68.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 117.023 0.412 . . . . 0.0 110.764 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 70.1 Cg_endo -74.9 51.57 2.78 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.854 2.37 . . . . 0.0 113.637 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.531 HG21 HG11 ' A' ' 2' ' ' VAL . 2.0 pp -91.83 26.58 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.023 0.44 . . . . 0.0 111.61 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 22.1 m -89.0 -26.19 21.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.781 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.61 33.8 67.24 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.256 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -131.03 142.55 50.33 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.149 0.499 . . . . 0.0 110.965 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -94.49 132.6 38.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.082 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 52.6 t -89.12 21.72 3.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.575 0.702 . . . . 0.0 109.428 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -60.47 -38.64 84.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.07 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.6 mt -92.4 5.22 51.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.408 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 62.08 41.1 99.68 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.263 -0.494 . . . . 0.0 112.876 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 91.7 m -158.31 134.12 9.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.738 0.304 . . . . 0.0 110.909 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 m -125.02 136.6 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.33 -25.59 22.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.816 0.341 . . . . 0.0 110.27 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.43 HG21 ' SG ' ' A' ' 19' ' ' CYS . 8.6 m -71.56 101.63 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.091 0.472 . . . . 0.0 110.365 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.1 24.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.905 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.5 -16.68 40.8 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.286 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' ' 16' ' ' THR . 88.9 m -87.76 136.5 32.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.137 0.494 . . . . 0.0 110.846 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -88.28 141.89 28.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.96 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.09 87.29 7.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.431 . . . . 0.0 110.187 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 p -100.45 85.22 2.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 21.5 t90 -37.03 127.59 0.78 Allowed Pre-proline 0 N--CA 1.462 0.152 0 O-C-N 123.998 0.811 . . . . 0.0 112.261 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 70.7 Cg_endo -102.23 33.81 7.59 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.372 -1.095 . . . . 0.0 114.148 0.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 26' ' ' CYS . 31.9 t -139.43 147.43 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 121.767 -0.583 . . . . 0.0 112.217 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.429 ' N ' HG12 ' A' ' 25' ' ' VAL . 64.9 m -88.96 120.41 30.35 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.672 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 9.4 p -106.93 138.79 42.43 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.684 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 10.7 tpt180 -111.04 110.58 21.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.701 -178.978 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 CA-C-O 120.327 -0.152 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.18 120.94 75.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 117.055 0.427 . . . . 0.0 110.505 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.88 52.23 4.15 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.018 2.479 . . . . 0.0 114.019 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.53 18.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.744 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.9 m -88.95 -37.96 14.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.762 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.73 42.82 95.06 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.4 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 26' ' ' CYS . 8.7 pt-20 -144.95 142.96 30.28 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.126 0.489 . . . . 0.0 110.957 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.3 p -98.57 131.23 44.95 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.697 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.798 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 28.5 p -103.3 56.47 0.75 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.237 0.541 . . . . 0.0 110.374 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 p -54.76 -41.0 69.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.572 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -93.15 22.68 4.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.226 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.27 45.58 96.19 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.955 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.5 m -149.11 132.28 16.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.525 -0.397 . . . . 0.0 111.058 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -110.07 140.29 44.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.032 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -89.56 -32.93 16.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.822 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.1 m -82.33 114.53 20.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.188 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.51 125.7 24.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.638 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.87 -17.26 38.81 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.827 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 72.4 m -88.83 129.78 35.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.135 0.493 . . . . 0.0 110.688 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 20.7 t -89.28 153.05 21.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.2 t -87.8 91.65 8.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.461 0.648 . . . . 0.0 111.915 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.5 m -89.94 63.94 6.15 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 t90 -25.46 124.65 0.2 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 114.076 -1.42 . . . . 0.0 113.412 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 76.6 Cg_endo -98.51 28.27 15.82 Favored 'Cis proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.928 -1.28 . . . . 0.0 114.083 0.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 26' ' ' CYS . 43.9 t -126.1 141.01 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 121.853 -0.529 . . . . 0.0 111.797 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.798 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 98.3 m -88.65 131.46 34.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.816 0.341 . . . . 0.0 110.782 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.6 p -124.5 131.19 53.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.579 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -89.19 109.23 20.13 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.443 -178.704 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 112.643 -0.183 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.474 HG11 ' HD2' ' A' ' 3' ' ' PRO . 16.5 t -81.12 125.72 78.85 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.121 0.486 . . . . 0.0 111.336 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.474 ' HD2' HG11 ' A' ' 2' ' ' VAL . 66.1 Cg_endo -74.7 71.72 4.68 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.928 2.419 . . . . 0.0 112.925 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.538 HD12 ' HD2' ' A' ' 28' ' ' ARG . 3.3 mt -87.27 -30.26 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.0 m -87.45 -39.56 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.421 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.37 31.53 79.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.606 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 34.1 mt-10 -89.07 153.06 21.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -89.95 129.57 36.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.166 0.507 . . . . 0.0 109.977 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 52.6 t -91.39 14.91 13.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.475 0.655 . . . . 0.0 109.764 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -61.21 -35.63 77.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.813 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.2 mt -84.84 -6.88 59.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.532 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.54 35.27 80.87 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.881 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.3 m -159.97 124.81 3.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.765 0.317 . . . . 0.0 111.027 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.5 m -99.73 138.29 37.03 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -89.02 -28.06 20.44 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.019 0.438 . . . . 0.0 110.316 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -86.68 103.85 15.53 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.483 0.658 . . . . 0.0 111.433 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.36 126.52 21.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.649 ' HA3' ' NH1' ' A' ' 28' ' ' ARG . . . 116.05 -27.37 8.23 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.734 -0.745 . . . . 0.0 111.8 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 1.7 m -88.42 134.23 33.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.105 0.479 . . . . 0.0 110.455 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 13.7 m -88.03 148.82 24.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.706 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 t -86.56 80.75 8.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.251 0.548 . . . . 0.0 110.087 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.5 m -89.94 74.65 7.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.561 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 19.6 t90 -33.63 126.97 0.44 Allowed Pre-proline 0 N--CA 1.464 0.258 0 O-C-N 124.122 0.889 . . . . 0.0 112.692 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.7 Cg_endo -99.46 33.97 8.68 Favored 'Cis proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.055 -1.227 . . . . 0.0 114.085 0.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 26' ' ' CYS . 48.2 t -137.53 140.63 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.474 0.654 . . . . 0.0 112.498 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.72 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 99.2 m -88.91 116.14 26.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 p -124.05 135.57 53.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.143 0.497 . . . . 0.0 111.384 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.649 ' NH1' ' HA3' ' A' ' 18' ' ' GLY . 61.3 ttm-85 -88.59 109.22 19.91 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.404 0.621 . . . . 0.0 109.546 -178.196 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 CA-C-O 120.377 -0.124 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.451 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 5.6 t -85.04 125.3 70.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.868 0.366 . . . . 0.0 110.316 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 3.0 Cg_exo -76.26 50.44 2.89 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.997 2.465 . . . . 0.0 114.598 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -94.68 32.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.309 0.576 . . . . 0.0 110.459 178.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.6 m -92.9 -39.54 11.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.369 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.9 36.09 53.05 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.293 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.642 ' OE2' HG21 ' A' ' 16' ' ' THR . 10.3 pt-20 -150.42 142.87 24.39 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.269 0.557 . . . . 0.0 110.442 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -89.62 133.16 34.76 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.676 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 11.9 t -91.78 41.66 1.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.185 0.517 . . . . 0.0 109.755 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.0 p -61.83 -37.79 85.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.022 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.94 -1.43 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.153 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 71.84 34.21 62.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.58 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 89.1 m -159.42 126.27 4.59 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.0 m -95.93 137.4 35.05 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -88.58 -28.59 20.62 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.991 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.642 HG21 ' OE2' ' A' ' 7' ' ' GLU . 10.8 t -84.59 111.91 19.96 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 122.344 1.069 . . . . 0.0 111.257 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.16 135.41 43.84 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.028 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.2 -22.44 37.88 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.399 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 65.3 m -88.85 132.78 34.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.407 0.622 . . . . 0.0 111.865 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m -89.32 151.57 22.02 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.247 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.3 t -88.78 110.73 21.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.263 0.554 . . . . 0.0 111.765 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 p -117.93 71.33 0.82 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 t90 -32.28 128.95 0.33 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.796 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.4 Cg_endo -99.45 30.83 11.8 Favored 'Cis proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.037 -1.235 . . . . 0.0 114.102 0.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 26' ' ' CYS . 37.4 t -132.44 147.41 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.838 -0.539 . . . . 0.0 111.433 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 88.3 m -90.53 133.64 34.93 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.108 -0.37 . . . . 0.0 110.211 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.4 p -123.79 131.55 53.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.101 0.477 . . . . 0.0 111.415 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 50.2 ttm-85 -93.0 109.96 21.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.426 -179.239 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-O 120.332 -0.149 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.68 HG12 HG21 ' A' ' 4' ' ' ILE . 10.5 t -90.99 123.41 64.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 117.181 0.491 . . . . 0.0 110.467 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HG3' HG23 ' A' ' 27' ' ' THR . 3.8 Cg_exo -74.29 53.07 2.91 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.002 2.468 . . . . 0.0 114.199 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.68 HG21 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.41 25.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.992 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 7.8 m -88.96 -32.8 17.48 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.48 42.22 95.9 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.713 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -150.23 147.12 27.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.113 0.483 . . . . 0.0 111.072 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.6 p -89.71 134.03 34.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.394 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.84 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 22.0 p -96.19 49.36 1.13 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.388 0.613 . . . . 0.0 111.284 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -60.54 136.3 58.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt 72.64 9.03 5.65 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.613 0.57 . . . . 0.0 111.133 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.19 56.44 5.21 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.718 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 10.0 t -150.41 142.48 24.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.065 0.459 . . . . 0.0 111.294 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.5 m -133.24 140.13 47.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.402 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -87.64 -31.61 19.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.034 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.538 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 8.4 m -78.65 112.92 16.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.623 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.31 125.86 25.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.646 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.76 52.04 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.37 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 90.0 m -88.16 128.48 35.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.148 0.499 . . . . 0.0 110.779 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 15.6 m -88.82 153.91 20.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.653 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.3 t -88.01 91.17 8.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.335 0.588 . . . . 0.0 112.086 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 m -93.96 62.93 3.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.8 t90 -27.88 127.96 0.21 Allowed Pre-proline 0 C--O 1.231 0.107 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.572 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 71.2 Cg_endo -96.48 26.34 19.96 Favored 'Cis proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.5 -1.458 . . . . 0.0 114.203 0.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG11 ' N ' ' A' ' 26' ' ' CYS . 38.2 t -124.19 144.83 32.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 121.793 -0.567 . . . . 0.0 112.377 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.84 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 70.9 m -87.71 130.76 34.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 110.206 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.547 HG23 ' HG3' ' A' ' 3' ' ' PRO . 24.3 p -112.67 130.49 56.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.108 0.48 . . . . 0.0 111.208 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.477 ' HB3' HD12 ' A' ' 4' ' ' ILE . 14.5 tpt180 -94.54 108.48 20.43 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.589 -179.311 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 112.917 -0.073 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.489 HG13 HG22 ' A' ' 4' ' ' ILE . 3.4 t -82.05 118.71 73.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 110.545 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 4.8 Cg_exo -79.52 51.71 3.99 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.075 2.517 . . . . 0.0 114.165 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.489 HG22 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -90.75 18.24 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.154 0.502 . . . . 0.0 110.659 178.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.2 m -89.52 -37.23 14.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.228 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.47 36.19 88.23 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.645 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.464 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 48.1 mt-10 -131.81 145.63 51.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.685 0.279 . . . . 0.0 111.208 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 p -89.56 132.4 35.1 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.71 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.3 p -101.09 53.65 0.84 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.581 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.6 p -61.88 122.12 14.62 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 11' ' ' LEU . 3.7 mm? 67.02 27.2 8.82 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.649 0.593 . . . . 0.0 110.828 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.32 44.87 89.71 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.585 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 26.9 m -118.88 128.5 54.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.987 0.394 . . . . 0.0 111.493 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.9 m -145.08 134.95 23.64 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.464 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 5.9 m-85 -89.64 -29.66 18.66 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.7 m -72.81 99.77 2.72 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.749 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.21 129.58 38.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.102 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA3' HH12 ' A' ' 28' ' ' ARG . . . 104.16 -16.51 49.62 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.245 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.04 128.88 35.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.002 0.429 . . . . 0.0 110.85 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -89.41 159.51 17.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.552 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.6 t -88.91 120.84 30.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.649 0.738 . . . . 0.0 111.756 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -123.98 63.84 1.06 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 11.9 t90 -26.1 125.99 0.2 Allowed Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 113.741 -1.572 . . . . 0.0 113.567 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 76.1 Cg_endo -98.04 29.41 14.61 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.7 -1.375 . . . . 0.0 114.328 0.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.69 147.82 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 55.5 m -87.97 130.98 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.2 p -125.96 132.33 52.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.172 0.511 . . . . 0.0 111.101 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.413 HH12 ' HA3' ' A' ' 18' ' ' GLY . 52.0 ttm-85 -90.35 107.77 19.35 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.24 0.543 . . . . 0.0 110.047 -178.6 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 120.171 -0.238 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.544 HG13 HD11 ' A' ' 4' ' ' ILE . 3.4 t -81.17 116.77 64.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 117.247 0.523 . . . . 0.0 110.476 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.3 Cg_exo -78.86 52.44 4.24 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.021 2.481 . . . . 0.0 114.376 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.544 HD11 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -95.33 16.99 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.79 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.0 m -88.75 -33.74 17.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.124 0.487 . . . . 0.0 109.783 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.29 31.03 73.8 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.666 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 99.3 mt-10 -120.2 144.19 47.85 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.843 0.354 . . . . 0.0 110.815 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -94.78 133.6 38.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.468 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.529 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 44.2 t -89.36 20.14 4.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.525 0.679 . . . . 0.0 109.845 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -62.6 -30.39 71.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.277 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.64 5.65 50.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.737 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.14 37.34 93.78 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.853 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.3 m -158.52 130.02 6.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.721 0.296 . . . . 0.0 110.791 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.8 m -109.36 139.47 44.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.42 -30.5 18.29 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.041 0.448 . . . . 0.0 109.846 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.1 m -78.82 108.56 12.35 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.43 0.633 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.28 137.87 46.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.79 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.71 -17.62 58.24 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.492 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -87.96 133.67 33.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.17 0.509 . . . . 0.0 110.349 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 12.7 m -88.01 147.81 24.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.87 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.35 82.27 7.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.178 0.513 . . . . 0.0 110.011 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 m -91.36 73.92 6.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.529 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 37.9 t90 -34.45 127.58 0.48 Allowed Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 123.975 0.797 . . . . 0.0 112.474 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 91.5 Cg_endo -98.69 33.35 9.49 Favored 'Cis proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.079 -1.217 . . . . 0.0 114.287 0.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -137.44 141.98 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 112.569 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 20' ' ' SER . 87.5 m -88.81 123.9 33.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.9 p -123.06 139.22 54.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.151 0.5 . . . . 0.0 112.128 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.42 ' HB3' HD13 ' A' ' 4' ' ' ILE . 16.0 tpp85 -88.22 98.91 11.83 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.438 -178.834 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.508 0 CA-C-O 120.188 -0.229 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.715 HG13 HD11 ' A' ' 4' ' ' ILE . 13.3 p -91.62 126.17 55.05 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 117.61 0.705 . . . . 0.0 111.319 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.83 54.08 4.95 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 123.027 2.485 . . . . 0.0 114.601 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.715 HD11 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -88.38 16.15 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.488 0.661 . . . . 0.0 110.09 178.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -89.06 -37.2 15.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.273 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.57 35.04 80.22 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.943 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -129.83 143.53 50.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.791 0.329 . . . . 0.0 110.671 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 p -104.21 130.93 51.99 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.603 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 29.3 p -107.1 58.95 0.63 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.366 0.603 . . . . 0.0 111.019 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -56.89 -39.49 74.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.139 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.62 20.41 9.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.859 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.76 48.01 84.55 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.989 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.2 m -149.2 135.94 19.59 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.575 -0.367 . . . . 0.0 110.722 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 59.9 m -130.0 137.53 50.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -89.64 -29.02 19.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.304 0.573 . . . . 0.0 109.738 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.528 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -69.74 107.15 3.36 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.713 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.57 135.84 56.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.06 -14.38 62.23 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.562 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 82.0 m -89.71 128.03 36.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.045 0.45 . . . . 0.0 111.015 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.6 t -89.44 153.4 20.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.329 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.7 t -88.67 88.69 7.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.248 0.547 . . . . 0.0 111.759 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 p -89.77 69.36 7.62 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 6.2 t90 -26.94 126.04 0.21 Allowed Pre-proline 0 N--CA 1.465 0.275 0 CA-C-N 113.872 -1.513 . . . . 0.0 113.518 -176.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 74.8 Cg_endo -99.9 29.35 13.24 Favored 'Cis proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.07 -1.221 . . . . 0.0 113.7 0.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 26' ' ' CYS . 41.2 t -125.6 143.56 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.031 -0.418 . . . . 0.0 111.813 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 60.9 m -89.09 127.22 35.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -127.18 130.15 49.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.098 0.475 . . . . 0.0 111.347 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.3 ttm180 -91.34 116.85 29.16 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.1 m120 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.888 -179.544 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.472 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.75 HG11 HG23 ' A' ' 4' ' ' ILE . 3.0 t -80.91 124.64 81.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.044 0.45 . . . . 0.0 110.813 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.481 ' HB3' HG23 ' A' ' 27' ' ' THR . 96.4 Cg_endo -80.81 50.77 3.68 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.727 2.284 . . . . 0.0 113.982 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.75 HG23 HG11 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -92.55 16.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.214 0.53 . . . . 0.0 110.69 178.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HB3' HG21 ' A' ' 16' ' ' THR . 8.9 m -89.34 -37.07 15.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.889 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.71 37.28 84.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.163 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -133.72 147.04 51.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.855 0.359 . . . . 0.0 110.613 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 p -102.39 130.83 49.25 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.475 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 11.1 t -95.61 40.61 1.11 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.115 0.483 . . . . 0.0 109.881 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.6 p -59.13 -42.58 90.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.58 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.7 mt -85.65 10.29 13.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.237 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.23 36.3 92.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.701 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -157.85 128.79 6.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.673 0.273 . . . . 0.0 110.58 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -107.63 140.04 41.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -88.38 -31.29 18.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.539 HG21 ' SG ' ' A' ' 19' ' ' CYS . 3.5 t -70.49 97.81 1.35 Allowed 'General case' 0 C--O 1.242 0.695 0 CA-C-O 122.04 0.924 . . . . 0.0 111.065 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.76 123.65 16.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.116 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.48 -22.6 14.92 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.041 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 85.8 m -88.37 139.27 30.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.088 0.471 . . . . 0.0 111.275 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.6 m -88.53 151.87 22.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.849 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.5 t -88.85 112.47 23.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 111.534 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.3 m -117.91 68.93 0.77 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 12.1 t90 -31.75 126.56 0.33 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.847 -177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.4 Cg_endo -99.56 32.24 10.23 Favored 'Cis proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.077 -1.218 . . . . 0.0 113.984 0.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG11 ' N ' ' A' ' 26' ' ' CYS . 44.7 t -129.78 142.38 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 121.799 -0.563 . . . . 0.0 111.862 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 77.5 m -89.54 124.73 34.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 3' ' ' PRO . 53.0 p -129.71 130.67 45.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.908 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.678 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 49.7 ttt180 -91.8 118.39 30.65 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.896 -178.979 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 120.371 -0.127 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.65 121.17 80.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.071 0.462 . . . . 0.0 110.709 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.25 52.16 4.21 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.691 2.261 . . . . 0.0 114.248 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -92.08 12.3 2.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.781 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -88.73 -36.66 16.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.164 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.75 33.06 83.07 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.147 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.33 144.87 48.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.798 0.332 . . . . 0.0 111.342 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -105.82 126.88 52.69 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.684 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 31.7 p -106.31 54.71 0.68 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.232 0.539 . . . . 0.0 111.104 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 p -57.05 -39.16 74.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.812 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -95.45 19.73 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.018 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.3 51.12 57.28 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.054 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.0 t -155.52 146.05 22.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.832 0.349 . . . . 0.0 111.329 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.2 m -140.82 139.65 34.55 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.46 -26.96 21.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.735 0.302 . . . . 0.0 110.326 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 m -73.83 106.31 5.5 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.176 0.512 . . . . 0.0 110.629 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.42 123.98 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.764 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.0 -17.57 32.09 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.11 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -88.13 130.11 35.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.112 0.482 . . . . 0.0 110.69 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.4 m -89.02 152.18 21.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.703 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.0 t -87.89 91.61 8.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.37 0.605 . . . . 0.0 111.407 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -89.66 64.07 6.42 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 6.6 t90 -25.42 124.28 0.2 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 114.017 -1.447 . . . . 0.0 113.543 -176.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.3 Cg_endo -99.25 30.38 12.52 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.085 -1.215 . . . . 0.0 113.819 0.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.14 140.25 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 O-C-N 122.015 -0.428 . . . . 0.0 111.952 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 62.9 m -87.82 126.61 35.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.2 p -129.18 132.57 47.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.088 0.471 . . . . 0.0 111.093 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 106.99 18.8 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.744 -177.847 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.415 ' CG1' HG23 ' A' ' 4' ' ' ILE . 3.0 t -82.21 121.01 78.39 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.058 0.456 . . . . 0.0 110.562 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.12 50.69 3.62 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.687 2.258 . . . . 0.0 114.308 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.455 HG23 HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -93.67 18.94 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.33 0.586 . . . . 0.0 110.322 178.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.7 m -89.74 -34.65 16.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.184 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.13 38.18 93.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.734 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.441 ' HG3' ' HG1' ' A' ' 16' ' ' THR . 1.4 mm-40 -130.54 152.79 49.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.96 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -107.91 130.06 55.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.045 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 16.6 t -100.04 34.29 2.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.298 0.57 . . . . 0.0 109.871 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -62.02 -30.07 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.439 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.37 15.87 20.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.946 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.16 36.76 93.87 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.535 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.2 m -157.22 135.29 11.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.5 m -112.66 133.77 54.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.587 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -88.17 -26.59 22.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.447 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.734 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -72.85 113.46 9.92 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.228 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.16 134.3 56.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.421 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.22 -4.27 77.43 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.353 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.734 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 88.4 m -92.04 135.01 34.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.342 0.571 . . . . 0.0 111.376 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 m -89.28 158.36 17.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.012 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -89.07 131.44 35.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.293 0.568 . . . . 0.0 111.518 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.0 m -140.91 63.41 1.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.4 t90 -29.18 126.63 0.24 Allowed Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 114.51 -1.223 . . . . 0.0 113.182 -177.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.4 Cg_endo -97.6 26.78 18.46 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.871 -1.304 . . . . 0.0 113.824 0.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 26' ' ' CYS . 38.4 t -125.05 147.23 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 121.997 -0.439 . . . . 0.0 111.972 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 77.8 m -94.51 128.46 41.11 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.5 p -126.15 132.57 51.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 0.0 111.25 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -89.87 112.5 23.87 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.171 -178.951 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 120.099 -0.278 . . . . 0.0 113.496 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 28' ' ' ARG . 7.7 p -93.13 118.71 67.85 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 117.599 0.7 . . . . 0.0 111.171 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 72.5 Cg_endo -75.45 50.86 2.77 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.102 2.535 . . . . 0.0 114.616 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -93.54 29.35 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.468 0.652 . . . . 0.0 110.563 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.438 ' HB3' HG23 ' A' ' 16' ' ' THR . 18.1 m -88.95 -31.57 18.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.73 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.05 32.81 56.01 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.202 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -134.1 142.82 47.66 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.047 0.451 . . . . 0.0 110.639 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.6 p -92.95 137.48 32.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 43.7 t -88.91 13.07 13.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.777 0.799 . . . . 0.0 109.572 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -62.9 -31.07 72.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.954 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.498 ' H ' HD13 ' A' ' 11' ' ' LEU . 6.4 mp -77.97 -7.41 56.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.882 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.39 32.25 62.55 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.884 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 t -175.85 149.64 0.95 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -122.52 138.69 54.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -88.67 -31.02 18.72 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.655 HG23 ' SG ' ' A' ' 19' ' ' CYS . 4.8 t -69.97 101.53 1.8 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.008 0.908 . . . . 0.0 111.027 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.29 135.37 44.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.316 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.95 -21.92 43.55 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.655 ' SG ' HG23 ' A' ' 16' ' ' THR . 71.0 m -89.3 135.59 33.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.178 0.513 . . . . 0.0 111.304 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 14.8 m -88.64 151.21 22.61 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.426 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.38 84.69 7.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.215 0.531 . . . . 0.0 110.157 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 m -94.49 75.46 3.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 12.3 t90 -35.22 127.39 0.55 Allowed Pre-proline 0 N--CA 1.464 0.267 0 O-C-N 124.042 0.839 . . . . 0.0 112.345 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 79.5 Cg_endo -100.0 37.04 6.25 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.174 -1.178 . . . . 0.0 114.369 1.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.46 HG21 ' N ' ' A' ' 26' ' ' CYS . 12.3 p -143.92 149.23 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.445 0.641 . . . . 0.0 112.445 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.46 ' N ' HG21 ' A' ' 25' ' ' VAL . 64.6 m -88.84 126.26 35.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 44.0 p -112.07 131.59 55.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.13 0.491 . . . . 0.0 112.147 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' O ' HG13 ' A' ' 2' ' ' VAL . 20.2 tpp85 -89.67 102.53 15.22 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.123 -179.492 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 120.31 -0.161 . . . . 0.0 112.97 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 3.6 t -85.61 121.19 73.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.088 0.444 . . . . 0.0 110.556 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.9 Cg_exo -77.93 53.52 4.46 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.019 2.479 . . . . 0.0 114.451 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -99.39 25.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.522 . . . . 0.0 110.832 178.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 11.2 m -88.85 -34.66 16.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.89 32.57 63.54 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.565 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -131.36 141.97 49.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 120.924 0.392 . . . . 0.0 111.012 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -103.13 128.6 50.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.614 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 32.1 p -103.61 53.74 0.75 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.367 0.604 . . . . 0.0 110.824 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -56.43 -39.29 72.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.363 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.442 ' N ' HD23 ' A' ' 11' ' ' LEU . 3.2 mm? -89.54 22.64 2.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.171 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.36 44.81 97.18 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.089 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.6 t -161.75 145.7 12.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 61.8 m -125.69 141.67 51.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.837 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.53 -31.71 18.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.578 HG21 ' SG ' ' A' ' 19' ' ' CYS . 4.5 t -71.12 100.13 1.99 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.027 0.918 . . . . 0.0 110.681 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 125.32 21.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.394 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.56 -24.42 17.6 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.318 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.578 ' SG ' HG21 ' A' ' 16' ' ' THR . 76.7 m -88.47 135.75 33.32 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 111.216 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 t -88.99 154.72 19.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.49 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -88.33 92.54 9.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.294 0.569 . . . . 0.0 112.002 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -92.39 64.07 4.29 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 176.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.7 t90 -24.6 123.73 0.19 Allowed Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.63 -176.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 84.5 Cg_endo -99.47 28.17 15.13 Favored 'Cis proline' 0 CA--C 1.537 0.631 0 C-N-CA 124.069 -1.221 . . . . 0.0 113.95 0.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.09 141.74 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 121.92 -0.488 . . . . 0.0 111.778 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 61.1 m -87.92 128.57 35.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.299 . . . . 0.0 110.224 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 49.3 p -116.11 132.65 56.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.142 0.496 . . . . 0.0 111.65 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.49 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 13.1 tpt180 -90.91 106.46 18.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.36 -179.055 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.626 -0.19 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.55 114.75 37.09 Favored Pre-proline 0 C--O 1.236 0.346 0 CA-C-O 121.312 0.577 . . . . 0.0 111.091 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.6 60.17 7.15 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.955 2.437 . . . . 0.0 113.656 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.94 -12.9 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.87 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.508 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 62.8 m -88.16 -43.34 11.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.339 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.35 21.62 70.51 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.6 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -89.61 146.99 24.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.717 0.258 . . . . 0.0 110.506 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -94.8 127.53 40.87 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 10.2 t -98.41 38.33 1.36 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.115 0.484 . . . . 0.0 110.395 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p -61.54 -37.87 85.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.989 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 11' ' ' LEU . 7.1 mp -87.44 7.48 28.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.114 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.52 94.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.792 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.5 m -157.65 132.59 8.7 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.827 -0.22 . . . . 0.0 110.693 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -119.25 134.74 55.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.9 -27.05 21.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.002 0.43 . . . . 0.0 110.609 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.508 ' HB ' ' SG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -77.78 104.6 8.42 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.363 0.602 . . . . 0.0 112.192 -179.244 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.66 131.91 50.36 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.529 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.32 -27.15 20.45 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.09 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.5 130.65 35.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.205 0.526 . . . . 0.0 110.648 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 16.0 t -88.68 162.46 16.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.849 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.0 t -87.59 83.29 7.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.288 0.566 . . . . 0.0 111.595 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.3 m -89.8 65.11 6.65 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.3 t90 -30.7 126.06 0.29 Allowed Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 114.662 -1.154 . . . . 0.0 112.867 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 87.1 Cg_endo -98.6 33.85 9.07 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.888 -1.297 . . . . 0.0 114.005 0.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 26' ' ' CYS . 44.2 t -132.56 140.62 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 112.1 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 62.5 m -89.46 120.68 31.0 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.8 p -132.44 138.69 47.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.849 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -88.61 99.37 12.27 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.167 -178.688 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 120.046 -0.308 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.687 HG12 HD12 ' A' ' 4' ' ' ILE . 14.7 p -89.68 125.97 59.4 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 117.654 0.727 . . . . 0.0 111.461 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.48 54.64 5.28 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.909 2.406 . . . . 0.0 114.508 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.687 HD12 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -88.27 15.0 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.416 0.627 . . . . 0.0 110.209 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.3 m -89.3 -36.61 15.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.428 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.54 34.56 73.62 Favored Glycine 0 C--O 1.227 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.223 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -130.47 143.06 50.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.825 0.345 . . . . 0.0 110.795 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.9 p -92.31 129.94 38.13 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.638 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.438 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 14.9 t -95.75 34.49 1.5 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.346 0.593 . . . . 0.0 110.109 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -63.43 -27.38 69.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.175 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.4 mt -95.9 13.31 27.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.082 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.44 45.17 96.45 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.583 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -167.33 151.77 6.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.696 0.284 . . . . 0.0 110.38 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -137.17 138.0 39.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -89.04 -28.14 20.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.133 0.492 . . . . 0.0 109.803 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.495 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -68.1 105.55 2.1 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.634 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.07 136.26 56.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.067 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.72 -11.48 66.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.848 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.495 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 95.1 m -88.94 132.1 34.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.107 0.48 . . . . 0.0 111.02 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 m -89.44 154.89 19.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.855 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.3 t -88.82 123.73 33.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.215 0.531 . . . . 0.0 111.028 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.9 t -131.38 67.47 1.51 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 21.5 t90 -31.33 128.18 0.29 Allowed Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.906 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 79.4 Cg_endo -97.93 32.69 10.39 Favored 'Cis proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.921 -1.283 . . . . 0.0 114.146 0.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 26' ' ' CYS . 14.5 p -135.67 146.91 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 121.66 -0.65 . . . . 0.0 112.139 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.438 ' N ' HG22 ' A' ' 25' ' ' VAL . 64.6 m -89.35 127.97 35.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.2 p -129.26 130.36 46.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.158 0.504 . . . . 0.0 111.142 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.513 ' O ' HG13 ' A' ' 2' ' ' VAL . 42.9 ttm180 -91.86 116.44 28.91 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.646 -179.188 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.5 t -85.97 117.53 68.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 117.125 0.462 . . . . 0.0 110.635 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.7 Cg_exo -75.16 51.14 2.76 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.138 2.558 . . . . 0.0 113.568 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pp -94.88 24.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.002 0.429 . . . . 0.0 111.391 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.63 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 20.5 m -88.69 -34.11 17.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.83 -5.59 46.55 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.887 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.485 ' OE1' HG23 ' A' ' 16' ' ' THR . 40.2 mt-10 -89.79 142.21 27.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.321 0.561 . . . . 0.0 110.726 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p -97.2 127.13 42.88 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.589 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 28.2 p -105.58 48.26 0.84 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.461 0.648 . . . . 0.0 110.73 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -61.25 -26.27 67.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.595 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -97.14 17.25 17.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.653 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.57 45.92 94.84 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.05 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -164.54 151.88 11.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.825 0.312 . . . . 0.0 111.031 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.6 m -132.61 142.15 49.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -88.28 -31.33 19.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.131 0.491 . . . . 0.0 109.705 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 5' ' ' CYS . 5.4 t -73.98 100.11 3.47 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.902 0.858 . . . . 0.0 110.482 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.47 125.08 18.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.103 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.46 -25.32 11.27 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.131 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' A' ' 16' ' ' THR . 96.7 m -87.84 132.64 34.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.175 0.512 . . . . 0.0 110.984 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.5 m -89.53 156.38 18.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.286 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.4 t -88.56 124.74 34.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.552 0.691 . . . . 0.0 111.331 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.8 m -128.68 67.25 1.4 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 4.0 t90 -24.32 122.93 0.19 Allowed Pre-proline 0 N--CA 1.463 0.194 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.581 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 68.1 Cg_endo -100.86 26.6 15.32 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.084 -1.215 . . . . 0.0 114.165 0.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.9 t -125.99 147.84 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.765 -0.584 . . . . 0.0 111.768 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.589 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 75.9 m -88.26 131.07 34.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.79 0.329 . . . . 0.0 110.243 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 30.7 p -110.09 136.94 48.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.153 0.501 . . . . 0.0 111.599 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.63 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 8.0 tpt180 -105.15 108.87 20.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.424 -179.202 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 120.233 -0.204 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 t -74.54 116.43 53.2 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 121.221 0.534 . . . . 0.0 110.825 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.96 57.78 6.42 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.789 2.326 . . . . 0.0 113.992 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.91 33.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.356 0.598 . . . . 0.0 110.778 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 91.1 m -141.48 -49.91 0.41 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.698 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.89 22.8 77.12 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.942 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.553 ' OE1' HG22 ' A' ' 16' ' ' THR . 42.7 mt-10 -89.06 145.53 25.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.004 0.402 . . . . 0.0 109.971 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.4 p -89.08 125.64 35.1 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 10.3 t -102.81 34.6 2.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.141 0.496 . . . . 0.0 109.953 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -34.56 75.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.096 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.507 ' N ' HD21 ' A' ' 11' ' ' LEU . 3.1 mm? -91.12 11.25 23.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.857 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.18 41.08 98.49 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.777 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.8 m -157.0 131.6 8.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.689 0.28 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.3 m -113.79 141.54 47.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -88.45 -31.36 18.83 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.713 HG21 ' HB2' ' A' ' 19' ' ' CYS . 3.4 t -71.9 99.08 2.14 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.985 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.16 64.32 0.1 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.989 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.52 -32.43 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.162 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.713 ' HB2' HG21 ' A' ' 16' ' ' THR . 2.1 m -89.42 145.98 24.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.861 0.362 . . . . 0.0 110.995 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -89.03 156.43 18.86 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.8 t -88.57 128.61 35.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.342 0.591 . . . . 0.0 111.168 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 m -137.3 72.5 1.42 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.7 t90 -30.93 125.5 0.31 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.871 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.4 Cg_endo -100.41 33.43 8.68 Favored 'Cis proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.15 -1.187 . . . . 0.0 113.961 0.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 26' ' ' CYS . 45.5 t -135.74 141.39 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 121.866 -0.521 . . . . 0.0 112.206 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 62.0 m -89.66 121.94 32.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.9 p -140.48 150.39 43.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.817 0.341 . . . . 0.0 110.407 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -96.18 101.51 13.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.351 -178.848 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 CA-C-O 120.368 -0.129 . . . . 0.0 112.817 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.622 HG13 HG21 ' A' ' 4' ' ' ILE . 4.4 t -80.42 124.21 82.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.75 52.67 4.4 Favored 'Trans proline' 0 CA--C 1.527 0.158 0 C-N-CA 122.709 2.272 . . . . 0.0 114.181 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.622 HG21 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -89.96 8.06 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.994 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.426 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 3.7 m -88.81 -36.01 16.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.109 0.481 . . . . 0.0 109.78 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.59 29.57 74.08 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.027 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 35.2 mt-10 -113.36 144.81 42.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.614 0.245 . . . . 0.0 110.604 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.4 p -91.22 129.19 37.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.332 -0.394 . . . . 0.0 109.939 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.449 ' O ' ' HD1' ' A' ' 23' ' ' TRP . 44.5 t -89.76 20.35 4.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.541 0.686 . . . . 0.0 109.661 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -58.93 -39.25 81.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.275 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.26 6.83 47.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.892 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.402 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 61.58 46.02 95.13 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.892 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 80.3 m -156.72 133.99 10.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.852 0.326 . . . . 0.0 111.152 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.8 m -126.4 136.77 53.1 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -88.34 -27.22 21.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.697 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.4 m -77.21 103.24 7.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.126 0.488 . . . . 0.0 110.753 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.35 122.93 13.73 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.334 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.94 -17.2 22.66 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.79 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 96.1 m -87.92 135.95 33.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.86 0.362 . . . . 0.0 110.378 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -88.28 143.6 26.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.826 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 t -87.61 81.54 7.69 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 m -89.97 76.5 7.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 26.9 t90 -34.89 127.07 0.52 Allowed Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 124.066 0.854 . . . . 0.0 112.382 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.1 Cg_endo -99.96 35.67 7.2 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.19 -1.171 . . . . 0.0 114.082 0.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.89 141.14 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.468 0.651 . . . . 0.0 112.445 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 93.0 m -88.52 116.16 26.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.1 p -121.98 132.61 54.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.003 0.43 . . . . 0.0 111.253 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 32.0 ttt85 -89.11 112.94 24.03 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 C--N 1.328 -0.368 0 O-C-N 123.564 0.54 . . . . 0.0 110.014 -178.82 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.505 0 N-CA-C 112.783 -0.127 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.885 HG11 HG21 ' A' ' 4' ' ' ILE . 3.3 t -81.59 119.15 74.79 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.94 0.4 . . . . 0.0 110.599 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.6 Cg_exo -79.33 51.49 3.89 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.118 2.545 . . . . 0.0 114.134 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.885 HG21 HG11 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.29 17.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.153 0.501 . . . . 0.0 110.617 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.2 m -89.45 -34.77 16.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.192 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.65 34.96 79.57 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.394 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -128.71 143.02 50.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.881 0.372 . . . . 0.0 111.34 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.4 p -97.19 127.11 42.86 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 7.6 t -99.74 35.66 1.96 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.977 0.418 . . . . 0.0 110.701 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -34.84 74.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.8 mt -98.44 14.23 28.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.416 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 63.44 49.33 70.88 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.918 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.2 m -155.68 134.96 12.29 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.667 -0.313 . . . . 0.0 111.062 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.5 m -137.45 135.02 36.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.87 -26.2 21.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.913 0.387 . . . . 0.0 110.306 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.425 HG22 ' SG ' ' A' ' 19' ' ' CYS . 5.3 m -73.25 97.33 2.42 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.23 0.538 . . . . 0.0 110.883 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.84 127.92 30.76 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.14 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.94 -16.11 39.74 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.075 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.425 ' SG ' HG22 ' A' ' 16' ' ' THR . 72.2 m -88.63 134.96 33.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.077 0.465 . . . . 0.0 110.808 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -88.49 155.31 19.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.099 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.0 t -87.99 84.63 6.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.071 0.462 . . . . 0.0 111.692 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 m -90.5 67.25 6.51 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 14.2 t90 -32.31 125.97 0.37 Allowed Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 124.461 1.101 . . . . 0.0 112.734 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.6 Cg_endo -99.44 36.33 6.87 Favored 'Cis proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.102 -1.207 . . . . 0.0 113.937 0.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.58 142.74 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 121.754 -0.591 . . . . 0.0 112.152 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 53.9 m -88.84 123.4 33.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.9 p -125.87 133.66 51.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.201 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -88.8 107.97 19.25 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.331 -179.019 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 112.758 -0.137 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.846 HG13 HG21 ' A' ' 4' ' ' ILE . 3.7 t -86.0 120.69 72.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.028 0.414 . . . . 0.0 110.391 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HG3' HG23 ' A' ' 27' ' ' THR . 6.2 Cg_exo -78.41 52.29 4.07 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.946 2.431 . . . . 0.0 114.202 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.846 HG21 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -92.46 20.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.049 0.452 . . . . 0.0 110.911 178.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 10.9 m -89.11 -29.66 19.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.006 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.79 32.5 74.12 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.355 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.64 143.81 51.11 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.845 0.355 . . . . 0.0 110.997 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -97.93 129.2 44.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 8.8 t -98.5 34.39 2.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.036 0.446 . . . . 0.0 110.419 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -34.94 75.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.859 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.95 11.99 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.887 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 62.97 46.58 93.25 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.912 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 58.0 m -156.39 135.57 12.08 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.659 -0.318 . . . . 0.0 111.079 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 m -132.35 135.87 46.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -88.76 -25.51 22.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.75 0.31 . . . . 0.0 110.444 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.426 HG21 ' SG ' ' A' ' 19' ' ' CYS . 8.4 m -72.86 97.63 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.147 0.498 . . . . 0.0 110.672 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.7 126.35 23.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.794 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.77 -16.81 33.46 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.94 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' HG21 ' A' ' 16' ' ' THR . 99.2 m -88.96 132.25 34.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.022 0.439 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -89.2 157.73 18.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.776 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.7 t -89.05 129.8 35.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.292 0.568 . . . . 0.0 111.424 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -138.53 68.63 1.39 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.2 t90 -31.68 126.03 0.33 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.931 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.2 Cg_endo -99.94 34.23 8.28 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.144 -1.19 . . . . 0.0 113.883 0.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.46 146.22 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.743 -0.598 . . . . 0.0 111.936 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.5 m -89.26 126.09 35.36 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.475 HG23 ' HG3' ' A' ' 3' ' ' PRO . 77.2 p -117.97 131.22 56.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.206 0.527 . . . . 0.0 111.596 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.552 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 35.4 ttt85 -92.56 108.21 19.8 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.926 -178.506 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 112.688 -0.165 . . . . 0.0 112.688 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.531 HG11 HG21 ' A' ' 4' ' ' ILE . 17.4 t -90.13 117.94 68.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 117.023 0.412 . . . . 0.0 110.764 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 70.1 Cg_endo -74.9 51.57 2.78 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.854 2.37 . . . . 0.0 113.637 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.531 HG21 HG11 ' A' ' 2' ' ' VAL . 2.0 pp -91.83 26.58 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.023 0.44 . . . . 0.0 111.61 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 22.1 m -89.0 -26.19 21.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.781 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.61 33.8 67.24 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.256 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -131.03 142.55 50.33 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.149 0.499 . . . . 0.0 110.965 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -94.49 132.6 38.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.082 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 52.6 t -89.12 21.72 3.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.575 0.702 . . . . 0.0 109.428 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -60.47 -38.64 84.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.07 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.6 mt -92.4 5.22 51.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 62.08 41.1 99.68 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.263 -0.494 . . . . 0.0 112.876 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 91.7 m -158.31 134.12 9.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.738 0.304 . . . . 0.0 110.909 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 m -125.02 136.6 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.33 -25.59 22.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.816 0.341 . . . . 0.0 110.27 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.43 HG21 ' SG ' ' A' ' 19' ' ' CYS . 8.6 m -71.56 101.63 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.091 0.472 . . . . 0.0 110.365 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.1 24.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.905 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.5 -16.68 40.8 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.286 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' ' 16' ' ' THR . 88.9 m -87.76 136.5 32.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.137 0.494 . . . . 0.0 110.846 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -88.28 141.89 28.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.96 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.09 87.29 7.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.431 . . . . 0.0 110.187 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 p -100.45 85.22 2.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 21.5 t90 -37.03 127.59 0.78 Allowed Pre-proline 0 N--CA 1.462 0.152 0 O-C-N 123.998 0.811 . . . . 0.0 112.261 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 70.7 Cg_endo -102.23 33.81 7.59 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.372 -1.095 . . . . 0.0 114.148 0.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 26' ' ' CYS . 31.9 t -139.43 147.43 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 121.767 -0.583 . . . . 0.0 112.217 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.429 ' N ' HG12 ' A' ' 25' ' ' VAL . 64.9 m -88.96 120.41 30.35 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.672 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 9.4 p -106.93 138.79 42.43 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.684 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 10.7 tpt180 -111.04 110.58 21.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.701 -178.978 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 CA-C-O 120.327 -0.152 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.18 120.94 75.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 117.055 0.427 . . . . 0.0 110.505 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.88 52.23 4.15 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.018 2.479 . . . . 0.0 114.019 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.53 18.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.744 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.9 m -88.95 -37.96 14.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.762 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.73 42.82 95.06 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.4 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 26' ' ' CYS . 8.7 pt-20 -144.95 142.96 30.28 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.126 0.489 . . . . 0.0 110.957 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.3 p -98.57 131.23 44.95 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.697 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.798 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 28.5 p -103.3 56.47 0.75 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.237 0.541 . . . . 0.0 110.374 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 p -54.76 -41.0 69.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.572 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -93.15 22.68 4.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.226 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.27 45.58 96.19 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.955 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.5 m -149.11 132.28 16.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.525 -0.397 . . . . 0.0 111.058 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -110.07 140.29 44.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.032 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -89.56 -32.93 16.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.822 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.1 m -82.33 114.53 20.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.188 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.51 125.7 24.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.638 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.87 -17.26 38.81 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.827 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 72.4 m -88.83 129.78 35.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.135 0.493 . . . . 0.0 110.688 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 20.7 t -89.28 153.05 21.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.2 t -87.8 91.65 8.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.461 0.648 . . . . 0.0 111.915 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.5 m -89.94 63.94 6.15 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 t90 -25.46 124.65 0.2 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 114.076 -1.42 . . . . 0.0 113.412 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 76.6 Cg_endo -98.51 28.27 15.82 Favored 'Cis proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.928 -1.28 . . . . 0.0 114.083 0.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.426 HG13 ' N ' ' A' ' 26' ' ' CYS . 43.9 t -126.1 141.01 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 121.853 -0.529 . . . . 0.0 111.797 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.798 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 98.3 m -88.65 131.46 34.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.816 0.341 . . . . 0.0 110.782 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.6 p -124.5 131.19 53.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.579 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -89.19 109.23 20.13 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.443 -178.704 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 112.643 -0.183 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.474 HG11 ' HD2' ' A' ' 3' ' ' PRO . 16.5 t -81.12 125.72 78.85 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.121 0.486 . . . . 0.0 111.336 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.474 ' HD2' HG11 ' A' ' 2' ' ' VAL . 66.1 Cg_endo -74.7 71.72 4.68 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.928 2.419 . . . . 0.0 112.925 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.538 HD12 ' HD2' ' A' ' 28' ' ' ARG . 3.3 mt -87.27 -30.26 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.0 m -87.45 -39.56 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.421 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.37 31.53 79.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.606 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.72 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 34.1 mt-10 -89.07 153.06 21.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -89.95 129.57 36.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.166 0.507 . . . . 0.0 109.977 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.561 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 52.6 t -91.39 14.91 13.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.475 0.655 . . . . 0.0 109.764 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -61.21 -35.63 77.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.813 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.2 mt -84.84 -6.88 59.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.532 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.54 35.27 80.87 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.881 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.3 m -159.97 124.81 3.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.765 0.317 . . . . 0.0 111.027 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.5 m -99.73 138.29 37.03 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -89.02 -28.06 20.44 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.019 0.438 . . . . 0.0 110.316 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -86.68 103.85 15.53 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.483 0.658 . . . . 0.0 111.433 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.36 126.52 21.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.649 ' HA3' ' NH1' ' A' ' 28' ' ' ARG . . . 116.05 -27.37 8.23 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.734 -0.745 . . . . 0.0 111.8 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 1.7 m -88.42 134.23 33.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.105 0.479 . . . . 0.0 110.455 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 13.7 m -88.03 148.82 24.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.706 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 t -86.56 80.75 8.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.251 0.548 . . . . 0.0 110.087 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.5 m -89.94 74.65 7.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.561 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 19.6 t90 -33.63 126.97 0.44 Allowed Pre-proline 0 N--CA 1.464 0.258 0 O-C-N 124.122 0.889 . . . . 0.0 112.692 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.7 Cg_endo -99.46 33.97 8.68 Favored 'Cis proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.055 -1.227 . . . . 0.0 114.085 0.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 26' ' ' CYS . 48.2 t -137.53 140.63 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.474 0.654 . . . . 0.0 112.498 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.72 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 99.2 m -88.91 116.14 26.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 p -124.05 135.57 53.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.143 0.497 . . . . 0.0 111.384 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.649 ' NH1' ' HA3' ' A' ' 18' ' ' GLY . 61.3 ttm-85 -88.59 109.22 19.91 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.404 0.621 . . . . 0.0 109.546 -178.196 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 CA-C-O 120.377 -0.124 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.451 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 5.6 t -85.04 125.3 70.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.868 0.366 . . . . 0.0 110.316 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 3.0 Cg_exo -76.26 50.44 2.89 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.997 2.465 . . . . 0.0 114.598 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -94.68 32.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.309 0.576 . . . . 0.0 110.459 178.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.6 m -92.9 -39.54 11.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.369 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.9 36.09 53.05 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.293 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.642 ' OE2' HG21 ' A' ' 16' ' ' THR . 10.3 pt-20 -150.42 142.87 24.39 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.269 0.557 . . . . 0.0 110.442 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -89.62 133.16 34.76 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.676 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 11.9 t -91.78 41.66 1.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.185 0.517 . . . . 0.0 109.755 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.0 p -61.83 -37.79 85.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.022 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.94 -1.43 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.153 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 71.84 34.21 62.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.58 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 89.1 m -159.42 126.27 4.59 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.0 m -95.93 137.4 35.05 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -88.58 -28.59 20.62 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.991 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.642 HG21 ' OE2' ' A' ' 7' ' ' GLU . 10.8 t -84.59 111.91 19.96 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 122.344 1.069 . . . . 0.0 111.257 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.16 135.41 43.84 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.028 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.2 -22.44 37.88 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.399 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 65.3 m -88.85 132.78 34.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.407 0.622 . . . . 0.0 111.865 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m -89.32 151.57 22.02 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.247 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.3 t -88.78 110.73 21.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.263 0.554 . . . . 0.0 111.765 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 p -117.93 71.33 0.82 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 t90 -32.28 128.95 0.33 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.796 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.4 Cg_endo -99.45 30.83 11.8 Favored 'Cis proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.037 -1.235 . . . . 0.0 114.102 0.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 26' ' ' CYS . 37.4 t -132.44 147.41 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.838 -0.539 . . . . 0.0 111.433 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 88.3 m -90.53 133.64 34.93 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.108 -0.37 . . . . 0.0 110.211 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.4 p -123.79 131.55 53.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.101 0.477 . . . . 0.0 111.415 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 50.2 ttm-85 -93.0 109.96 21.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.426 -179.239 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-O 120.332 -0.149 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.68 HG12 HG21 ' A' ' 4' ' ' ILE . 10.5 t -90.99 123.41 64.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 117.181 0.491 . . . . 0.0 110.467 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HG3' HG23 ' A' ' 27' ' ' THR . 3.8 Cg_exo -74.29 53.07 2.91 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.002 2.468 . . . . 0.0 114.199 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.68 HG21 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.41 25.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.992 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 7.8 m -88.96 -32.8 17.48 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.48 42.22 95.9 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.713 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -150.23 147.12 27.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.113 0.483 . . . . 0.0 111.072 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.6 p -89.71 134.03 34.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.394 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.84 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 22.0 p -96.19 49.36 1.13 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.388 0.613 . . . . 0.0 111.284 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -60.54 136.3 58.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt 72.64 9.03 5.65 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.613 0.57 . . . . 0.0 111.133 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.19 56.44 5.21 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.718 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 10.0 t -150.41 142.48 24.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.065 0.459 . . . . 0.0 111.294 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.5 m -133.24 140.13 47.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.402 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -87.64 -31.61 19.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.034 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.538 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 8.4 m -78.65 112.92 16.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.623 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.31 125.86 25.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.646 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.76 52.04 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.37 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 90.0 m -88.16 128.48 35.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.148 0.499 . . . . 0.0 110.779 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 15.6 m -88.82 153.91 20.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.653 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.3 t -88.01 91.17 8.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.335 0.588 . . . . 0.0 112.086 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 m -93.96 62.93 3.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.8 t90 -27.88 127.96 0.21 Allowed Pre-proline 0 C--O 1.231 0.107 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.572 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 71.2 Cg_endo -96.48 26.34 19.96 Favored 'Cis proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.5 -1.458 . . . . 0.0 114.203 0.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG11 ' N ' ' A' ' 26' ' ' CYS . 38.2 t -124.19 144.83 32.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 121.793 -0.567 . . . . 0.0 112.377 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.84 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 70.9 m -87.71 130.76 34.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 110.206 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.547 HG23 ' HG3' ' A' ' 3' ' ' PRO . 24.3 p -112.67 130.49 56.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.108 0.48 . . . . 0.0 111.208 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.477 ' HB3' HD12 ' A' ' 4' ' ' ILE . 14.5 tpt180 -94.54 108.48 20.43 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.589 -179.311 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 112.917 -0.073 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.489 HG13 HG22 ' A' ' 4' ' ' ILE . 3.4 t -82.05 118.71 73.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 110.545 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 4.8 Cg_exo -79.52 51.71 3.99 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.075 2.517 . . . . 0.0 114.165 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.489 HG22 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -90.75 18.24 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.154 0.502 . . . . 0.0 110.659 178.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.2 m -89.52 -37.23 14.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.228 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.47 36.19 88.23 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.645 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.464 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 48.1 mt-10 -131.81 145.63 51.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.685 0.279 . . . . 0.0 111.208 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 p -89.56 132.4 35.1 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.71 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.3 p -101.09 53.65 0.84 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.581 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.6 p -61.88 122.12 14.62 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 11' ' ' LEU . 3.7 mm? 67.02 27.2 8.82 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.649 0.593 . . . . 0.0 110.828 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.32 44.87 89.71 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.585 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 26.9 m -118.88 128.5 54.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.987 0.394 . . . . 0.0 111.493 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.9 m -145.08 134.95 23.64 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.464 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 5.9 m-85 -89.64 -29.66 18.66 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.7 m -72.81 99.77 2.72 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.749 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.21 129.58 38.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.102 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA3' HH12 ' A' ' 28' ' ' ARG . . . 104.16 -16.51 49.62 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.245 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.04 128.88 35.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.002 0.429 . . . . 0.0 110.85 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -89.41 159.51 17.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.552 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.6 t -88.91 120.84 30.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.649 0.738 . . . . 0.0 111.756 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -123.98 63.84 1.06 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 11.9 t90 -26.1 125.99 0.2 Allowed Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 113.741 -1.572 . . . . 0.0 113.567 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 76.1 Cg_endo -98.04 29.41 14.61 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.7 -1.375 . . . . 0.0 114.328 0.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.69 147.82 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 55.5 m -87.97 130.98 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.2 p -125.96 132.33 52.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.172 0.511 . . . . 0.0 111.101 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.413 HH12 ' HA3' ' A' ' 18' ' ' GLY . 52.0 ttm-85 -90.35 107.77 19.35 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.24 0.543 . . . . 0.0 110.047 -178.6 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 120.171 -0.238 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.544 HG13 HD11 ' A' ' 4' ' ' ILE . 3.4 t -81.17 116.77 64.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 117.247 0.523 . . . . 0.0 110.476 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.3 Cg_exo -78.86 52.44 4.24 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.021 2.481 . . . . 0.0 114.376 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.544 HD11 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -95.33 16.99 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.79 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.0 m -88.75 -33.74 17.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.124 0.487 . . . . 0.0 109.783 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.29 31.03 73.8 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.666 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 99.3 mt-10 -120.2 144.19 47.85 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.843 0.354 . . . . 0.0 110.815 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -94.78 133.6 38.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.468 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.529 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 44.2 t -89.36 20.14 4.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.525 0.679 . . . . 0.0 109.845 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -62.6 -30.39 71.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.277 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.64 5.65 50.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.737 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.14 37.34 93.78 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.853 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.3 m -158.52 130.02 6.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.721 0.296 . . . . 0.0 110.791 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.8 m -109.36 139.47 44.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.42 -30.5 18.29 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.041 0.448 . . . . 0.0 109.846 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.1 m -78.82 108.56 12.35 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.43 0.633 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.28 137.87 46.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.79 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.71 -17.62 58.24 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.492 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -87.96 133.67 33.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.17 0.509 . . . . 0.0 110.349 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 12.7 m -88.01 147.81 24.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.87 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.35 82.27 7.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.178 0.513 . . . . 0.0 110.011 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 m -91.36 73.92 6.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.529 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 37.9 t90 -34.45 127.58 0.48 Allowed Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 123.975 0.797 . . . . 0.0 112.474 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 91.5 Cg_endo -98.69 33.35 9.49 Favored 'Cis proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.079 -1.217 . . . . 0.0 114.287 0.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -137.44 141.98 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 112.569 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 20' ' ' SER . 87.5 m -88.81 123.9 33.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.9 p -123.06 139.22 54.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.151 0.5 . . . . 0.0 112.128 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.42 ' HB3' HD13 ' A' ' 4' ' ' ILE . 16.0 tpp85 -88.22 98.91 11.83 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.438 -178.834 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.508 0 CA-C-O 120.188 -0.229 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.715 HG13 HD11 ' A' ' 4' ' ' ILE . 13.3 p -91.62 126.17 55.05 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 117.61 0.705 . . . . 0.0 111.319 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.83 54.08 4.95 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 123.027 2.485 . . . . 0.0 114.601 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.715 HD11 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -88.38 16.15 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.488 0.661 . . . . 0.0 110.09 178.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -89.06 -37.2 15.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.273 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.57 35.04 80.22 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.943 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -129.83 143.53 50.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.791 0.329 . . . . 0.0 110.671 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 p -104.21 130.93 51.99 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.603 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 29.3 p -107.1 58.95 0.63 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.366 0.603 . . . . 0.0 111.019 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -56.89 -39.49 74.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.139 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.62 20.41 9.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.859 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.76 48.01 84.55 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.989 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.2 m -149.2 135.94 19.59 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.575 -0.367 . . . . 0.0 110.722 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 59.9 m -130.0 137.53 50.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -89.64 -29.02 19.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.304 0.573 . . . . 0.0 109.738 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.528 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -69.74 107.15 3.36 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.713 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.57 135.84 56.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.06 -14.38 62.23 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.562 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 82.0 m -89.71 128.03 36.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.045 0.45 . . . . 0.0 111.015 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.6 t -89.44 153.4 20.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.329 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.7 t -88.67 88.69 7.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.248 0.547 . . . . 0.0 111.759 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 p -89.77 69.36 7.62 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 6.2 t90 -26.94 126.04 0.21 Allowed Pre-proline 0 N--CA 1.465 0.275 0 CA-C-N 113.872 -1.513 . . . . 0.0 113.518 -176.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 74.8 Cg_endo -99.9 29.35 13.24 Favored 'Cis proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.07 -1.221 . . . . 0.0 113.7 0.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 26' ' ' CYS . 41.2 t -125.6 143.56 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.031 -0.418 . . . . 0.0 111.813 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 60.9 m -89.09 127.22 35.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.0 p -127.18 130.15 49.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.098 0.475 . . . . 0.0 111.347 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.3 ttm180 -91.34 116.85 29.16 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.1 m120 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.888 -179.544 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.472 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.75 HG11 HG23 ' A' ' 4' ' ' ILE . 3.0 t -80.91 124.64 81.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.044 0.45 . . . . 0.0 110.813 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.481 ' HB3' HG23 ' A' ' 27' ' ' THR . 96.4 Cg_endo -80.81 50.77 3.68 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.727 2.284 . . . . 0.0 113.982 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.75 HG23 HG11 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -92.55 16.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.214 0.53 . . . . 0.0 110.69 178.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HB3' HG21 ' A' ' 16' ' ' THR . 8.9 m -89.34 -37.07 15.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.889 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.71 37.28 84.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.163 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -133.72 147.04 51.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.855 0.359 . . . . 0.0 110.613 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 p -102.39 130.83 49.25 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.475 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 11.1 t -95.61 40.61 1.11 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.115 0.483 . . . . 0.0 109.881 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.6 p -59.13 -42.58 90.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.58 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.7 mt -85.65 10.29 13.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.237 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.23 36.3 92.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.701 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -157.85 128.79 6.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.673 0.273 . . . . 0.0 110.58 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -107.63 140.04 41.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -88.38 -31.29 18.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.539 HG21 ' SG ' ' A' ' 19' ' ' CYS . 3.5 t -70.49 97.81 1.35 Allowed 'General case' 0 C--O 1.242 0.695 0 CA-C-O 122.04 0.924 . . . . 0.0 111.065 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.76 123.65 16.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.116 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.48 -22.6 14.92 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.041 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 85.8 m -88.37 139.27 30.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.088 0.471 . . . . 0.0 111.275 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.6 m -88.53 151.87 22.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.849 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.5 t -88.85 112.47 23.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 111.534 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.3 m -117.91 68.93 0.77 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 12.1 t90 -31.75 126.56 0.33 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.847 -177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.4 Cg_endo -99.56 32.24 10.23 Favored 'Cis proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.077 -1.218 . . . . 0.0 113.984 0.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG11 ' N ' ' A' ' 26' ' ' CYS . 44.7 t -129.78 142.38 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 121.799 -0.563 . . . . 0.0 111.862 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 77.5 m -89.54 124.73 34.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 3' ' ' PRO . 53.0 p -129.71 130.67 45.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.908 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.678 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 49.7 ttt180 -91.8 118.39 30.65 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.896 -178.979 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 120.371 -0.127 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.65 121.17 80.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.071 0.462 . . . . 0.0 110.709 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.25 52.16 4.21 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.691 2.261 . . . . 0.0 114.248 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -92.08 12.3 2.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.781 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -88.73 -36.66 16.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.164 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.75 33.06 83.07 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.147 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.33 144.87 48.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.798 0.332 . . . . 0.0 111.342 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -105.82 126.88 52.69 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.684 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 31.7 p -106.31 54.71 0.68 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.232 0.539 . . . . 0.0 111.104 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 p -57.05 -39.16 74.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.812 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -95.45 19.73 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.018 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.3 51.12 57.28 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.054 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.0 t -155.52 146.05 22.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.832 0.349 . . . . 0.0 111.329 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.2 m -140.82 139.65 34.55 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.46 -26.96 21.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.735 0.302 . . . . 0.0 110.326 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 m -73.83 106.31 5.5 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.176 0.512 . . . . 0.0 110.629 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.42 123.98 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.764 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.0 -17.57 32.09 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.11 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -88.13 130.11 35.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.112 0.482 . . . . 0.0 110.69 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.4 m -89.02 152.18 21.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.703 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.0 t -87.89 91.61 8.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.37 0.605 . . . . 0.0 111.407 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -89.66 64.07 6.42 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 6.6 t90 -25.42 124.28 0.2 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 114.017 -1.447 . . . . 0.0 113.543 -176.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.3 Cg_endo -99.25 30.38 12.52 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.085 -1.215 . . . . 0.0 113.819 0.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.14 140.25 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 O-C-N 122.015 -0.428 . . . . 0.0 111.952 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 62.9 m -87.82 126.61 35.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.2 p -129.18 132.57 47.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.088 0.471 . . . . 0.0 111.093 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 106.99 18.8 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.744 -177.847 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.415 ' CG1' HG23 ' A' ' 4' ' ' ILE . 3.0 t -82.21 121.01 78.39 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.058 0.456 . . . . 0.0 110.562 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.12 50.69 3.62 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.687 2.258 . . . . 0.0 114.308 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.455 HG23 HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -93.67 18.94 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.33 0.586 . . . . 0.0 110.322 178.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.7 m -89.74 -34.65 16.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.184 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.13 38.18 93.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.734 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.441 ' HG3' ' HG1' ' A' ' 16' ' ' THR . 1.4 mm-40 -130.54 152.79 49.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.96 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -107.91 130.06 55.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.045 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 16.6 t -100.04 34.29 2.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.298 0.57 . . . . 0.0 109.871 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -62.02 -30.07 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.439 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.4 mt -96.37 15.87 20.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.946 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.16 36.76 93.87 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.535 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.2 m -157.22 135.29 11.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.5 m -112.66 133.77 54.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.587 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -88.17 -26.59 22.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.447 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.734 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -72.85 113.46 9.92 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.228 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.16 134.3 56.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.421 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.22 -4.27 77.43 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.353 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.734 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 88.4 m -92.04 135.01 34.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.342 0.571 . . . . 0.0 111.376 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 m -89.28 158.36 17.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.012 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -89.07 131.44 35.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.293 0.568 . . . . 0.0 111.518 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.0 m -140.91 63.41 1.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.4 t90 -29.18 126.63 0.24 Allowed Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 114.51 -1.223 . . . . 0.0 113.182 -177.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.4 Cg_endo -97.6 26.78 18.46 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.871 -1.304 . . . . 0.0 113.824 0.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 26' ' ' CYS . 38.4 t -125.05 147.23 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 121.997 -0.439 . . . . 0.0 111.972 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 77.8 m -94.51 128.46 41.11 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.5 p -126.15 132.57 51.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 0.0 111.25 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -89.87 112.5 23.87 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.171 -178.951 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 120.099 -0.278 . . . . 0.0 113.496 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 28' ' ' ARG . 7.7 p -93.13 118.71 67.85 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 117.599 0.7 . . . . 0.0 111.171 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 72.5 Cg_endo -75.45 50.86 2.77 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.102 2.535 . . . . 0.0 114.616 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -93.54 29.35 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.468 0.652 . . . . 0.0 110.563 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.438 ' HB3' HG23 ' A' ' 16' ' ' THR . 18.1 m -88.95 -31.57 18.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.73 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.05 32.81 56.01 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.202 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -134.1 142.82 47.66 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.047 0.451 . . . . 0.0 110.639 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.6 p -92.95 137.48 32.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 43.7 t -88.91 13.07 13.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.777 0.799 . . . . 0.0 109.572 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -62.9 -31.07 72.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.954 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.498 ' H ' HD13 ' A' ' 11' ' ' LEU . 6.4 mp -77.97 -7.41 56.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.882 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.39 32.25 62.55 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.884 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 t -175.85 149.64 0.95 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -122.52 138.69 54.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -88.67 -31.02 18.72 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.655 HG23 ' SG ' ' A' ' 19' ' ' CYS . 4.8 t -69.97 101.53 1.8 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.008 0.908 . . . . 0.0 111.027 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.29 135.37 44.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.316 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.95 -21.92 43.55 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.655 ' SG ' HG23 ' A' ' 16' ' ' THR . 71.0 m -89.3 135.59 33.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.178 0.513 . . . . 0.0 111.304 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 14.8 m -88.64 151.21 22.61 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.426 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.38 84.69 7.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.215 0.531 . . . . 0.0 110.157 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 m -94.49 75.46 3.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 12.3 t90 -35.22 127.39 0.55 Allowed Pre-proline 0 N--CA 1.464 0.267 0 O-C-N 124.042 0.839 . . . . 0.0 112.345 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 79.5 Cg_endo -100.0 37.04 6.25 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.174 -1.178 . . . . 0.0 114.369 1.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.46 HG21 ' N ' ' A' ' 26' ' ' CYS . 12.3 p -143.92 149.23 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.445 0.641 . . . . 0.0 112.445 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.46 ' N ' HG21 ' A' ' 25' ' ' VAL . 64.6 m -88.84 126.26 35.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 44.0 p -112.07 131.59 55.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.13 0.491 . . . . 0.0 112.147 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' O ' HG13 ' A' ' 2' ' ' VAL . 20.2 tpp85 -89.67 102.53 15.22 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.123 -179.492 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 120.31 -0.161 . . . . 0.0 112.97 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 3.6 t -85.61 121.19 73.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.088 0.444 . . . . 0.0 110.556 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.9 Cg_exo -77.93 53.52 4.46 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.019 2.479 . . . . 0.0 114.451 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -99.39 25.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.522 . . . . 0.0 110.832 178.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 11.2 m -88.85 -34.66 16.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.89 32.57 63.54 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.565 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -131.36 141.97 49.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 120.924 0.392 . . . . 0.0 111.012 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -103.13 128.6 50.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.614 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 32.1 p -103.61 53.74 0.75 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.367 0.604 . . . . 0.0 110.824 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -56.43 -39.29 72.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.363 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.442 ' N ' HD23 ' A' ' 11' ' ' LEU . 3.2 mm? -89.54 22.64 2.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.171 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.36 44.81 97.18 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.089 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.6 t -161.75 145.7 12.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 61.8 m -125.69 141.67 51.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.837 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.53 -31.71 18.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.578 HG21 ' SG ' ' A' ' 19' ' ' CYS . 4.5 t -71.12 100.13 1.99 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.027 0.918 . . . . 0.0 110.681 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 125.32 21.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.394 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.56 -24.42 17.6 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.318 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.578 ' SG ' HG21 ' A' ' 16' ' ' THR . 76.7 m -88.47 135.75 33.32 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 111.216 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 t -88.99 154.72 19.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.49 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -88.33 92.54 9.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.294 0.569 . . . . 0.0 112.002 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -92.39 64.07 4.29 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 176.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.7 t90 -24.6 123.73 0.19 Allowed Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.63 -176.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 84.5 Cg_endo -99.47 28.17 15.13 Favored 'Cis proline' 0 CA--C 1.537 0.631 0 C-N-CA 124.069 -1.221 . . . . 0.0 113.95 0.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.09 141.74 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 121.92 -0.488 . . . . 0.0 111.778 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 61.1 m -87.92 128.57 35.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.299 . . . . 0.0 110.224 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 49.3 p -116.11 132.65 56.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.142 0.496 . . . . 0.0 111.65 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.49 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 13.1 tpt180 -90.91 106.46 18.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.36 -179.055 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.626 -0.19 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.55 114.75 37.09 Favored Pre-proline 0 C--O 1.236 0.346 0 CA-C-O 121.312 0.577 . . . . 0.0 111.091 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.6 60.17 7.15 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.955 2.437 . . . . 0.0 113.656 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.94 -12.9 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.87 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.508 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 62.8 m -88.16 -43.34 11.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.339 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.35 21.62 70.51 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.6 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -89.61 146.99 24.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.717 0.258 . . . . 0.0 110.506 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -94.8 127.53 40.87 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 10.2 t -98.41 38.33 1.36 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.115 0.484 . . . . 0.0 110.395 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p -61.54 -37.87 85.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.989 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 11' ' ' LEU . 7.1 mp -87.44 7.48 28.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.114 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.52 94.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.792 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.5 m -157.65 132.59 8.7 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.827 -0.22 . . . . 0.0 110.693 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -119.25 134.74 55.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.9 -27.05 21.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.002 0.43 . . . . 0.0 110.609 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.508 ' HB ' ' SG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -77.78 104.6 8.42 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.363 0.602 . . . . 0.0 112.192 -179.244 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.66 131.91 50.36 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.529 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.32 -27.15 20.45 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.09 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.5 130.65 35.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.205 0.526 . . . . 0.0 110.648 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 16.0 t -88.68 162.46 16.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.849 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.0 t -87.59 83.29 7.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.288 0.566 . . . . 0.0 111.595 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.3 m -89.8 65.11 6.65 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.3 t90 -30.7 126.06 0.29 Allowed Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 114.662 -1.154 . . . . 0.0 112.867 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 87.1 Cg_endo -98.6 33.85 9.07 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.888 -1.297 . . . . 0.0 114.005 0.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 26' ' ' CYS . 44.2 t -132.56 140.62 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 112.1 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 62.5 m -89.46 120.68 31.0 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.8 p -132.44 138.69 47.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.849 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -88.61 99.37 12.27 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.167 -178.688 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 120.046 -0.308 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.687 HG12 HD12 ' A' ' 4' ' ' ILE . 14.7 p -89.68 125.97 59.4 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 117.654 0.727 . . . . 0.0 111.461 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.48 54.64 5.28 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.909 2.406 . . . . 0.0 114.508 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.687 HD12 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -88.27 15.0 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.416 0.627 . . . . 0.0 110.209 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.3 m -89.3 -36.61 15.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.428 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.54 34.56 73.62 Favored Glycine 0 C--O 1.227 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.223 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -130.47 143.06 50.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.825 0.345 . . . . 0.0 110.795 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.9 p -92.31 129.94 38.13 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.638 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.438 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 14.9 t -95.75 34.49 1.5 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.346 0.593 . . . . 0.0 110.109 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -63.43 -27.38 69.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.175 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.4 mt -95.9 13.31 27.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.082 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.44 45.17 96.45 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.583 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -167.33 151.77 6.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.696 0.284 . . . . 0.0 110.38 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -137.17 138.0 39.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -89.04 -28.14 20.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.133 0.492 . . . . 0.0 109.803 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.495 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -68.1 105.55 2.1 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.634 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.07 136.26 56.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.067 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.72 -11.48 66.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.848 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.495 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 95.1 m -88.94 132.1 34.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.107 0.48 . . . . 0.0 111.02 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 m -89.44 154.89 19.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.855 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.3 t -88.82 123.73 33.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.215 0.531 . . . . 0.0 111.028 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.9 t -131.38 67.47 1.51 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 21.5 t90 -31.33 128.18 0.29 Allowed Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.906 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 79.4 Cg_endo -97.93 32.69 10.39 Favored 'Cis proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.921 -1.283 . . . . 0.0 114.146 0.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 26' ' ' CYS . 14.5 p -135.67 146.91 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 121.66 -0.65 . . . . 0.0 112.139 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.438 ' N ' HG22 ' A' ' 25' ' ' VAL . 64.6 m -89.35 127.97 35.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.2 p -129.26 130.36 46.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.158 0.504 . . . . 0.0 111.142 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.513 ' O ' HG13 ' A' ' 2' ' ' VAL . 42.9 ttm180 -91.86 116.44 28.91 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.646 -179.188 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.5 t -85.97 117.53 68.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 117.125 0.462 . . . . 0.0 110.635 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.7 Cg_exo -75.16 51.14 2.76 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.138 2.558 . . . . 0.0 113.568 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pp -94.88 24.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.002 0.429 . . . . 0.0 111.391 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.63 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 20.5 m -88.69 -34.11 17.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.83 -5.59 46.55 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.887 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.485 ' OE1' HG23 ' A' ' 16' ' ' THR . 40.2 mt-10 -89.79 142.21 27.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.321 0.561 . . . . 0.0 110.726 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p -97.2 127.13 42.88 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.589 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 28.2 p -105.58 48.26 0.84 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.461 0.648 . . . . 0.0 110.73 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -61.25 -26.27 67.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.595 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -97.14 17.25 17.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.653 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.57 45.92 94.84 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.05 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -164.54 151.88 11.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.825 0.312 . . . . 0.0 111.031 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.6 m -132.61 142.15 49.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -88.28 -31.33 19.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.131 0.491 . . . . 0.0 109.705 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 5' ' ' CYS . 5.4 t -73.98 100.11 3.47 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.902 0.858 . . . . 0.0 110.482 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.47 125.08 18.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.103 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.46 -25.32 11.27 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.131 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' A' ' 16' ' ' THR . 96.7 m -87.84 132.64 34.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.175 0.512 . . . . 0.0 110.984 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.5 m -89.53 156.38 18.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.286 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.4 t -88.56 124.74 34.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.552 0.691 . . . . 0.0 111.331 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.8 m -128.68 67.25 1.4 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 4.0 t90 -24.32 122.93 0.19 Allowed Pre-proline 0 N--CA 1.463 0.194 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.581 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 68.1 Cg_endo -100.86 26.6 15.32 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.084 -1.215 . . . . 0.0 114.165 0.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.9 t -125.99 147.84 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.765 -0.584 . . . . 0.0 111.768 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.589 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 75.9 m -88.26 131.07 34.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.79 0.329 . . . . 0.0 110.243 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 30.7 p -110.09 136.94 48.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.153 0.501 . . . . 0.0 111.599 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.63 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 8.0 tpt180 -105.15 108.87 20.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.424 -179.202 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 120.233 -0.204 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.6 t -74.54 116.43 53.2 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 121.221 0.534 . . . . 0.0 110.825 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.96 57.78 6.42 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.789 2.326 . . . . 0.0 113.992 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.91 33.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.356 0.598 . . . . 0.0 110.778 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 91.1 m -141.48 -49.91 0.41 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.698 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.89 22.8 77.12 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.942 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.553 ' OE1' HG22 ' A' ' 16' ' ' THR . 42.7 mt-10 -89.06 145.53 25.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.004 0.402 . . . . 0.0 109.971 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.4 p -89.08 125.64 35.1 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.644 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 10.3 t -102.81 34.6 2.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.141 0.496 . . . . 0.0 109.953 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -34.56 75.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.096 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' N ' HD21 ' A' ' 11' ' ' LEU . 3.1 mm? -91.12 11.25 23.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.857 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.18 41.08 98.49 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.777 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.8 m -157.0 131.6 8.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.689 0.28 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.3 m -113.79 141.54 47.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -88.45 -31.36 18.83 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.713 HG21 ' HB2' ' A' ' 19' ' ' CYS . 3.4 t -71.9 99.08 2.14 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.985 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.16 64.32 0.1 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.989 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.52 -32.43 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.162 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.713 ' HB2' HG21 ' A' ' 16' ' ' THR . 2.1 m -89.42 145.98 24.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.861 0.362 . . . . 0.0 110.995 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -89.03 156.43 18.86 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.8 t -88.57 128.61 35.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.342 0.591 . . . . 0.0 111.168 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 m -137.3 72.5 1.42 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.7 t90 -30.93 125.5 0.31 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.871 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.4 Cg_endo -100.41 33.43 8.68 Favored 'Cis proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.15 -1.187 . . . . 0.0 113.961 0.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 26' ' ' CYS . 45.5 t -135.74 141.39 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 121.866 -0.521 . . . . 0.0 112.206 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 62.0 m -89.66 121.94 32.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.9 p -140.48 150.39 43.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.817 0.341 . . . . 0.0 110.407 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 tpt85 -96.18 101.51 13.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.351 -178.848 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 CA-C-O 120.368 -0.129 . . . . 0.0 112.817 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.624 HG12 HG23 ' A' ' 4' ' ' ILE . 4.4 t -80.42 124.21 82.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 27' ' ' THR . 88.7 Cg_endo -79.75 52.67 4.4 Favored 'Trans proline' 0 CA--C 1.527 0.158 0 C-N-CA 122.709 2.272 . . . . 0.0 114.181 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -89.96 8.06 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.994 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 3.7 m -88.81 -36.01 16.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.109 0.481 . . . . 0.0 109.78 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.59 29.57 74.08 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.027 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 35.2 mt-10 -113.36 144.81 42.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.614 0.245 . . . . 0.0 110.604 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.4 p -91.22 129.19 37.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.332 -0.394 . . . . 0.0 109.939 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.454 ' O ' ' HD1' ' A' ' 23' ' ' TRP . 44.5 t -89.76 20.35 4.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.541 0.686 . . . . 0.0 109.661 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -58.93 -39.25 81.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.275 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.26 6.83 47.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.892 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.58 46.02 95.13 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.892 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 m -156.72 133.99 10.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.852 0.326 . . . . 0.0 111.152 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.8 m -126.4 136.77 53.1 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -88.34 -27.22 21.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.697 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.4 m -77.21 103.24 7.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.126 0.488 . . . . 0.0 110.753 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.35 122.93 13.73 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.334 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.94 -17.2 22.66 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.79 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 96.1 m -87.92 135.95 33.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.86 0.362 . . . . 0.0 110.378 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -88.28 143.6 26.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.826 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 t -87.61 81.54 7.69 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 m -89.97 76.5 7.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 26.9 t90 -34.89 127.07 0.52 Allowed Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 124.066 0.854 . . . . 0.0 112.382 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.1 Cg_endo -99.96 35.67 7.2 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.19 -1.171 . . . . 0.0 114.082 0.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.89 141.14 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.468 0.651 . . . . 0.0 112.445 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 93.0 m -88.52 116.16 26.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 3' ' ' PRO . 23.1 p -121.98 132.61 54.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.003 0.43 . . . . 0.0 111.253 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.663 ' HB3' HD11 ' A' ' 4' ' ' ILE . 32.0 ttt85 -89.11 112.94 24.03 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 C--N 1.328 -0.368 0 O-C-N 123.564 0.54 . . . . 0.0 110.014 -178.82 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.505 0 N-CA-C 112.783 -0.127 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.711 HG12 HG23 ' A' ' 4' ' ' ILE . 3.3 t -81.59 119.15 74.79 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.94 0.4 . . . . 0.0 110.599 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.6 Cg_exo -79.33 51.49 3.89 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.118 2.545 . . . . 0.0 114.134 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.711 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.29 17.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.153 0.501 . . . . 0.0 110.617 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.2 m -89.45 -34.77 16.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.192 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.65 34.96 79.57 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.394 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -128.71 143.02 50.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.881 0.372 . . . . 0.0 111.34 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.4 p -97.19 127.11 42.86 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 7.6 t -99.74 35.66 1.96 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.977 0.418 . . . . 0.0 110.701 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -34.84 74.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.8 mt -98.44 14.23 28.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.41 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 63.44 49.33 70.88 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.918 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.2 m -155.68 134.96 12.29 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.667 -0.313 . . . . 0.0 111.062 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.5 m -137.45 135.02 36.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.87 -26.2 21.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.913 0.387 . . . . 0.0 110.306 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 m -73.25 97.33 2.42 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.23 0.538 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.84 127.92 30.76 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.14 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.407 ' HA3' HH12 ' A' ' 28' ' ' ARG . . . 106.94 -16.11 39.74 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.075 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.2 m -88.63 134.96 33.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.077 0.465 . . . . 0.0 110.808 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -88.49 155.31 19.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.099 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.0 t -87.99 84.63 6.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.071 0.462 . . . . 0.0 111.692 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 m -90.5 67.25 6.51 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 14.2 t90 -32.31 125.97 0.37 Allowed Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 124.461 1.101 . . . . 0.0 112.734 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.6 Cg_endo -99.44 36.33 6.87 Favored 'Cis proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.102 -1.207 . . . . 0.0 113.937 0.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.58 142.74 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 121.754 -0.591 . . . . 0.0 112.152 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 53.9 m -88.84 123.4 33.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.9 p -125.87 133.66 51.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.201 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HB3' HD11 ' A' ' 4' ' ' ILE . 51.7 ttm-85 -88.8 107.97 19.25 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.331 -179.019 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 112.758 -0.137 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.692 HG12 HG23 ' A' ' 4' ' ' ILE . 3.7 t -86.0 120.69 72.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.028 0.414 . . . . 0.0 110.391 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.2 Cg_exo -78.41 52.29 4.07 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.946 2.431 . . . . 0.0 114.202 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.703 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -92.46 20.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.049 0.452 . . . . 0.0 110.911 178.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 10.9 m -89.11 -29.66 19.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.006 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.79 32.5 74.12 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.355 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.64 143.81 51.11 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.845 0.355 . . . . 0.0 110.997 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -97.93 129.2 44.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 8.8 t -98.5 34.39 2.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.036 0.446 . . . . 0.0 110.419 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -34.94 75.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.859 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.95 11.99 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.887 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.46 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 62.97 46.58 93.25 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.912 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m -156.39 135.57 12.08 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.659 -0.318 . . . . 0.0 111.079 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 m -132.35 135.87 46.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -88.76 -25.51 22.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.75 0.31 . . . . 0.0 110.444 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -72.86 97.63 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.147 0.498 . . . . 0.0 110.672 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.7 126.35 23.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.794 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.77 -16.81 33.46 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.94 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.2 m -88.96 132.25 34.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.022 0.439 . . . . 0.0 110.738 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -89.2 157.73 18.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.776 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.7 t -89.05 129.8 35.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.292 0.568 . . . . 0.0 111.424 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -138.53 68.63 1.39 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.2 t90 -31.68 126.03 0.33 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.931 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.2 Cg_endo -99.94 34.23 8.28 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.144 -1.19 . . . . 0.0 113.883 0.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.46 146.22 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.743 -0.598 . . . . 0.0 111.936 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.5 m -89.26 126.09 35.36 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 77.2 p -117.97 131.22 56.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.206 0.527 . . . . 0.0 111.596 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.561 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 35.4 ttt85 -92.56 108.21 19.8 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.926 -178.506 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 112.688 -0.165 . . . . 0.0 112.688 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.4 t -90.13 117.94 68.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 117.023 0.412 . . . . 0.0 110.764 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 70.1 Cg_endo -74.9 51.57 2.78 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.854 2.37 . . . . 0.0 113.637 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -91.83 26.58 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.023 0.44 . . . . 0.0 111.61 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.7 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 22.1 m -89.0 -26.19 21.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.781 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.61 33.8 67.24 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.256 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -131.03 142.55 50.33 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.149 0.499 . . . . 0.0 110.965 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -94.49 132.6 38.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.082 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 52.6 t -89.12 21.72 3.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.575 0.702 . . . . 0.0 109.428 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -60.47 -38.64 84.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.07 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.6 mt -92.4 5.22 51.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.08 41.1 99.68 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.263 -0.494 . . . . 0.0 112.876 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -158.31 134.12 9.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.738 0.304 . . . . 0.0 110.909 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 m -125.02 136.6 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.33 -25.59 22.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.816 0.341 . . . . 0.0 110.27 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -71.56 101.63 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.091 0.472 . . . . 0.0 110.365 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.1 24.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.905 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.5 -16.68 40.8 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.286 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.9 m -87.76 136.5 32.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.137 0.494 . . . . 0.0 110.846 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -88.28 141.89 28.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.96 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.09 87.29 7.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.431 . . . . 0.0 110.187 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 p -100.45 85.22 2.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 21.5 t90 -37.03 127.59 0.78 Allowed Pre-proline 0 N--CA 1.462 0.152 0 O-C-N 123.998 0.811 . . . . 0.0 112.261 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 70.7 Cg_endo -102.23 33.81 7.59 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.372 -1.095 . . . . 0.0 114.148 0.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 t -139.43 147.43 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 121.767 -0.583 . . . . 0.0 112.217 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.9 m -88.96 120.41 30.35 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 9.4 p -106.93 138.79 42.43 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.7 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 10.7 tpt180 -111.04 110.58 21.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.701 -178.978 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 CA-C-O 120.327 -0.152 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.706 HG12 HG23 ' A' ' 4' ' ' ILE . 3.8 t -84.18 120.94 75.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 117.055 0.427 . . . . 0.0 110.505 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.7 Cg_exo -78.88 52.23 4.15 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.018 2.479 . . . . 0.0 114.019 -178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.706 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.53 18.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.744 178.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.9 m -88.95 -37.96 14.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.762 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.73 42.82 95.06 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.4 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 26' ' ' CYS . 8.7 pt-20 -144.95 142.96 30.28 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.126 0.489 . . . . 0.0 110.957 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.3 p -98.57 131.23 44.95 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.697 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.797 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 28.5 p -103.3 56.47 0.75 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.237 0.541 . . . . 0.0 110.374 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 p -54.76 -41.0 69.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.572 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -93.15 22.68 4.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.226 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.27 45.58 96.19 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.955 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.5 m -149.11 132.28 16.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.525 -0.397 . . . . 0.0 111.058 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -110.07 140.29 44.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.032 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -89.56 -32.93 16.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.822 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.1 m -82.33 114.53 20.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.188 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.51 125.7 24.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.638 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.87 -17.26 38.81 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.827 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 72.4 m -88.83 129.78 35.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.135 0.493 . . . . 0.0 110.688 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 20.7 t -89.28 153.05 21.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.2 t -87.8 91.65 8.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.461 0.648 . . . . 0.0 111.915 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.5 m -89.94 63.94 6.15 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 t90 -25.46 124.65 0.2 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 114.076 -1.42 . . . . 0.0 113.412 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 76.6 Cg_endo -98.51 28.27 15.82 Favored 'Cis proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.928 -1.28 . . . . 0.0 114.083 0.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.1 141.01 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 121.853 -0.529 . . . . 0.0 111.797 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 98.3 m -88.65 131.46 34.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.816 0.341 . . . . 0.0 110.782 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.6 p -124.5 131.19 53.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.579 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.474 ' HB3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -89.19 109.23 20.13 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.443 -178.704 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 112.643 -0.183 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 t -81.12 125.72 78.85 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.121 0.486 . . . . 0.0 111.336 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.7 71.72 4.68 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.928 2.419 . . . . 0.0 112.925 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.611 HD12 ' HB3' ' A' ' 28' ' ' ARG . 3.3 mt -87.27 -30.26 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.0 m -87.45 -39.56 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.421 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.37 31.53 79.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.606 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 34.1 mt-10 -89.07 153.06 21.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -89.95 129.57 36.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.166 0.507 . . . . 0.0 109.977 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 52.6 t -91.39 14.91 13.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.475 0.655 . . . . 0.0 109.764 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -61.21 -35.63 77.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.813 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.2 mt -84.84 -6.88 59.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.532 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.54 35.27 80.87 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.881 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.3 m -159.97 124.81 3.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.765 0.317 . . . . 0.0 111.027 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.5 m -99.73 138.29 37.03 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -89.02 -28.06 20.44 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.019 0.438 . . . . 0.0 110.316 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -86.68 103.85 15.53 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.483 0.658 . . . . 0.0 111.433 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.36 126.52 21.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.659 ' HA3' ' NH1' ' A' ' 28' ' ' ARG . . . 116.05 -27.37 8.23 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.734 -0.745 . . . . 0.0 111.8 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 1.7 m -88.42 134.23 33.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.105 0.479 . . . . 0.0 110.455 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 13.7 m -88.03 148.82 24.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.706 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 t -86.56 80.75 8.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.251 0.548 . . . . 0.0 110.087 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.5 m -89.94 74.65 7.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.578 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 19.6 t90 -33.63 126.97 0.44 Allowed Pre-proline 0 N--CA 1.464 0.258 0 O-C-N 124.122 0.889 . . . . 0.0 112.692 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.7 Cg_endo -99.46 33.97 8.68 Favored 'Cis proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.055 -1.227 . . . . 0.0 114.085 0.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.53 140.63 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.474 0.654 . . . . 0.0 112.498 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 99.2 m -88.91 116.14 26.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 p -124.05 135.57 53.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.143 0.497 . . . . 0.0 111.384 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.659 ' NH1' ' HA3' ' A' ' 18' ' ' GLY . 61.3 ttm-85 -88.59 109.22 19.91 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.404 0.621 . . . . 0.0 109.546 -178.196 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 CA-C-O 120.377 -0.124 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.589 HG12 HG23 ' A' ' 4' ' ' ILE . 5.6 t -85.04 125.3 70.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.868 0.366 . . . . 0.0 110.316 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 3.0 Cg_exo -76.26 50.44 2.89 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.997 2.465 . . . . 0.0 114.598 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.637 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -94.68 32.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.309 0.576 . . . . 0.0 110.459 178.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.6 m -92.9 -39.54 11.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.369 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.9 36.09 53.05 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.293 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.643 ' OE2' HG22 ' A' ' 16' ' ' THR . 10.3 pt-20 -150.42 142.87 24.39 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.269 0.557 . . . . 0.0 110.442 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -89.62 133.16 34.76 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.676 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 11.9 t -91.78 41.66 1.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.185 0.517 . . . . 0.0 109.755 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.0 p -61.83 -37.79 85.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.022 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.94 -1.43 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.153 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.84 34.21 62.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.58 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.1 m -159.42 126.27 4.59 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.0 m -95.93 137.4 35.05 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -88.58 -28.59 20.62 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.991 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.643 HG22 ' OE2' ' A' ' 7' ' ' GLU . 10.8 t -84.59 111.91 19.96 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 122.344 1.069 . . . . 0.0 111.257 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.16 135.41 43.84 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.028 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.2 -22.44 37.88 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.399 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 65.3 m -88.85 132.78 34.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.407 0.622 . . . . 0.0 111.865 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m -89.32 151.57 22.02 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.247 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.3 t -88.78 110.73 21.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.263 0.554 . . . . 0.0 111.765 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 p -117.93 71.33 0.82 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 t90 -32.28 128.95 0.33 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.796 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.4 Cg_endo -99.45 30.83 11.8 Favored 'Cis proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.037 -1.235 . . . . 0.0 114.102 0.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.4 t -132.44 147.41 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.838 -0.539 . . . . 0.0 111.433 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 88.3 m -90.53 133.64 34.93 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.108 -0.37 . . . . 0.0 110.211 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.4 p -123.79 131.55 53.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.101 0.477 . . . . 0.0 111.415 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 50.2 ttm-85 -93.0 109.96 21.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.426 -179.239 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-O 120.332 -0.149 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.588 HG12 HG23 ' A' ' 4' ' ' ILE . 10.5 t -90.99 123.41 64.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 117.181 0.491 . . . . 0.0 110.467 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 3.8 Cg_exo -74.29 53.07 2.91 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.002 2.468 . . . . 0.0 114.199 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.588 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.41 25.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.992 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 7.8 m -88.96 -32.8 17.48 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.48 42.22 95.9 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.713 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -150.23 147.12 27.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.113 0.483 . . . . 0.0 111.072 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.6 p -89.71 134.03 34.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.394 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.858 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 22.0 p -96.19 49.36 1.13 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.388 0.613 . . . . 0.0 111.284 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -60.54 136.3 58.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt 72.64 9.03 5.65 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.613 0.57 . . . . 0.0 111.133 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.19 56.44 5.21 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.718 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 10.0 t -150.41 142.48 24.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.065 0.459 . . . . 0.0 111.294 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.5 m -133.24 140.13 47.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.402 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -87.64 -31.61 19.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.034 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.545 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 8.4 m -78.65 112.92 16.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.623 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.31 125.86 25.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.646 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.76 52.04 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.37 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 90.0 m -88.16 128.48 35.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.148 0.499 . . . . 0.0 110.779 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 15.6 m -88.82 153.91 20.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.653 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.3 t -88.01 91.17 8.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.335 0.588 . . . . 0.0 112.086 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 m -93.96 62.93 3.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.8 t90 -27.88 127.96 0.21 Allowed Pre-proline 0 C--O 1.231 0.107 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.572 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 71.2 Cg_endo -96.48 26.34 19.96 Favored 'Cis proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.5 -1.458 . . . . 0.0 114.203 0.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.19 144.83 32.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 121.793 -0.567 . . . . 0.0 112.377 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.858 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 70.9 m -87.71 130.76 34.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 110.206 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 24.3 p -112.67 130.49 56.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.108 0.48 . . . . 0.0 111.208 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.485 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 14.5 tpt180 -94.54 108.48 20.43 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.589 -179.311 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 112.917 -0.073 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.726 HG12 HG23 ' A' ' 4' ' ' ILE . 3.4 t -82.05 118.71 73.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 110.545 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 4.8 Cg_exo -79.52 51.71 3.99 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.075 2.517 . . . . 0.0 114.165 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.726 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -90.75 18.24 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.154 0.502 . . . . 0.0 110.659 178.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.2 m -89.52 -37.23 14.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.228 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.47 36.19 88.23 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.645 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 48.1 mt-10 -131.81 145.63 51.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.685 0.279 . . . . 0.0 111.208 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 p -89.56 132.4 35.1 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.724 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.3 p -101.09 53.65 0.84 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.581 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.6 p -61.88 122.12 14.62 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 67.02 27.2 8.82 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.649 0.593 . . . . 0.0 110.828 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.32 44.87 89.71 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.585 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 26.9 m -118.88 128.5 54.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.987 0.394 . . . . 0.0 111.493 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.9 m -145.08 134.95 23.64 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.458 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 5.9 m-85 -89.64 -29.66 18.66 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.7 m -72.81 99.77 2.72 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.749 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.21 129.58 38.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.102 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA3' HH12 ' A' ' 28' ' ' ARG . . . 104.16 -16.51 49.62 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.245 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.04 128.88 35.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.002 0.429 . . . . 0.0 110.85 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -89.41 159.51 17.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.552 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.6 t -88.91 120.84 30.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.649 0.738 . . . . 0.0 111.756 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -123.98 63.84 1.06 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 11.9 t90 -26.1 125.99 0.2 Allowed Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 113.741 -1.572 . . . . 0.0 113.567 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 76.1 Cg_endo -98.04 29.41 14.61 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.7 -1.375 . . . . 0.0 114.328 0.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.69 147.82 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.724 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 55.5 m -87.97 130.98 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.2 p -125.96 132.33 52.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.172 0.511 . . . . 0.0 111.101 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.425 HH12 ' HA3' ' A' ' 18' ' ' GLY . 52.0 ttm-85 -90.35 107.77 19.35 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.24 0.543 . . . . 0.0 110.047 -178.6 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 120.171 -0.238 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.747 HG12 HG23 ' A' ' 4' ' ' ILE . 3.4 t -81.17 116.77 64.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 117.247 0.523 . . . . 0.0 110.476 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.3 Cg_exo -78.86 52.44 4.24 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.021 2.481 . . . . 0.0 114.376 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.747 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -95.33 16.99 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.79 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.0 m -88.75 -33.74 17.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.124 0.487 . . . . 0.0 109.783 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.29 31.03 73.8 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.666 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 99.3 mt-10 -120.2 144.19 47.85 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.843 0.354 . . . . 0.0 110.815 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -94.78 133.6 38.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.468 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 44.2 t -89.36 20.14 4.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.525 0.679 . . . . 0.0 109.845 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -62.6 -30.39 71.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.277 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.64 5.65 50.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.737 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.14 37.34 93.78 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.853 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.3 m -158.52 130.02 6.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.721 0.296 . . . . 0.0 110.791 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.8 m -109.36 139.47 44.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.42 -30.5 18.29 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.041 0.448 . . . . 0.0 109.846 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.1 m -78.82 108.56 12.35 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.43 0.633 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.28 137.87 46.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.79 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.71 -17.62 58.24 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.492 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -87.96 133.67 33.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.17 0.509 . . . . 0.0 110.349 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 12.7 m -88.01 147.81 24.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.87 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.35 82.27 7.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.178 0.513 . . . . 0.0 110.011 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 m -91.36 73.92 6.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 37.9 t90 -34.45 127.58 0.48 Allowed Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 123.975 0.797 . . . . 0.0 112.474 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 91.5 Cg_endo -98.69 33.35 9.49 Favored 'Cis proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.079 -1.217 . . . . 0.0 114.287 0.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -137.44 141.98 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 112.569 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 20' ' ' SER . 87.5 m -88.81 123.9 33.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.9 p -123.06 139.22 54.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.151 0.5 . . . . 0.0 112.128 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HB3' HD11 ' A' ' 4' ' ' ILE . 16.0 tpp85 -88.22 98.91 11.83 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.438 -178.834 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.508 0 CA-C-O 120.188 -0.229 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.838 HG13 HD12 ' A' ' 4' ' ' ILE . 13.3 p -91.62 126.17 55.05 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 117.61 0.705 . . . . 0.0 111.319 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.624 ' HB3' HG22 ' A' ' 27' ' ' THR . 73.2 Cg_endo -78.83 54.08 4.95 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 123.027 2.485 . . . . 0.0 114.601 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.838 HD12 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -88.38 16.15 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.488 0.661 . . . . 0.0 110.09 178.407 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -89.06 -37.2 15.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.273 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.57 35.04 80.22 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.943 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -129.83 143.53 50.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.791 0.329 . . . . 0.0 110.671 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 p -104.21 130.93 51.99 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.603 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 29.3 p -107.1 58.95 0.63 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.366 0.603 . . . . 0.0 111.019 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -56.89 -39.49 74.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.139 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.62 20.41 9.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.859 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.76 48.01 84.55 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.989 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.2 m -149.2 135.94 19.59 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.575 -0.367 . . . . 0.0 110.722 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 59.9 m -130.0 137.53 50.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -89.64 -29.02 19.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.304 0.573 . . . . 0.0 109.738 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.539 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -69.74 107.15 3.36 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.713 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.57 135.84 56.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.06 -14.38 62.23 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.562 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 82.0 m -89.71 128.03 36.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.045 0.45 . . . . 0.0 111.015 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.6 t -89.44 153.4 20.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.329 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.7 t -88.67 88.69 7.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.248 0.547 . . . . 0.0 111.759 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 p -89.77 69.36 7.62 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 6.2 t90 -26.94 126.04 0.21 Allowed Pre-proline 0 N--CA 1.465 0.275 0 CA-C-N 113.872 -1.513 . . . . 0.0 113.518 -176.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 74.8 Cg_endo -99.9 29.35 13.24 Favored 'Cis proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.07 -1.221 . . . . 0.0 113.7 0.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.6 143.56 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.031 -0.418 . . . . 0.0 111.813 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 60.9 m -89.09 127.22 35.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.624 HG22 ' HB3' ' A' ' 3' ' ' PRO . 31.0 p -127.18 130.15 49.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.098 0.475 . . . . 0.0 111.347 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.592 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.3 ttm180 -91.34 116.85 29.16 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.888 -179.544 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.472 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.674 HG12 HG23 ' A' ' 4' ' ' ILE . 3.0 t -80.91 124.64 81.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.044 0.45 . . . . 0.0 110.813 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 27' ' ' THR . 96.4 Cg_endo -80.81 50.77 3.68 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.727 2.284 . . . . 0.0 113.982 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -92.55 16.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.214 0.53 . . . . 0.0 110.69 178.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.85 ' HB3' HG21 ' A' ' 16' ' ' THR . 8.9 m -89.34 -37.07 15.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.889 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.71 37.28 84.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.163 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -133.72 147.04 51.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.855 0.359 . . . . 0.0 110.613 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 p -102.39 130.83 49.25 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.475 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 11.1 t -95.61 40.61 1.11 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.115 0.483 . . . . 0.0 109.881 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.6 p -59.13 -42.58 90.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.58 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.7 mt -85.65 10.29 13.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.237 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.23 36.3 92.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.701 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -157.85 128.79 6.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.673 0.273 . . . . 0.0 110.58 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -107.63 140.04 41.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -88.38 -31.29 18.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.85 HG21 ' HB3' ' A' ' 5' ' ' CYS . 3.5 t -70.49 97.81 1.35 Allowed 'General case' 0 C--O 1.242 0.695 0 CA-C-O 122.04 0.924 . . . . 0.0 111.065 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.76 123.65 16.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.116 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.48 -22.6 14.92 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.041 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 85.8 m -88.37 139.27 30.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.088 0.471 . . . . 0.0 111.275 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.6 m -88.53 151.87 22.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.849 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.5 t -88.85 112.47 23.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 111.534 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.3 m -117.91 68.93 0.77 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 12.1 t90 -31.75 126.56 0.33 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.847 -177.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.4 Cg_endo -99.56 32.24 10.23 Favored 'Cis proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.077 -1.218 . . . . 0.0 113.984 0.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.78 142.38 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 121.799 -0.563 . . . . 0.0 111.862 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 77.5 m -89.54 124.73 34.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 3' ' ' PRO . 53.0 p -129.71 130.67 45.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.908 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.689 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 49.7 ttt180 -91.8 118.39 30.65 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.896 -178.979 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 120.371 -0.127 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.719 HG12 HG23 ' A' ' 4' ' ' ILE . 3.5 t -80.65 121.17 80.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.071 0.462 . . . . 0.0 110.709 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.25 52.16 4.21 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.691 2.261 . . . . 0.0 114.248 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.719 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -92.08 12.3 2.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.781 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -88.73 -36.66 16.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.164 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.75 33.06 83.07 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.147 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.33 144.87 48.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.798 0.332 . . . . 0.0 111.342 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -105.82 126.88 52.69 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.688 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 31.7 p -106.31 54.71 0.68 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.232 0.539 . . . . 0.0 111.104 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 p -57.05 -39.16 74.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.812 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -95.45 19.73 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.018 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.3 51.12 57.28 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.054 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.0 t -155.52 146.05 22.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.832 0.349 . . . . 0.0 111.329 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.2 m -140.82 139.65 34.55 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.46 -26.96 21.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.735 0.302 . . . . 0.0 110.326 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 m -73.83 106.31 5.5 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.176 0.512 . . . . 0.0 110.629 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.42 123.98 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.764 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.0 -17.57 32.09 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.11 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -88.13 130.11 35.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.112 0.482 . . . . 0.0 110.69 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.4 m -89.02 152.18 21.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.703 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.0 t -87.89 91.61 8.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.37 0.605 . . . . 0.0 111.407 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -89.66 64.07 6.42 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 6.6 t90 -25.42 124.28 0.2 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 114.017 -1.447 . . . . 0.0 113.543 -176.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.3 Cg_endo -99.25 30.38 12.52 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.085 -1.215 . . . . 0.0 113.819 0.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.14 140.25 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 O-C-N 122.015 -0.428 . . . . 0.0 111.952 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 62.9 m -87.82 126.61 35.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.2 p -129.18 132.57 47.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.088 0.471 . . . . 0.0 111.093 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HB3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -89.31 106.99 18.8 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.744 -177.847 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.713 HG12 HG23 ' A' ' 4' ' ' ILE . 3.0 t -82.21 121.01 78.39 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.058 0.456 . . . . 0.0 110.562 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HB3' HG22 ' A' ' 27' ' ' THR . 89.9 Cg_endo -80.12 50.69 3.62 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.687 2.258 . . . . 0.0 114.308 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -93.67 18.94 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.33 0.586 . . . . 0.0 110.322 178.48 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.7 m -89.74 -34.65 16.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.184 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.13 38.18 93.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.734 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.54 152.79 49.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.96 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -107.91 130.06 55.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.045 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 16.6 t -100.04 34.29 2.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.298 0.57 . . . . 0.0 109.871 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.405 HG23 ' HG ' ' A' ' 11' ' ' LEU . 8.1 t -62.02 -30.07 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.439 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.405 ' HG ' HG23 ' A' ' 10' ' ' THR . 94.4 mt -96.37 15.87 20.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.946 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.16 36.76 93.87 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.535 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.2 m -157.22 135.29 11.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.5 m -112.66 133.77 54.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.587 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -88.17 -26.59 22.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.447 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.74 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -72.85 113.46 9.92 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.228 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.16 134.3 56.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.421 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.22 -4.27 77.43 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.353 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.74 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 88.4 m -92.04 135.01 34.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.342 0.571 . . . . 0.0 111.376 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 m -89.28 158.36 17.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.012 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -89.07 131.44 35.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.293 0.568 . . . . 0.0 111.518 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.0 m -140.91 63.41 1.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.4 t90 -29.18 126.63 0.24 Allowed Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 114.51 -1.223 . . . . 0.0 113.182 -177.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.4 Cg_endo -97.6 26.78 18.46 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.871 -1.304 . . . . 0.0 113.824 0.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -125.05 147.23 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 121.997 -0.439 . . . . 0.0 111.972 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 77.8 m -94.51 128.46 41.11 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.513 HG22 ' HB3' ' A' ' 3' ' ' PRO . 80.5 p -126.15 132.57 51.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 0.0 111.25 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -89.87 112.5 23.87 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.171 -178.951 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 120.099 -0.278 . . . . 0.0 113.496 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.13 118.71 67.85 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 117.599 0.7 . . . . 0.0 111.171 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 72.5 Cg_endo -75.45 50.86 2.77 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.102 2.535 . . . . 0.0 114.616 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -93.54 29.35 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.468 0.652 . . . . 0.0 110.563 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.88 ' HB3' HG21 ' A' ' 16' ' ' THR . 18.1 m -88.95 -31.57 18.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.73 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.05 32.81 56.01 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.202 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -134.1 142.82 47.66 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.047 0.451 . . . . 0.0 110.639 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.6 p -92.95 137.48 32.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 43.7 t -88.91 13.07 13.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.777 0.799 . . . . 0.0 109.572 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -62.9 -31.07 72.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.954 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -77.97 -7.41 56.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.882 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.39 32.25 62.55 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.884 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 t -175.85 149.64 0.95 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -122.52 138.69 54.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -88.67 -31.02 18.72 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.88 HG21 ' HB3' ' A' ' 5' ' ' CYS . 4.8 t -69.97 101.53 1.8 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.008 0.908 . . . . 0.0 111.027 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.29 135.37 44.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.316 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.95 -21.92 43.55 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.697 ' HB2' HG23 ' A' ' 16' ' ' THR . 71.0 m -89.3 135.59 33.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.178 0.513 . . . . 0.0 111.304 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 14.8 m -88.64 151.21 22.61 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.426 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.38 84.69 7.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.215 0.531 . . . . 0.0 110.157 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 m -94.49 75.46 3.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.509 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 12.3 t90 -35.22 127.39 0.55 Allowed Pre-proline 0 N--CA 1.464 0.267 0 O-C-N 124.042 0.839 . . . . 0.0 112.345 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 79.5 Cg_endo -100.0 37.04 6.25 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.174 -1.178 . . . . 0.0 114.369 1.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.92 149.23 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.445 0.641 . . . . 0.0 112.445 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 20' ' ' SER . 64.6 m -88.84 126.26 35.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 44.0 p -112.07 131.59 55.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.13 0.491 . . . . 0.0 112.147 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -89.67 102.53 15.22 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.123 -179.492 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 120.31 -0.161 . . . . 0.0 112.97 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.661 HG12 HG23 ' A' ' 4' ' ' ILE . 3.6 t -85.61 121.19 73.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.088 0.444 . . . . 0.0 110.556 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.9 Cg_exo -77.93 53.52 4.46 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.019 2.479 . . . . 0.0 114.451 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.683 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -99.39 25.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.522 . . . . 0.0 110.832 178.655 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.843 ' HB3' HG21 ' A' ' 16' ' ' THR . 11.2 m -88.85 -34.66 16.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.89 32.57 63.54 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.565 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.436 ' OE1' HG22 ' A' ' 16' ' ' THR . 86.0 mt-10 -131.36 141.97 49.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 120.924 0.392 . . . . 0.0 111.012 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -103.13 128.6 50.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.617 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 32.1 p -103.61 53.74 0.75 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.367 0.604 . . . . 0.0 110.824 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -56.43 -39.29 72.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.363 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.54 22.64 2.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.171 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.36 44.81 97.18 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.089 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.6 t -161.75 145.7 12.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 61.8 m -125.69 141.67 51.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.837 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.53 -31.71 18.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.843 HG21 ' HB3' ' A' ' 5' ' ' CYS . 4.5 t -71.12 100.13 1.99 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.027 0.918 . . . . 0.0 110.681 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 125.32 21.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.394 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.56 -24.42 17.6 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.318 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.674 ' HB2' HG23 ' A' ' 16' ' ' THR . 76.7 m -88.47 135.75 33.32 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 111.216 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 18.3 t -88.99 154.72 19.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.49 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -88.33 92.54 9.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.294 0.569 . . . . 0.0 112.002 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -92.39 64.07 4.29 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 176.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.7 t90 -24.6 123.73 0.19 Allowed Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.63 -176.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 84.5 Cg_endo -99.47 28.17 15.13 Favored 'Cis proline' 0 CA--C 1.537 0.631 0 C-N-CA 124.069 -1.221 . . . . 0.0 113.95 0.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.09 141.74 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 121.92 -0.488 . . . . 0.0 111.778 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 61.1 m -87.92 128.57 35.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.299 . . . . 0.0 110.224 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.3 p -116.11 132.65 56.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.142 0.496 . . . . 0.0 111.65 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.503 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 13.1 tpt180 -90.91 106.46 18.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.36 -179.055 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.626 -0.19 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 4' ' ' ILE . 5.8 t -74.55 114.75 37.09 Favored Pre-proline 0 C--O 1.236 0.346 0 CA-C-O 121.312 0.577 . . . . 0.0 111.091 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.6 60.17 7.15 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.955 2.437 . . . . 0.0 113.656 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -87.94 -12.9 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.87 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 62.8 m -88.16 -43.34 11.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.339 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.35 21.62 70.51 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.6 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -89.61 146.99 24.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.717 0.258 . . . . 0.0 110.506 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -94.8 127.53 40.87 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 10.2 t -98.41 38.33 1.36 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.115 0.484 . . . . 0.0 110.395 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p -61.54 -37.87 85.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.989 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.44 7.48 28.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.114 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.52 94.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.792 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.5 m -157.65 132.59 8.7 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.827 -0.22 . . . . 0.0 110.693 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -119.25 134.74 55.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.9 -27.05 21.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.002 0.43 . . . . 0.0 110.609 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.52 ' HB ' ' SG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -77.78 104.6 8.42 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.363 0.602 . . . . 0.0 112.192 -179.244 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.66 131.91 50.36 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.529 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.32 -27.15 20.45 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.09 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.5 130.65 35.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.205 0.526 . . . . 0.0 110.648 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 16.0 t -88.68 162.46 16.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.849 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.0 t -87.59 83.29 7.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.288 0.566 . . . . 0.0 111.595 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.3 m -89.8 65.11 6.65 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.3 t90 -30.7 126.06 0.29 Allowed Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 114.662 -1.154 . . . . 0.0 112.867 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 87.1 Cg_endo -98.6 33.85 9.07 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.888 -1.297 . . . . 0.0 114.005 0.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.56 140.62 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 112.1 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 20' ' ' SER . 62.5 m -89.46 120.68 31.0 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.8 p -132.44 138.69 47.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.849 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -88.61 99.37 12.27 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.167 -178.688 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 120.046 -0.308 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.828 HG13 HD12 ' A' ' 4' ' ' ILE . 14.7 p -89.68 125.97 59.4 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 117.654 0.727 . . . . 0.0 111.461 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.579 ' HB3' HG22 ' A' ' 27' ' ' THR . 83.6 Cg_endo -79.48 54.64 5.28 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.909 2.406 . . . . 0.0 114.508 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.828 HD12 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -88.27 15.0 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.416 0.627 . . . . 0.0 110.209 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.3 m -89.3 -36.61 15.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.428 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.54 34.56 73.62 Favored Glycine 0 C--O 1.227 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.223 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -130.47 143.06 50.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.825 0.345 . . . . 0.0 110.795 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . 20.9 p -92.31 129.94 38.13 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.638 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.439 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 14.9 t -95.75 34.49 1.5 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.346 0.593 . . . . 0.0 110.109 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -63.43 -27.38 69.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.175 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.4 mt -95.9 13.31 27.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.082 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.44 45.17 96.45 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.583 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -167.33 151.77 6.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.696 0.284 . . . . 0.0 110.38 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -137.17 138.0 39.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -89.04 -28.14 20.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.133 0.492 . . . . 0.0 109.803 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.506 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -68.1 105.55 2.1 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.634 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.07 136.26 56.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.067 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.72 -11.48 66.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.848 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.506 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 95.1 m -88.94 132.1 34.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.107 0.48 . . . . 0.0 111.02 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 m -89.44 154.89 19.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.855 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.3 t -88.82 123.73 33.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.215 0.531 . . . . 0.0 111.028 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.9 t -131.38 67.47 1.51 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 21.5 t90 -31.33 128.18 0.29 Allowed Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.906 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 79.4 Cg_endo -97.93 32.69 10.39 Favored 'Cis proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.921 -1.283 . . . . 0.0 114.146 0.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 14.5 p -135.67 146.91 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 121.66 -0.65 . . . . 0.0 112.139 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 64.6 m -89.35 127.97 35.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 3' ' ' PRO . 33.2 p -129.26 130.36 46.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.158 0.504 . . . . 0.0 111.142 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.9 ttm180 -91.86 116.44 28.91 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.646 -179.188 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.5 t -85.97 117.53 68.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 117.125 0.462 . . . . 0.0 110.635 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.7 Cg_exo -75.16 51.14 2.76 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.138 2.558 . . . . 0.0 113.568 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 28' ' ' ARG . 1.9 pp -94.88 24.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.002 0.429 . . . . 0.0 111.391 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 20.5 m -88.69 -34.11 17.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.83 -5.59 46.55 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.887 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.602 ' OE1' HG22 ' A' ' 16' ' ' THR . 40.2 mt-10 -89.79 142.21 27.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.321 0.561 . . . . 0.0 110.726 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p -97.2 127.13 42.88 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 28.2 p -105.58 48.26 0.84 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.461 0.648 . . . . 0.0 110.73 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -61.25 -26.27 67.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.595 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -97.14 17.25 17.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.653 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.57 45.92 94.84 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.05 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -164.54 151.88 11.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.825 0.312 . . . . 0.0 111.031 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.6 m -132.61 142.15 49.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -88.28 -31.33 19.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.131 0.491 . . . . 0.0 109.705 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.604 HG21 ' HB3' ' A' ' 5' ' ' CYS . 5.4 t -73.98 100.11 3.47 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.902 0.858 . . . . 0.0 110.482 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.47 125.08 18.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.103 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.46 -25.32 11.27 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.131 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.602 ' HB2' HG23 ' A' ' 16' ' ' THR . 96.7 m -87.84 132.64 34.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.175 0.512 . . . . 0.0 110.984 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.5 m -89.53 156.38 18.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.286 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.4 t -88.56 124.74 34.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.552 0.691 . . . . 0.0 111.331 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.8 m -128.68 67.25 1.4 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 4.0 t90 -24.32 122.93 0.19 Allowed Pre-proline 0 N--CA 1.463 0.194 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.581 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 68.1 Cg_endo -100.86 26.6 15.32 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.084 -1.215 . . . . 0.0 114.165 0.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.9 t -125.99 147.84 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.765 -0.584 . . . . 0.0 111.768 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 75.9 m -88.26 131.07 34.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.79 0.329 . . . . 0.0 110.243 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 30.7 p -110.09 136.94 48.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.153 0.501 . . . . 0.0 111.599 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.646 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 8.0 tpt180 -105.15 108.87 20.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.424 -179.202 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 120.233 -0.204 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.72 HG12 HG23 ' A' ' 4' ' ' ILE . 10.6 t -74.54 116.43 53.2 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 121.221 0.534 . . . . 0.0 110.825 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.96 57.78 6.42 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.789 2.326 . . . . 0.0 113.992 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.747 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -88.91 33.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.356 0.598 . . . . 0.0 110.778 178.82 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' SG ' HG21 ' A' ' 16' ' ' THR . 91.1 m -141.48 -49.91 0.41 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.698 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.89 22.8 77.12 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.942 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.627 ' OE1' HG22 ' A' ' 16' ' ' THR . 42.7 mt-10 -89.06 145.53 25.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.004 0.402 . . . . 0.0 109.971 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.4 p -89.08 125.64 35.1 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 10.3 t -102.81 34.6 2.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.141 0.496 . . . . 0.0 109.953 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -34.56 75.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.096 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.12 11.25 23.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.857 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.18 41.08 98.49 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.777 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.8 m -157.0 131.6 8.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.689 0.28 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.3 m -113.79 141.54 47.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -88.45 -31.36 18.83 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.627 HG22 ' OE1' ' A' ' 7' ' ' GLU . 3.4 t -71.9 99.08 2.14 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.985 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.16 64.32 0.1 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.989 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.52 -32.43 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.162 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.568 ' HB2' HG23 ' A' ' 16' ' ' THR . 2.1 m -89.42 145.98 24.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.861 0.362 . . . . 0.0 110.995 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -89.03 156.43 18.86 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.8 t -88.57 128.61 35.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.342 0.591 . . . . 0.0 111.168 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 m -137.3 72.5 1.42 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.7 t90 -30.93 125.5 0.31 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.871 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.4 Cg_endo -100.41 33.43 8.68 Favored 'Cis proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.15 -1.187 . . . . 0.0 113.961 0.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.5 t -135.74 141.39 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 121.866 -0.521 . . . . 0.0 112.206 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 62.0 m -89.66 121.94 32.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.9 p -140.48 150.39 43.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.817 0.341 . . . . 0.0 110.407 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.568 ' HB3' HD11 ' A' ' 4' ' ' ILE . 8.9 tpt85 -96.18 101.51 13.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.351 -178.848 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 CA-C-O 120.368 -0.129 . . . . 0.0 112.817 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.624 HG12 HG23 ' A' ' 4' ' ' ILE . 4.4 t -80.42 124.21 82.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 27' ' ' THR . 88.7 Cg_endo -79.75 52.67 4.4 Favored 'Trans proline' 0 CA--C 1.527 0.158 0 C-N-CA 122.709 2.272 . . . . 0.0 114.181 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -89.96 8.06 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.994 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 3.7 m -88.81 -36.01 16.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.109 0.481 . . . . 0.0 109.78 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.59 29.57 74.08 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.027 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 35.2 mt-10 -113.36 144.81 42.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.614 0.245 . . . . 0.0 110.604 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.4 p -91.22 129.19 37.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.332 -0.394 . . . . 0.0 109.939 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.454 ' O ' ' HD1' ' A' ' 23' ' ' TRP . 44.5 t -89.76 20.35 4.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.541 0.686 . . . . 0.0 109.661 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -58.93 -39.25 81.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.275 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.26 6.83 47.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.892 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.58 46.02 95.13 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.892 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 m -156.72 133.99 10.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.852 0.326 . . . . 0.0 111.152 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.8 m -126.4 136.77 53.1 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -88.34 -27.22 21.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.697 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.4 m -77.21 103.24 7.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.126 0.488 . . . . 0.0 110.753 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.35 122.93 13.73 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.334 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.94 -17.2 22.66 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.79 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 96.1 m -87.92 135.95 33.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.86 0.362 . . . . 0.0 110.378 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -88.28 143.6 26.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.826 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 t -87.61 81.54 7.69 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 m -89.97 76.5 7.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 26.9 t90 -34.89 127.07 0.52 Allowed Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 124.066 0.854 . . . . 0.0 112.382 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.1 Cg_endo -99.96 35.67 7.2 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.19 -1.171 . . . . 0.0 114.082 0.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.89 141.14 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.468 0.651 . . . . 0.0 112.445 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 93.0 m -88.52 116.16 26.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 3' ' ' PRO . 23.1 p -121.98 132.61 54.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.003 0.43 . . . . 0.0 111.253 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.663 ' HB3' HD11 ' A' ' 4' ' ' ILE . 32.0 ttt85 -89.11 112.94 24.03 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 C--N 1.328 -0.368 0 O-C-N 123.564 0.54 . . . . 0.0 110.014 -178.82 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.505 0 N-CA-C 112.783 -0.127 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.711 HG12 HG23 ' A' ' 4' ' ' ILE . 3.3 t -81.59 119.15 74.79 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.94 0.4 . . . . 0.0 110.599 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.6 Cg_exo -79.33 51.49 3.89 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.118 2.545 . . . . 0.0 114.134 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.711 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.29 17.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.153 0.501 . . . . 0.0 110.617 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.2 m -89.45 -34.77 16.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.192 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.65 34.96 79.57 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.394 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -128.71 143.02 50.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.881 0.372 . . . . 0.0 111.34 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.4 p -97.19 127.11 42.86 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 7.6 t -99.74 35.66 1.96 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.977 0.418 . . . . 0.0 110.701 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -34.84 74.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.8 mt -98.44 14.23 28.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.41 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 63.44 49.33 70.88 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.918 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.2 m -155.68 134.96 12.29 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.667 -0.313 . . . . 0.0 111.062 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.5 m -137.45 135.02 36.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.87 -26.2 21.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.913 0.387 . . . . 0.0 110.306 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 m -73.25 97.33 2.42 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.23 0.538 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.84 127.92 30.76 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.14 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.407 ' HA3' HH12 ' A' ' 28' ' ' ARG . . . 106.94 -16.11 39.74 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.075 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.2 m -88.63 134.96 33.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.077 0.465 . . . . 0.0 110.808 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -88.49 155.31 19.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.099 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.0 t -87.99 84.63 6.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.071 0.462 . . . . 0.0 111.692 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 m -90.5 67.25 6.51 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 14.2 t90 -32.31 125.97 0.37 Allowed Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 124.461 1.101 . . . . 0.0 112.734 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.6 Cg_endo -99.44 36.33 6.87 Favored 'Cis proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.102 -1.207 . . . . 0.0 113.937 0.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.58 142.74 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 121.754 -0.591 . . . . 0.0 112.152 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 53.9 m -88.84 123.4 33.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.9 p -125.87 133.66 51.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.201 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HB3' HD11 ' A' ' 4' ' ' ILE . 51.7 ttm-85 -88.8 107.97 19.25 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.331 -179.019 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 112.758 -0.137 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.692 HG12 HG23 ' A' ' 4' ' ' ILE . 3.7 t -86.0 120.69 72.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.028 0.414 . . . . 0.0 110.391 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.2 Cg_exo -78.41 52.29 4.07 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.946 2.431 . . . . 0.0 114.202 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.703 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -92.46 20.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.049 0.452 . . . . 0.0 110.911 178.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 10.9 m -89.11 -29.66 19.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.006 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.79 32.5 74.12 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.355 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.64 143.81 51.11 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.845 0.355 . . . . 0.0 110.997 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -97.93 129.2 44.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 8.8 t -98.5 34.39 2.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.036 0.446 . . . . 0.0 110.419 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -34.94 75.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.859 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.95 11.99 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.887 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.46 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 62.97 46.58 93.25 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.912 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m -156.39 135.57 12.08 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.659 -0.318 . . . . 0.0 111.079 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 m -132.35 135.87 46.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -88.76 -25.51 22.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.75 0.31 . . . . 0.0 110.444 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -72.86 97.63 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.147 0.498 . . . . 0.0 110.672 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.7 126.35 23.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.794 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.77 -16.81 33.46 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.94 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.2 m -88.96 132.25 34.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.022 0.439 . . . . 0.0 110.738 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -89.2 157.73 18.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.776 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.7 t -89.05 129.8 35.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.292 0.568 . . . . 0.0 111.424 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -138.53 68.63 1.39 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.2 t90 -31.68 126.03 0.33 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.931 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.2 Cg_endo -99.94 34.23 8.28 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.144 -1.19 . . . . 0.0 113.883 0.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.46 146.22 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.743 -0.598 . . . . 0.0 111.936 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.5 m -89.26 126.09 35.36 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 77.2 p -117.97 131.22 56.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.206 0.527 . . . . 0.0 111.596 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.561 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 35.4 ttt85 -92.56 108.21 19.8 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.926 -178.506 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 112.688 -0.165 . . . . 0.0 112.688 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.4 t -90.13 117.94 68.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 117.023 0.412 . . . . 0.0 110.764 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 70.1 Cg_endo -74.9 51.57 2.78 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.854 2.37 . . . . 0.0 113.637 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -91.83 26.58 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.023 0.44 . . . . 0.0 111.61 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.7 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 22.1 m -89.0 -26.19 21.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.781 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.61 33.8 67.24 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.256 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -131.03 142.55 50.33 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.149 0.499 . . . . 0.0 110.965 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -94.49 132.6 38.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.082 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 52.6 t -89.12 21.72 3.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.575 0.702 . . . . 0.0 109.428 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -60.47 -38.64 84.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.07 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.6 mt -92.4 5.22 51.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.08 41.1 99.68 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.263 -0.494 . . . . 0.0 112.876 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -158.31 134.12 9.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.738 0.304 . . . . 0.0 110.909 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 m -125.02 136.6 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.33 -25.59 22.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.816 0.341 . . . . 0.0 110.27 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -71.56 101.63 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.091 0.472 . . . . 0.0 110.365 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.1 24.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.905 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.5 -16.68 40.8 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.286 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.9 m -87.76 136.5 32.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.137 0.494 . . . . 0.0 110.846 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -88.28 141.89 28.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.96 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.09 87.29 7.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.431 . . . . 0.0 110.187 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 p -100.45 85.22 2.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 21.5 t90 -37.03 127.59 0.78 Allowed Pre-proline 0 N--CA 1.462 0.152 0 O-C-N 123.998 0.811 . . . . 0.0 112.261 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 70.7 Cg_endo -102.23 33.81 7.59 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.372 -1.095 . . . . 0.0 114.148 0.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 t -139.43 147.43 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 121.767 -0.583 . . . . 0.0 112.217 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.9 m -88.96 120.41 30.35 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 9.4 p -106.93 138.79 42.43 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.7 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 10.7 tpt180 -111.04 110.58 21.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.701 -178.978 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 CA-C-O 120.327 -0.152 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.706 HG12 HG23 ' A' ' 4' ' ' ILE . 3.8 t -84.18 120.94 75.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 117.055 0.427 . . . . 0.0 110.505 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.7 Cg_exo -78.88 52.23 4.15 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.018 2.479 . . . . 0.0 114.019 -178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.706 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.53 18.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.744 178.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.9 m -88.95 -37.96 14.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.762 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.73 42.82 95.06 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.4 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 26' ' ' CYS . 8.7 pt-20 -144.95 142.96 30.28 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.126 0.489 . . . . 0.0 110.957 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.3 p -98.57 131.23 44.95 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.697 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.797 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 28.5 p -103.3 56.47 0.75 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.237 0.541 . . . . 0.0 110.374 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 p -54.76 -41.0 69.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.572 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -93.15 22.68 4.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.226 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.27 45.58 96.19 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.955 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.5 m -149.11 132.28 16.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.525 -0.397 . . . . 0.0 111.058 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -110.07 140.29 44.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.032 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -89.56 -32.93 16.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.822 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.1 m -82.33 114.53 20.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.188 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.51 125.7 24.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.638 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.87 -17.26 38.81 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.827 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 72.4 m -88.83 129.78 35.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.135 0.493 . . . . 0.0 110.688 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 20.7 t -89.28 153.05 21.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.2 t -87.8 91.65 8.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.461 0.648 . . . . 0.0 111.915 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.5 m -89.94 63.94 6.15 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 t90 -25.46 124.65 0.2 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 114.076 -1.42 . . . . 0.0 113.412 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 76.6 Cg_endo -98.51 28.27 15.82 Favored 'Cis proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.928 -1.28 . . . . 0.0 114.083 0.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.1 141.01 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 121.853 -0.529 . . . . 0.0 111.797 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 98.3 m -88.65 131.46 34.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.816 0.341 . . . . 0.0 110.782 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.6 p -124.5 131.19 53.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.579 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.474 ' HB3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -89.19 109.23 20.13 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.443 -178.704 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 112.643 -0.183 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 t -81.12 125.72 78.85 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.121 0.486 . . . . 0.0 111.336 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.7 71.72 4.68 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.928 2.419 . . . . 0.0 112.925 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.611 HD12 ' HB3' ' A' ' 28' ' ' ARG . 3.3 mt -87.27 -30.26 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.0 m -87.45 -39.56 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.421 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.37 31.53 79.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.606 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 34.1 mt-10 -89.07 153.06 21.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -89.95 129.57 36.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.166 0.507 . . . . 0.0 109.977 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 52.6 t -91.39 14.91 13.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.475 0.655 . . . . 0.0 109.764 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -61.21 -35.63 77.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.813 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.2 mt -84.84 -6.88 59.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.532 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.54 35.27 80.87 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.881 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.3 m -159.97 124.81 3.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.765 0.317 . . . . 0.0 111.027 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.5 m -99.73 138.29 37.03 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -89.02 -28.06 20.44 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.019 0.438 . . . . 0.0 110.316 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -86.68 103.85 15.53 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.483 0.658 . . . . 0.0 111.433 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.36 126.52 21.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.659 ' HA3' ' NH1' ' A' ' 28' ' ' ARG . . . 116.05 -27.37 8.23 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.734 -0.745 . . . . 0.0 111.8 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 1.7 m -88.42 134.23 33.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.105 0.479 . . . . 0.0 110.455 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 13.7 m -88.03 148.82 24.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.706 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 t -86.56 80.75 8.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.251 0.548 . . . . 0.0 110.087 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.5 m -89.94 74.65 7.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.578 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 19.6 t90 -33.63 126.97 0.44 Allowed Pre-proline 0 N--CA 1.464 0.258 0 O-C-N 124.122 0.889 . . . . 0.0 112.692 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.7 Cg_endo -99.46 33.97 8.68 Favored 'Cis proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.055 -1.227 . . . . 0.0 114.085 0.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.53 140.63 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.474 0.654 . . . . 0.0 112.498 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 99.2 m -88.91 116.14 26.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 p -124.05 135.57 53.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.143 0.497 . . . . 0.0 111.384 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.659 ' NH1' ' HA3' ' A' ' 18' ' ' GLY . 61.3 ttm-85 -88.59 109.22 19.91 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.404 0.621 . . . . 0.0 109.546 -178.196 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 CA-C-O 120.377 -0.124 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.589 HG12 HG23 ' A' ' 4' ' ' ILE . 5.6 t -85.04 125.3 70.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.868 0.366 . . . . 0.0 110.316 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 3.0 Cg_exo -76.26 50.44 2.89 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.997 2.465 . . . . 0.0 114.598 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.637 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -94.68 32.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.309 0.576 . . . . 0.0 110.459 178.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.6 m -92.9 -39.54 11.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.369 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.9 36.09 53.05 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.293 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.643 ' OE2' HG22 ' A' ' 16' ' ' THR . 10.3 pt-20 -150.42 142.87 24.39 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.269 0.557 . . . . 0.0 110.442 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -89.62 133.16 34.76 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.676 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 11.9 t -91.78 41.66 1.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.185 0.517 . . . . 0.0 109.755 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.0 p -61.83 -37.79 85.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.022 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.94 -1.43 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.153 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.84 34.21 62.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.58 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.1 m -159.42 126.27 4.59 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.0 m -95.93 137.4 35.05 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -88.58 -28.59 20.62 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.991 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.643 HG22 ' OE2' ' A' ' 7' ' ' GLU . 10.8 t -84.59 111.91 19.96 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 122.344 1.069 . . . . 0.0 111.257 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.16 135.41 43.84 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.028 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.2 -22.44 37.88 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.399 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 65.3 m -88.85 132.78 34.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.407 0.622 . . . . 0.0 111.865 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m -89.32 151.57 22.02 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.247 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.3 t -88.78 110.73 21.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.263 0.554 . . . . 0.0 111.765 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 p -117.93 71.33 0.82 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 t90 -32.28 128.95 0.33 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.796 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.4 Cg_endo -99.45 30.83 11.8 Favored 'Cis proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.037 -1.235 . . . . 0.0 114.102 0.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.4 t -132.44 147.41 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.838 -0.539 . . . . 0.0 111.433 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 88.3 m -90.53 133.64 34.93 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.108 -0.37 . . . . 0.0 110.211 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.4 p -123.79 131.55 53.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.101 0.477 . . . . 0.0 111.415 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 50.2 ttm-85 -93.0 109.96 21.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.426 -179.239 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-O 120.332 -0.149 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.588 HG12 HG23 ' A' ' 4' ' ' ILE . 10.5 t -90.99 123.41 64.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 117.181 0.491 . . . . 0.0 110.467 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 3.8 Cg_exo -74.29 53.07 2.91 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.002 2.468 . . . . 0.0 114.199 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.588 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.41 25.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.992 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 7.8 m -88.96 -32.8 17.48 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.48 42.22 95.9 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.713 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -150.23 147.12 27.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.113 0.483 . . . . 0.0 111.072 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.6 p -89.71 134.03 34.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.394 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.858 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 22.0 p -96.19 49.36 1.13 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.388 0.613 . . . . 0.0 111.284 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -60.54 136.3 58.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt 72.64 9.03 5.65 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.613 0.57 . . . . 0.0 111.133 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.19 56.44 5.21 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.718 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 10.0 t -150.41 142.48 24.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.065 0.459 . . . . 0.0 111.294 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.5 m -133.24 140.13 47.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.402 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -87.64 -31.61 19.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.034 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.545 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 8.4 m -78.65 112.92 16.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.623 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.31 125.86 25.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.646 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.76 52.04 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.37 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 90.0 m -88.16 128.48 35.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.148 0.499 . . . . 0.0 110.779 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 15.6 m -88.82 153.91 20.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.653 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.3 t -88.01 91.17 8.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.335 0.588 . . . . 0.0 112.086 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 m -93.96 62.93 3.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.8 t90 -27.88 127.96 0.21 Allowed Pre-proline 0 C--O 1.231 0.107 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.572 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 71.2 Cg_endo -96.48 26.34 19.96 Favored 'Cis proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.5 -1.458 . . . . 0.0 114.203 0.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.19 144.83 32.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 121.793 -0.567 . . . . 0.0 112.377 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.858 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 70.9 m -87.71 130.76 34.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 110.206 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 24.3 p -112.67 130.49 56.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.108 0.48 . . . . 0.0 111.208 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.485 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 14.5 tpt180 -94.54 108.48 20.43 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.589 -179.311 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 112.917 -0.073 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.726 HG12 HG23 ' A' ' 4' ' ' ILE . 3.4 t -82.05 118.71 73.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 110.545 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 4.8 Cg_exo -79.52 51.71 3.99 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.075 2.517 . . . . 0.0 114.165 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.726 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -90.75 18.24 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.154 0.502 . . . . 0.0 110.659 178.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.2 m -89.52 -37.23 14.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.228 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.47 36.19 88.23 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.645 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 48.1 mt-10 -131.81 145.63 51.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.685 0.279 . . . . 0.0 111.208 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 p -89.56 132.4 35.1 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.724 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.3 p -101.09 53.65 0.84 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.581 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.6 p -61.88 122.12 14.62 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 67.02 27.2 8.82 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.649 0.593 . . . . 0.0 110.828 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.32 44.87 89.71 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.585 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 26.9 m -118.88 128.5 54.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.987 0.394 . . . . 0.0 111.493 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.9 m -145.08 134.95 23.64 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.458 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 5.9 m-85 -89.64 -29.66 18.66 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.7 m -72.81 99.77 2.72 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.749 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.21 129.58 38.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.102 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA3' HH12 ' A' ' 28' ' ' ARG . . . 104.16 -16.51 49.62 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.245 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.04 128.88 35.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.002 0.429 . . . . 0.0 110.85 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -89.41 159.51 17.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.552 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.6 t -88.91 120.84 30.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.649 0.738 . . . . 0.0 111.756 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -123.98 63.84 1.06 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 11.9 t90 -26.1 125.99 0.2 Allowed Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 113.741 -1.572 . . . . 0.0 113.567 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 76.1 Cg_endo -98.04 29.41 14.61 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.7 -1.375 . . . . 0.0 114.328 0.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.69 147.82 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.724 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 55.5 m -87.97 130.98 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.2 p -125.96 132.33 52.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.172 0.511 . . . . 0.0 111.101 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.425 HH12 ' HA3' ' A' ' 18' ' ' GLY . 52.0 ttm-85 -90.35 107.77 19.35 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.24 0.543 . . . . 0.0 110.047 -178.6 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 120.171 -0.238 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.747 HG12 HG23 ' A' ' 4' ' ' ILE . 3.4 t -81.17 116.77 64.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 117.247 0.523 . . . . 0.0 110.476 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.3 Cg_exo -78.86 52.44 4.24 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.021 2.481 . . . . 0.0 114.376 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.747 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -95.33 16.99 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.79 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.0 m -88.75 -33.74 17.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.124 0.487 . . . . 0.0 109.783 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.29 31.03 73.8 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.666 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 99.3 mt-10 -120.2 144.19 47.85 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.843 0.354 . . . . 0.0 110.815 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -94.78 133.6 38.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.468 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 44.2 t -89.36 20.14 4.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.525 0.679 . . . . 0.0 109.845 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -62.6 -30.39 71.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.277 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.64 5.65 50.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.737 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.14 37.34 93.78 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.853 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.3 m -158.52 130.02 6.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.721 0.296 . . . . 0.0 110.791 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.8 m -109.36 139.47 44.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.42 -30.5 18.29 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.041 0.448 . . . . 0.0 109.846 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.1 m -78.82 108.56 12.35 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.43 0.633 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.28 137.87 46.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.79 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.71 -17.62 58.24 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.492 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -87.96 133.67 33.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.17 0.509 . . . . 0.0 110.349 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 12.7 m -88.01 147.81 24.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.87 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.35 82.27 7.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.178 0.513 . . . . 0.0 110.011 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 m -91.36 73.92 6.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 37.9 t90 -34.45 127.58 0.48 Allowed Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 123.975 0.797 . . . . 0.0 112.474 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 91.5 Cg_endo -98.69 33.35 9.49 Favored 'Cis proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.079 -1.217 . . . . 0.0 114.287 0.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -137.44 141.98 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 112.569 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 20' ' ' SER . 87.5 m -88.81 123.9 33.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.9 p -123.06 139.22 54.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.151 0.5 . . . . 0.0 112.128 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HB3' HD11 ' A' ' 4' ' ' ILE . 16.0 tpp85 -88.22 98.91 11.83 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.438 -178.834 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.508 0 CA-C-O 120.188 -0.229 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.838 HG13 HD12 ' A' ' 4' ' ' ILE . 13.3 p -91.62 126.17 55.05 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 117.61 0.705 . . . . 0.0 111.319 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.624 ' HB3' HG22 ' A' ' 27' ' ' THR . 73.2 Cg_endo -78.83 54.08 4.95 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 123.027 2.485 . . . . 0.0 114.601 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.838 HD12 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -88.38 16.15 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.488 0.661 . . . . 0.0 110.09 178.407 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -89.06 -37.2 15.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.273 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.57 35.04 80.22 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.943 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -129.83 143.53 50.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.791 0.329 . . . . 0.0 110.671 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 p -104.21 130.93 51.99 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.603 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 29.3 p -107.1 58.95 0.63 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.366 0.603 . . . . 0.0 111.019 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -56.89 -39.49 74.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.139 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.62 20.41 9.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.859 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.76 48.01 84.55 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.989 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.2 m -149.2 135.94 19.59 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.575 -0.367 . . . . 0.0 110.722 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 59.9 m -130.0 137.53 50.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -89.64 -29.02 19.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.304 0.573 . . . . 0.0 109.738 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.539 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -69.74 107.15 3.36 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.713 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.57 135.84 56.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.06 -14.38 62.23 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.562 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 82.0 m -89.71 128.03 36.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.045 0.45 . . . . 0.0 111.015 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.6 t -89.44 153.4 20.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.329 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.7 t -88.67 88.69 7.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.248 0.547 . . . . 0.0 111.759 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 p -89.77 69.36 7.62 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 6.2 t90 -26.94 126.04 0.21 Allowed Pre-proline 0 N--CA 1.465 0.275 0 CA-C-N 113.872 -1.513 . . . . 0.0 113.518 -176.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 74.8 Cg_endo -99.9 29.35 13.24 Favored 'Cis proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.07 -1.221 . . . . 0.0 113.7 0.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.6 143.56 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.031 -0.418 . . . . 0.0 111.813 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 60.9 m -89.09 127.22 35.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.624 HG22 ' HB3' ' A' ' 3' ' ' PRO . 31.0 p -127.18 130.15 49.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.098 0.475 . . . . 0.0 111.347 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.592 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.3 ttm180 -91.34 116.85 29.16 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.888 -179.544 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.472 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.674 HG12 HG23 ' A' ' 4' ' ' ILE . 3.0 t -80.91 124.64 81.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.044 0.45 . . . . 0.0 110.813 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 27' ' ' THR . 96.4 Cg_endo -80.81 50.77 3.68 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.727 2.284 . . . . 0.0 113.982 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -92.55 16.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.214 0.53 . . . . 0.0 110.69 178.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.85 ' HB3' HG21 ' A' ' 16' ' ' THR . 8.9 m -89.34 -37.07 15.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.889 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.71 37.28 84.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.163 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -133.72 147.04 51.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.855 0.359 . . . . 0.0 110.613 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 p -102.39 130.83 49.25 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.475 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 11.1 t -95.61 40.61 1.11 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.115 0.483 . . . . 0.0 109.881 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.6 p -59.13 -42.58 90.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.58 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.7 mt -85.65 10.29 13.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.237 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.23 36.3 92.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.701 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -157.85 128.79 6.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.673 0.273 . . . . 0.0 110.58 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -107.63 140.04 41.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -88.38 -31.29 18.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.85 HG21 ' HB3' ' A' ' 5' ' ' CYS . 3.5 t -70.49 97.81 1.35 Allowed 'General case' 0 C--O 1.242 0.695 0 CA-C-O 122.04 0.924 . . . . 0.0 111.065 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.76 123.65 16.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.116 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.48 -22.6 14.92 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.041 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 85.8 m -88.37 139.27 30.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.088 0.471 . . . . 0.0 111.275 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.6 m -88.53 151.87 22.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.849 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.5 t -88.85 112.47 23.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 111.534 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.3 m -117.91 68.93 0.77 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 12.1 t90 -31.75 126.56 0.33 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.847 -177.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.4 Cg_endo -99.56 32.24 10.23 Favored 'Cis proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.077 -1.218 . . . . 0.0 113.984 0.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.78 142.38 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 121.799 -0.563 . . . . 0.0 111.862 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 77.5 m -89.54 124.73 34.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 3' ' ' PRO . 53.0 p -129.71 130.67 45.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.908 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.689 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 49.7 ttt180 -91.8 118.39 30.65 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.896 -178.979 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 120.371 -0.127 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.719 HG12 HG23 ' A' ' 4' ' ' ILE . 3.5 t -80.65 121.17 80.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.071 0.462 . . . . 0.0 110.709 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.25 52.16 4.21 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.691 2.261 . . . . 0.0 114.248 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.719 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -92.08 12.3 2.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.781 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -88.73 -36.66 16.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.164 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.75 33.06 83.07 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.147 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.33 144.87 48.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.798 0.332 . . . . 0.0 111.342 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -105.82 126.88 52.69 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.688 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 31.7 p -106.31 54.71 0.68 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.232 0.539 . . . . 0.0 111.104 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 p -57.05 -39.16 74.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.812 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -95.45 19.73 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.018 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.3 51.12 57.28 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.054 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.0 t -155.52 146.05 22.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.832 0.349 . . . . 0.0 111.329 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.2 m -140.82 139.65 34.55 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.46 -26.96 21.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.735 0.302 . . . . 0.0 110.326 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 m -73.83 106.31 5.5 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.176 0.512 . . . . 0.0 110.629 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.42 123.98 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.764 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.0 -17.57 32.09 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.11 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -88.13 130.11 35.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.112 0.482 . . . . 0.0 110.69 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.4 m -89.02 152.18 21.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.703 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.0 t -87.89 91.61 8.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.37 0.605 . . . . 0.0 111.407 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -89.66 64.07 6.42 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 6.6 t90 -25.42 124.28 0.2 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 114.017 -1.447 . . . . 0.0 113.543 -176.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.3 Cg_endo -99.25 30.38 12.52 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.085 -1.215 . . . . 0.0 113.819 0.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.14 140.25 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 O-C-N 122.015 -0.428 . . . . 0.0 111.952 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 62.9 m -87.82 126.61 35.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.2 p -129.18 132.57 47.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.088 0.471 . . . . 0.0 111.093 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HB3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -89.31 106.99 18.8 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.744 -177.847 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.713 HG12 HG23 ' A' ' 4' ' ' ILE . 3.0 t -82.21 121.01 78.39 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.058 0.456 . . . . 0.0 110.562 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HB3' HG22 ' A' ' 27' ' ' THR . 89.9 Cg_endo -80.12 50.69 3.62 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.687 2.258 . . . . 0.0 114.308 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -93.67 18.94 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.33 0.586 . . . . 0.0 110.322 178.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.7 m -89.74 -34.65 16.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.184 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.13 38.18 93.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.734 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.54 152.79 49.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.96 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -107.91 130.06 55.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.045 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 16.6 t -100.04 34.29 2.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.298 0.57 . . . . 0.0 109.871 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.405 HG23 ' HG ' ' A' ' 11' ' ' LEU . 8.1 t -62.02 -30.07 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.439 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.405 ' HG ' HG23 ' A' ' 10' ' ' THR . 94.4 mt -96.37 15.87 20.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.946 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.16 36.76 93.87 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.535 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.2 m -157.22 135.29 11.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.5 m -112.66 133.77 54.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.587 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -88.17 -26.59 22.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.447 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.74 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -72.85 113.46 9.92 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.228 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.16 134.3 56.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.421 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.22 -4.27 77.43 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.353 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.74 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 88.4 m -92.04 135.01 34.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.342 0.571 . . . . 0.0 111.376 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 m -89.28 158.36 17.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.012 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -89.07 131.44 35.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.293 0.568 . . . . 0.0 111.518 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.0 m -140.91 63.41 1.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.4 t90 -29.18 126.63 0.24 Allowed Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 114.51 -1.223 . . . . 0.0 113.182 -177.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.4 Cg_endo -97.6 26.78 18.46 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.871 -1.304 . . . . 0.0 113.824 0.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -125.05 147.23 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 121.997 -0.439 . . . . 0.0 111.972 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 77.8 m -94.51 128.46 41.11 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.513 HG22 ' HB3' ' A' ' 3' ' ' PRO . 80.5 p -126.15 132.57 51.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 0.0 111.25 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -89.87 112.5 23.87 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.171 -178.951 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 120.099 -0.278 . . . . 0.0 113.496 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.13 118.71 67.85 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 117.599 0.7 . . . . 0.0 111.171 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 72.5 Cg_endo -75.45 50.86 2.77 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.102 2.535 . . . . 0.0 114.616 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -93.54 29.35 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.468 0.652 . . . . 0.0 110.563 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.88 ' HB3' HG21 ' A' ' 16' ' ' THR . 18.1 m -88.95 -31.57 18.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.73 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.05 32.81 56.01 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.202 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -134.1 142.82 47.66 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.047 0.451 . . . . 0.0 110.639 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.6 p -92.95 137.48 32.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 43.7 t -88.91 13.07 13.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.777 0.799 . . . . 0.0 109.572 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -62.9 -31.07 72.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.954 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -77.97 -7.41 56.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.882 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.39 32.25 62.55 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.884 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 t -175.85 149.64 0.95 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -122.52 138.69 54.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -88.67 -31.02 18.72 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.88 HG21 ' HB3' ' A' ' 5' ' ' CYS . 4.8 t -69.97 101.53 1.8 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.008 0.908 . . . . 0.0 111.027 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.29 135.37 44.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.316 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.95 -21.92 43.55 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.697 ' HB2' HG23 ' A' ' 16' ' ' THR . 71.0 m -89.3 135.59 33.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.178 0.513 . . . . 0.0 111.304 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 14.8 m -88.64 151.21 22.61 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.426 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.38 84.69 7.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.215 0.531 . . . . 0.0 110.157 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 m -94.49 75.46 3.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.509 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 12.3 t90 -35.22 127.39 0.55 Allowed Pre-proline 0 N--CA 1.464 0.267 0 O-C-N 124.042 0.839 . . . . 0.0 112.345 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 79.5 Cg_endo -100.0 37.04 6.25 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.174 -1.178 . . . . 0.0 114.369 1.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.92 149.23 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.445 0.641 . . . . 0.0 112.445 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 20' ' ' SER . 64.6 m -88.84 126.26 35.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 44.0 p -112.07 131.59 55.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.13 0.491 . . . . 0.0 112.147 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -89.67 102.53 15.22 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.123 -179.492 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 120.31 -0.161 . . . . 0.0 112.97 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.661 HG12 HG23 ' A' ' 4' ' ' ILE . 3.6 t -85.61 121.19 73.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.088 0.444 . . . . 0.0 110.556 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.9 Cg_exo -77.93 53.52 4.46 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.019 2.479 . . . . 0.0 114.451 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.683 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -99.39 25.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.522 . . . . 0.0 110.832 178.655 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.843 ' HB3' HG21 ' A' ' 16' ' ' THR . 11.2 m -88.85 -34.66 16.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.89 32.57 63.54 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.565 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.436 ' OE1' HG22 ' A' ' 16' ' ' THR . 86.0 mt-10 -131.36 141.97 49.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 120.924 0.392 . . . . 0.0 111.012 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -103.13 128.6 50.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.617 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 32.1 p -103.61 53.74 0.75 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.367 0.604 . . . . 0.0 110.824 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -56.43 -39.29 72.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.363 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.54 22.64 2.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.171 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.36 44.81 97.18 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.089 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.6 t -161.75 145.7 12.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 61.8 m -125.69 141.67 51.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.837 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.53 -31.71 18.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.843 HG21 ' HB3' ' A' ' 5' ' ' CYS . 4.5 t -71.12 100.13 1.99 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.027 0.918 . . . . 0.0 110.681 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 125.32 21.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.394 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.56 -24.42 17.6 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.318 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.674 ' HB2' HG23 ' A' ' 16' ' ' THR . 76.7 m -88.47 135.75 33.32 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 111.216 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 18.3 t -88.99 154.72 19.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.49 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -88.33 92.54 9.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.294 0.569 . . . . 0.0 112.002 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -92.39 64.07 4.29 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 176.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.7 t90 -24.6 123.73 0.19 Allowed Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.63 -176.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 84.5 Cg_endo -99.47 28.17 15.13 Favored 'Cis proline' 0 CA--C 1.537 0.631 0 C-N-CA 124.069 -1.221 . . . . 0.0 113.95 0.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.09 141.74 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 121.92 -0.488 . . . . 0.0 111.778 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 61.1 m -87.92 128.57 35.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.299 . . . . 0.0 110.224 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.3 p -116.11 132.65 56.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.142 0.496 . . . . 0.0 111.65 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 13.1 tpt180 -90.91 106.46 18.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.36 -179.055 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.626 -0.19 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 4' ' ' ILE . 5.8 t -74.55 114.75 37.09 Favored Pre-proline 0 C--O 1.236 0.346 0 CA-C-O 121.312 0.577 . . . . 0.0 111.091 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.6 60.17 7.15 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.955 2.437 . . . . 0.0 113.656 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -87.94 -12.9 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.87 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 62.8 m -88.16 -43.34 11.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.339 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.35 21.62 70.51 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.6 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -89.61 146.99 24.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.717 0.258 . . . . 0.0 110.506 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -94.8 127.53 40.87 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 10.2 t -98.41 38.33 1.36 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.115 0.484 . . . . 0.0 110.395 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p -61.54 -37.87 85.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.989 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.44 7.48 28.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.114 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.52 94.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.792 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.5 m -157.65 132.59 8.7 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.827 -0.22 . . . . 0.0 110.693 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -119.25 134.74 55.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.9 -27.05 21.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.002 0.43 . . . . 0.0 110.609 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.52 ' HB ' ' SG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -77.78 104.6 8.42 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.363 0.602 . . . . 0.0 112.192 -179.244 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.66 131.91 50.36 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.529 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.32 -27.15 20.45 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.09 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.5 130.65 35.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.205 0.526 . . . . 0.0 110.648 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 16.0 t -88.68 162.46 16.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.849 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.0 t -87.59 83.29 7.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.288 0.566 . . . . 0.0 111.595 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.3 m -89.8 65.11 6.65 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.3 t90 -30.7 126.06 0.29 Allowed Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 114.662 -1.154 . . . . 0.0 112.867 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 87.1 Cg_endo -98.6 33.85 9.07 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.888 -1.297 . . . . 0.0 114.005 0.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.56 140.62 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 112.1 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 20' ' ' SER . 62.5 m -89.46 120.68 31.0 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.8 p -132.44 138.69 47.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.849 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -88.61 99.37 12.27 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.167 -178.688 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 120.046 -0.308 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.828 HG13 HD12 ' A' ' 4' ' ' ILE . 14.7 p -89.68 125.97 59.4 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 117.654 0.727 . . . . 0.0 111.461 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.579 ' HB3' HG22 ' A' ' 27' ' ' THR . 83.6 Cg_endo -79.48 54.64 5.28 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.909 2.406 . . . . 0.0 114.508 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.828 HD12 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -88.27 15.0 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.416 0.627 . . . . 0.0 110.209 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.3 m -89.3 -36.61 15.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.428 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.54 34.56 73.62 Favored Glycine 0 C--O 1.227 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.223 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -130.47 143.06 50.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.825 0.345 . . . . 0.0 110.795 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . 20.9 p -92.31 129.94 38.13 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.638 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.439 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 14.9 t -95.75 34.49 1.5 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.346 0.593 . . . . 0.0 110.109 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -63.43 -27.38 69.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.175 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.4 mt -95.9 13.31 27.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.082 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.44 45.17 96.45 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.583 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -167.33 151.77 6.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.696 0.284 . . . . 0.0 110.38 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -137.17 138.0 39.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -89.04 -28.14 20.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.133 0.492 . . . . 0.0 109.803 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.506 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -68.1 105.55 2.1 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.634 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.07 136.26 56.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.067 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.72 -11.48 66.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.848 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.506 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 95.1 m -88.94 132.1 34.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.107 0.48 . . . . 0.0 111.02 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 m -89.44 154.89 19.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.855 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.3 t -88.82 123.73 33.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.215 0.531 . . . . 0.0 111.028 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.9 t -131.38 67.47 1.51 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 21.5 t90 -31.33 128.18 0.29 Allowed Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.906 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 79.4 Cg_endo -97.93 32.69 10.39 Favored 'Cis proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.921 -1.283 . . . . 0.0 114.146 0.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 14.5 p -135.67 146.91 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 121.66 -0.65 . . . . 0.0 112.139 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 64.6 m -89.35 127.97 35.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 3' ' ' PRO . 33.2 p -129.26 130.36 46.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.158 0.504 . . . . 0.0 111.142 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.9 ttm180 -91.86 116.44 28.91 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.646 -179.188 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.5 t -85.97 117.53 68.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 117.125 0.462 . . . . 0.0 110.635 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.7 Cg_exo -75.16 51.14 2.76 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.138 2.558 . . . . 0.0 113.568 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 28' ' ' ARG . 1.9 pp -94.88 24.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.002 0.429 . . . . 0.0 111.391 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 20.5 m -88.69 -34.11 17.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.83 -5.59 46.55 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.887 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.602 ' OE1' HG22 ' A' ' 16' ' ' THR . 40.2 mt-10 -89.79 142.21 27.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.321 0.561 . . . . 0.0 110.726 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p -97.2 127.13 42.88 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 28.2 p -105.58 48.26 0.84 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.461 0.648 . . . . 0.0 110.73 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -61.25 -26.27 67.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.595 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -97.14 17.25 17.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.653 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.57 45.92 94.84 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.05 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -164.54 151.88 11.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.825 0.312 . . . . 0.0 111.031 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.6 m -132.61 142.15 49.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -88.28 -31.33 19.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.131 0.491 . . . . 0.0 109.705 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.604 HG21 ' HB3' ' A' ' 5' ' ' CYS . 5.4 t -73.98 100.11 3.47 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.902 0.858 . . . . 0.0 110.482 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.47 125.08 18.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.103 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.46 -25.32 11.27 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.131 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.602 ' HB2' HG23 ' A' ' 16' ' ' THR . 96.7 m -87.84 132.64 34.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.175 0.512 . . . . 0.0 110.984 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.5 m -89.53 156.38 18.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.286 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.4 t -88.56 124.74 34.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.552 0.691 . . . . 0.0 111.331 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.8 m -128.68 67.25 1.4 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 4.0 t90 -24.32 122.93 0.19 Allowed Pre-proline 0 N--CA 1.463 0.194 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.581 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 68.1 Cg_endo -100.86 26.6 15.32 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.084 -1.215 . . . . 0.0 114.165 0.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.9 t -125.99 147.84 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.765 -0.584 . . . . 0.0 111.768 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 75.9 m -88.26 131.07 34.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.79 0.329 . . . . 0.0 110.243 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 30.7 p -110.09 136.94 48.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.153 0.501 . . . . 0.0 111.599 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.646 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 8.0 tpt180 -105.15 108.87 20.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.424 -179.202 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 120.233 -0.204 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.72 HG12 HG23 ' A' ' 4' ' ' ILE . 10.6 t -74.54 116.43 53.2 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 121.221 0.534 . . . . 0.0 110.825 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.96 57.78 6.42 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.789 2.326 . . . . 0.0 113.992 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.747 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -88.91 33.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.356 0.598 . . . . 0.0 110.778 178.82 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' SG ' HG21 ' A' ' 16' ' ' THR . 91.1 m -141.48 -49.91 0.41 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.698 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.89 22.8 77.12 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.942 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.627 ' OE1' HG22 ' A' ' 16' ' ' THR . 42.7 mt-10 -89.06 145.53 25.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.004 0.402 . . . . 0.0 109.971 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.4 p -89.08 125.64 35.1 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 10.3 t -102.81 34.6 2.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.141 0.496 . . . . 0.0 109.953 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -34.56 75.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.096 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.12 11.25 23.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.857 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.18 41.08 98.49 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.777 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.8 m -157.0 131.6 8.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.689 0.28 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.3 m -113.79 141.54 47.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -88.45 -31.36 18.83 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.627 HG22 ' OE1' ' A' ' 7' ' ' GLU . 3.4 t -71.9 99.08 2.14 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.985 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.16 64.32 0.1 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.989 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.52 -32.43 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.162 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.568 ' HB2' HG23 ' A' ' 16' ' ' THR . 2.1 m -89.42 145.98 24.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.861 0.362 . . . . 0.0 110.995 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -89.03 156.43 18.86 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.8 t -88.57 128.61 35.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.342 0.591 . . . . 0.0 111.168 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 m -137.3 72.5 1.42 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.7 t90 -30.93 125.5 0.31 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.871 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.4 Cg_endo -100.41 33.43 8.68 Favored 'Cis proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.15 -1.187 . . . . 0.0 113.961 0.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.5 t -135.74 141.39 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 121.866 -0.521 . . . . 0.0 112.206 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 62.0 m -89.66 121.94 32.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.9 p -140.48 150.39 43.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.817 0.341 . . . . 0.0 110.407 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.568 ' HB3' HD11 ' A' ' 4' ' ' ILE . 8.9 tpt85 -96.18 101.51 13.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.351 -178.848 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 CA-C-O 120.368 -0.129 . . . . 0.0 112.817 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.624 HG12 HG23 ' A' ' 4' ' ' ILE . 4.4 t -80.42 124.21 82.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 27' ' ' THR . 88.7 Cg_endo -79.75 52.67 4.4 Favored 'Trans proline' 0 CA--C 1.527 0.158 0 C-N-CA 122.709 2.272 . . . . 0.0 114.181 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -89.96 8.06 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.994 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 3.7 m -88.81 -36.01 16.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.109 0.481 . . . . 0.0 109.78 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.59 29.57 74.08 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.027 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 35.2 mt-10 -113.36 144.81 42.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.614 0.245 . . . . 0.0 110.604 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.4 p -91.22 129.19 37.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.332 -0.394 . . . . 0.0 109.939 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.454 ' O ' ' HD1' ' A' ' 23' ' ' TRP . 44.5 t -89.76 20.35 4.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.541 0.686 . . . . 0.0 109.661 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -58.93 -39.25 81.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.275 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.26 6.83 47.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.892 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.58 46.02 95.13 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.892 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 m -156.72 133.99 10.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.852 0.326 . . . . 0.0 111.152 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.8 m -126.4 136.77 53.1 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -88.34 -27.22 21.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.697 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.4 m -77.21 103.24 7.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.126 0.488 . . . . 0.0 110.753 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.35 122.93 13.73 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.334 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.94 -17.2 22.66 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.79 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 96.1 m -87.92 135.95 33.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.86 0.362 . . . . 0.0 110.378 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -88.28 143.6 26.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.826 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 t -87.61 81.54 7.69 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 m -89.97 76.5 7.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 26.9 t90 -34.89 127.07 0.52 Allowed Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 124.066 0.854 . . . . 0.0 112.382 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.1 Cg_endo -99.96 35.67 7.2 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.19 -1.171 . . . . 0.0 114.082 0.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.89 141.14 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.468 0.651 . . . . 0.0 112.445 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 93.0 m -88.52 116.16 26.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 3' ' ' PRO . 23.1 p -121.98 132.61 54.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.003 0.43 . . . . 0.0 111.253 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.663 ' HB3' HD11 ' A' ' 4' ' ' ILE . 32.0 ttt85 -89.11 112.94 24.03 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 C--N 1.328 -0.368 0 O-C-N 123.564 0.54 . . . . 0.0 110.014 -178.82 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.505 0 N-CA-C 112.783 -0.127 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.711 HG12 HG23 ' A' ' 4' ' ' ILE . 3.3 t -81.59 119.15 74.79 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.94 0.4 . . . . 0.0 110.599 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.6 Cg_exo -79.33 51.49 3.89 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.118 2.545 . . . . 0.0 114.134 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.711 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.29 17.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.153 0.501 . . . . 0.0 110.617 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.2 m -89.45 -34.77 16.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.192 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.65 34.96 79.57 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.394 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -128.71 143.02 50.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.881 0.372 . . . . 0.0 111.34 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.4 p -97.19 127.11 42.86 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 7.6 t -99.74 35.66 1.96 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.977 0.418 . . . . 0.0 110.701 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -34.84 74.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.8 mt -98.44 14.23 28.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.41 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 63.44 49.33 70.88 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.918 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.2 m -155.68 134.96 12.29 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.667 -0.313 . . . . 0.0 111.062 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.5 m -137.45 135.02 36.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.87 -26.2 21.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.913 0.387 . . . . 0.0 110.306 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 m -73.25 97.33 2.42 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.23 0.538 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.84 127.92 30.76 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.14 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.407 ' HA3' HH12 ' A' ' 28' ' ' ARG . . . 106.94 -16.11 39.74 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.075 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.2 m -88.63 134.96 33.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.077 0.465 . . . . 0.0 110.808 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -88.49 155.31 19.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.099 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.0 t -87.99 84.63 6.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.071 0.462 . . . . 0.0 111.692 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 m -90.5 67.25 6.51 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 14.2 t90 -32.31 125.97 0.37 Allowed Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 124.461 1.101 . . . . 0.0 112.734 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.6 Cg_endo -99.44 36.33 6.87 Favored 'Cis proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.102 -1.207 . . . . 0.0 113.937 0.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.58 142.74 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 121.754 -0.591 . . . . 0.0 112.152 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 53.9 m -88.84 123.4 33.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.9 p -125.87 133.66 51.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.201 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HB3' HD11 ' A' ' 4' ' ' ILE . 51.7 ttm-85 -88.8 107.97 19.25 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.331 -179.019 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 112.758 -0.137 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.692 HG12 HG23 ' A' ' 4' ' ' ILE . 3.7 t -86.0 120.69 72.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.028 0.414 . . . . 0.0 110.391 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.2 Cg_exo -78.41 52.29 4.07 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.946 2.431 . . . . 0.0 114.202 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.703 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -92.46 20.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.049 0.452 . . . . 0.0 110.911 178.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 10.9 m -89.11 -29.66 19.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.006 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.79 32.5 74.12 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.355 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.64 143.81 51.11 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.845 0.355 . . . . 0.0 110.997 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -97.93 129.2 44.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 8.8 t -98.5 34.39 2.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.036 0.446 . . . . 0.0 110.419 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -34.94 75.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.859 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.95 11.99 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.887 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.46 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 62.97 46.58 93.25 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.912 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m -156.39 135.57 12.08 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.659 -0.318 . . . . 0.0 111.079 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 m -132.35 135.87 46.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -88.76 -25.51 22.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.75 0.31 . . . . 0.0 110.444 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -72.86 97.63 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.147 0.498 . . . . 0.0 110.672 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.7 126.35 23.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.794 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.77 -16.81 33.46 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.94 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.2 m -88.96 132.25 34.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.022 0.439 . . . . 0.0 110.738 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -89.2 157.73 18.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.776 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.7 t -89.05 129.8 35.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.292 0.568 . . . . 0.0 111.424 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -138.53 68.63 1.39 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.2 t90 -31.68 126.03 0.33 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.931 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.2 Cg_endo -99.94 34.23 8.28 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.144 -1.19 . . . . 0.0 113.883 0.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.46 146.22 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.743 -0.598 . . . . 0.0 111.936 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.5 m -89.26 126.09 35.36 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 77.2 p -117.97 131.22 56.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.206 0.527 . . . . 0.0 111.596 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.561 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 35.4 ttt85 -92.56 108.21 19.8 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.926 -178.506 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 112.688 -0.165 . . . . 0.0 112.688 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.4 t -90.13 117.94 68.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 117.023 0.412 . . . . 0.0 110.764 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 70.1 Cg_endo -74.9 51.57 2.78 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.854 2.37 . . . . 0.0 113.637 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -91.83 26.58 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.023 0.44 . . . . 0.0 111.61 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.7 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 22.1 m -89.0 -26.19 21.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.781 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.61 33.8 67.24 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.256 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -131.03 142.55 50.33 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.149 0.499 . . . . 0.0 110.965 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -94.49 132.6 38.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.082 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 52.6 t -89.12 21.72 3.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.575 0.702 . . . . 0.0 109.428 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -60.47 -38.64 84.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.07 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.6 mt -92.4 5.22 51.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.08 41.1 99.68 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.263 -0.494 . . . . 0.0 112.876 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -158.31 134.12 9.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.738 0.304 . . . . 0.0 110.909 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 m -125.02 136.6 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.33 -25.59 22.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.816 0.341 . . . . 0.0 110.27 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -71.56 101.63 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.091 0.472 . . . . 0.0 110.365 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.1 24.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.905 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.5 -16.68 40.8 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.286 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.9 m -87.76 136.5 32.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.137 0.494 . . . . 0.0 110.846 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -88.28 141.89 28.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.96 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.09 87.29 7.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.431 . . . . 0.0 110.187 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 p -100.45 85.22 2.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 21.5 t90 -37.03 127.59 0.78 Allowed Pre-proline 0 N--CA 1.462 0.152 0 O-C-N 123.998 0.811 . . . . 0.0 112.261 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 70.7 Cg_endo -102.23 33.81 7.59 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.372 -1.095 . . . . 0.0 114.148 0.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 t -139.43 147.43 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 121.767 -0.583 . . . . 0.0 112.217 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.9 m -88.96 120.41 30.35 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 9.4 p -106.93 138.79 42.43 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.7 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 10.7 tpt180 -111.04 110.58 21.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.701 -178.978 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 CA-C-O 120.327 -0.152 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.706 HG12 HG23 ' A' ' 4' ' ' ILE . 3.8 t -84.18 120.94 75.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 117.055 0.427 . . . . 0.0 110.505 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.7 Cg_exo -78.88 52.23 4.15 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.018 2.479 . . . . 0.0 114.019 -178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.706 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.53 18.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.744 178.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.9 m -88.95 -37.96 14.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.762 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.73 42.82 95.06 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.4 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 26' ' ' CYS . 8.7 pt-20 -144.95 142.96 30.28 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.126 0.489 . . . . 0.0 110.957 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.3 p -98.57 131.23 44.95 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.697 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.797 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 28.5 p -103.3 56.47 0.75 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.237 0.541 . . . . 0.0 110.374 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 p -54.76 -41.0 69.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.572 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -93.15 22.68 4.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.226 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.27 45.58 96.19 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.955 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.5 m -149.11 132.28 16.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.525 -0.397 . . . . 0.0 111.058 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -110.07 140.29 44.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.032 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -89.56 -32.93 16.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.822 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.1 m -82.33 114.53 20.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.188 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.51 125.7 24.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.638 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.87 -17.26 38.81 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.827 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 72.4 m -88.83 129.78 35.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.135 0.493 . . . . 0.0 110.688 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 20.7 t -89.28 153.05 21.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.2 t -87.8 91.65 8.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.461 0.648 . . . . 0.0 111.915 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.5 m -89.94 63.94 6.15 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 t90 -25.46 124.65 0.2 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 114.076 -1.42 . . . . 0.0 113.412 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 76.6 Cg_endo -98.51 28.27 15.82 Favored 'Cis proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.928 -1.28 . . . . 0.0 114.083 0.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.1 141.01 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 121.853 -0.529 . . . . 0.0 111.797 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 98.3 m -88.65 131.46 34.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.816 0.341 . . . . 0.0 110.782 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.6 p -124.5 131.19 53.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.579 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.474 ' HB3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -89.19 109.23 20.13 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.443 -178.704 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 112.643 -0.183 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 t -81.12 125.72 78.85 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.121 0.486 . . . . 0.0 111.336 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.7 71.72 4.68 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.928 2.419 . . . . 0.0 112.925 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.611 HD12 ' HB3' ' A' ' 28' ' ' ARG . 3.3 mt -87.27 -30.26 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.0 m -87.45 -39.56 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.421 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.37 31.53 79.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.606 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 34.1 mt-10 -89.07 153.06 21.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -89.95 129.57 36.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.166 0.507 . . . . 0.0 109.977 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 52.6 t -91.39 14.91 13.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.475 0.655 . . . . 0.0 109.764 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -61.21 -35.63 77.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.813 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.2 mt -84.84 -6.88 59.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.532 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.54 35.27 80.87 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.881 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.3 m -159.97 124.81 3.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.765 0.317 . . . . 0.0 111.027 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.5 m -99.73 138.29 37.03 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -89.02 -28.06 20.44 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.019 0.438 . . . . 0.0 110.316 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -86.68 103.85 15.53 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.483 0.658 . . . . 0.0 111.433 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.36 126.52 21.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.659 ' HA3' ' NH1' ' A' ' 28' ' ' ARG . . . 116.05 -27.37 8.23 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.734 -0.745 . . . . 0.0 111.8 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 1.7 m -88.42 134.23 33.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.105 0.479 . . . . 0.0 110.455 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 13.7 m -88.03 148.82 24.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.706 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 t -86.56 80.75 8.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.251 0.548 . . . . 0.0 110.087 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.5 m -89.94 74.65 7.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.578 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 19.6 t90 -33.63 126.97 0.44 Allowed Pre-proline 0 N--CA 1.464 0.258 0 O-C-N 124.122 0.889 . . . . 0.0 112.692 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.7 Cg_endo -99.46 33.97 8.68 Favored 'Cis proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.055 -1.227 . . . . 0.0 114.085 0.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.53 140.63 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.474 0.654 . . . . 0.0 112.498 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 99.2 m -88.91 116.14 26.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 p -124.05 135.57 53.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.143 0.497 . . . . 0.0 111.384 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.659 ' NH1' ' HA3' ' A' ' 18' ' ' GLY . 61.3 ttm-85 -88.59 109.22 19.91 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.404 0.621 . . . . 0.0 109.546 -178.196 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 CA-C-O 120.377 -0.124 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.589 HG12 HG23 ' A' ' 4' ' ' ILE . 5.6 t -85.04 125.3 70.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.868 0.366 . . . . 0.0 110.316 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 3.0 Cg_exo -76.26 50.44 2.89 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.997 2.465 . . . . 0.0 114.598 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.637 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -94.68 32.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.309 0.576 . . . . 0.0 110.459 178.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.6 m -92.9 -39.54 11.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.369 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.9 36.09 53.05 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.293 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.643 ' OE2' HG22 ' A' ' 16' ' ' THR . 10.3 pt-20 -150.42 142.87 24.39 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.269 0.557 . . . . 0.0 110.442 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -89.62 133.16 34.76 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.676 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 11.9 t -91.78 41.66 1.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.185 0.517 . . . . 0.0 109.755 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.0 p -61.83 -37.79 85.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.022 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.94 -1.43 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.153 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.84 34.21 62.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.58 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.1 m -159.42 126.27 4.59 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.0 m -95.93 137.4 35.05 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -88.58 -28.59 20.62 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.991 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.643 HG22 ' OE2' ' A' ' 7' ' ' GLU . 10.8 t -84.59 111.91 19.96 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 122.344 1.069 . . . . 0.0 111.257 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.16 135.41 43.84 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.028 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.2 -22.44 37.88 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.399 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 65.3 m -88.85 132.78 34.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.407 0.622 . . . . 0.0 111.865 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m -89.32 151.57 22.02 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.247 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.3 t -88.78 110.73 21.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.263 0.554 . . . . 0.0 111.765 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 p -117.93 71.33 0.82 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 t90 -32.28 128.95 0.33 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.796 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.4 Cg_endo -99.45 30.83 11.8 Favored 'Cis proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.037 -1.235 . . . . 0.0 114.102 0.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.4 t -132.44 147.41 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.838 -0.539 . . . . 0.0 111.433 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 88.3 m -90.53 133.64 34.93 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.108 -0.37 . . . . 0.0 110.211 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.4 p -123.79 131.55 53.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.101 0.477 . . . . 0.0 111.415 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 50.2 ttm-85 -93.0 109.96 21.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.426 -179.239 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-O 120.332 -0.149 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.588 HG12 HG23 ' A' ' 4' ' ' ILE . 10.5 t -90.99 123.41 64.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 117.181 0.491 . . . . 0.0 110.467 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 3.8 Cg_exo -74.29 53.07 2.91 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.002 2.468 . . . . 0.0 114.199 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.588 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.41 25.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.992 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 7.8 m -88.96 -32.8 17.48 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.48 42.22 95.9 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.713 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -150.23 147.12 27.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.113 0.483 . . . . 0.0 111.072 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.6 p -89.71 134.03 34.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.394 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.858 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 22.0 p -96.19 49.36 1.13 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.388 0.613 . . . . 0.0 111.284 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -60.54 136.3 58.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt 72.64 9.03 5.65 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.613 0.57 . . . . 0.0 111.133 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.19 56.44 5.21 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.718 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 10.0 t -150.41 142.48 24.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.065 0.459 . . . . 0.0 111.294 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.5 m -133.24 140.13 47.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.402 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -87.64 -31.61 19.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.034 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.545 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 8.4 m -78.65 112.92 16.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.623 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.31 125.86 25.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.646 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.76 52.04 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.37 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 90.0 m -88.16 128.48 35.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.148 0.499 . . . . 0.0 110.779 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 15.6 m -88.82 153.91 20.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.653 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.3 t -88.01 91.17 8.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.335 0.588 . . . . 0.0 112.086 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 m -93.96 62.93 3.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.8 t90 -27.88 127.96 0.21 Allowed Pre-proline 0 C--O 1.231 0.107 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.572 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 71.2 Cg_endo -96.48 26.34 19.96 Favored 'Cis proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.5 -1.458 . . . . 0.0 114.203 0.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.19 144.83 32.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 121.793 -0.567 . . . . 0.0 112.377 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.858 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 70.9 m -87.71 130.76 34.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 110.206 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 24.3 p -112.67 130.49 56.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.108 0.48 . . . . 0.0 111.208 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.485 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 14.5 tpt180 -94.54 108.48 20.43 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.589 -179.311 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 112.917 -0.073 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.726 HG12 HG23 ' A' ' 4' ' ' ILE . 3.4 t -82.05 118.71 73.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 110.545 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 4.8 Cg_exo -79.52 51.71 3.99 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.075 2.517 . . . . 0.0 114.165 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.726 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -90.75 18.24 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.154 0.502 . . . . 0.0 110.659 178.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.2 m -89.52 -37.23 14.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.228 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.47 36.19 88.23 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.645 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 48.1 mt-10 -131.81 145.63 51.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.685 0.279 . . . . 0.0 111.208 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 p -89.56 132.4 35.1 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.724 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.3 p -101.09 53.65 0.84 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.581 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.6 p -61.88 122.12 14.62 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 67.02 27.2 8.82 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.649 0.593 . . . . 0.0 110.828 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.32 44.87 89.71 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.585 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 26.9 m -118.88 128.5 54.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.987 0.394 . . . . 0.0 111.493 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.9 m -145.08 134.95 23.64 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.458 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 5.9 m-85 -89.64 -29.66 18.66 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.7 m -72.81 99.77 2.72 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.749 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.21 129.58 38.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.102 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA3' HH12 ' A' ' 28' ' ' ARG . . . 104.16 -16.51 49.62 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.245 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.04 128.88 35.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.002 0.429 . . . . 0.0 110.85 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -89.41 159.51 17.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.552 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.6 t -88.91 120.84 30.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.649 0.738 . . . . 0.0 111.756 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -123.98 63.84 1.06 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 11.9 t90 -26.1 125.99 0.2 Allowed Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 113.741 -1.572 . . . . 0.0 113.567 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 76.1 Cg_endo -98.04 29.41 14.61 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.7 -1.375 . . . . 0.0 114.328 0.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.69 147.82 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.724 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 55.5 m -87.97 130.98 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.2 p -125.96 132.33 52.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.172 0.511 . . . . 0.0 111.101 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.425 HH12 ' HA3' ' A' ' 18' ' ' GLY . 52.0 ttm-85 -90.35 107.77 19.35 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.24 0.543 . . . . 0.0 110.047 -178.6 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 120.171 -0.238 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.747 HG12 HG23 ' A' ' 4' ' ' ILE . 3.4 t -81.17 116.77 64.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 117.247 0.523 . . . . 0.0 110.476 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.3 Cg_exo -78.86 52.44 4.24 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.021 2.481 . . . . 0.0 114.376 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.747 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -95.33 16.99 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.79 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.0 m -88.75 -33.74 17.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.124 0.487 . . . . 0.0 109.783 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.29 31.03 73.8 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.666 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 99.3 mt-10 -120.2 144.19 47.85 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.843 0.354 . . . . 0.0 110.815 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -94.78 133.6 38.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.468 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 44.2 t -89.36 20.14 4.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.525 0.679 . . . . 0.0 109.845 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -62.6 -30.39 71.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.277 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.64 5.65 50.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.737 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.14 37.34 93.78 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.853 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.3 m -158.52 130.02 6.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.721 0.296 . . . . 0.0 110.791 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.8 m -109.36 139.47 44.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.42 -30.5 18.29 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.041 0.448 . . . . 0.0 109.846 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.1 m -78.82 108.56 12.35 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.43 0.633 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.28 137.87 46.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.79 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.71 -17.62 58.24 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.492 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -87.96 133.67 33.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.17 0.509 . . . . 0.0 110.349 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 12.7 m -88.01 147.81 24.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.87 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.35 82.27 7.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.178 0.513 . . . . 0.0 110.011 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 m -91.36 73.92 6.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 37.9 t90 -34.45 127.58 0.48 Allowed Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 123.975 0.797 . . . . 0.0 112.474 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 91.5 Cg_endo -98.69 33.35 9.49 Favored 'Cis proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.079 -1.217 . . . . 0.0 114.287 0.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -137.44 141.98 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 112.569 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 20' ' ' SER . 87.5 m -88.81 123.9 33.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.9 p -123.06 139.22 54.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.151 0.5 . . . . 0.0 112.128 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HB3' HD11 ' A' ' 4' ' ' ILE . 16.0 tpp85 -88.22 98.91 11.83 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.438 -178.834 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.508 0 CA-C-O 120.188 -0.229 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.838 HG13 HD12 ' A' ' 4' ' ' ILE . 13.3 p -91.62 126.17 55.05 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 117.61 0.705 . . . . 0.0 111.319 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.624 ' HB3' HG22 ' A' ' 27' ' ' THR . 73.2 Cg_endo -78.83 54.08 4.95 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 123.027 2.485 . . . . 0.0 114.601 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.838 HD12 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -88.38 16.15 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.488 0.661 . . . . 0.0 110.09 178.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -89.06 -37.2 15.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.273 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.57 35.04 80.22 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.943 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -129.83 143.53 50.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.791 0.329 . . . . 0.0 110.671 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 p -104.21 130.93 51.99 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.603 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 29.3 p -107.1 58.95 0.63 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.366 0.603 . . . . 0.0 111.019 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -56.89 -39.49 74.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.139 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.62 20.41 9.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.859 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.76 48.01 84.55 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.989 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.2 m -149.2 135.94 19.59 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.575 -0.367 . . . . 0.0 110.722 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 59.9 m -130.0 137.53 50.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -89.64 -29.02 19.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.304 0.573 . . . . 0.0 109.738 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.539 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -69.74 107.15 3.36 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.713 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.57 135.84 56.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.06 -14.38 62.23 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.562 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 82.0 m -89.71 128.03 36.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.045 0.45 . . . . 0.0 111.015 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.6 t -89.44 153.4 20.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.329 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.7 t -88.67 88.69 7.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.248 0.547 . . . . 0.0 111.759 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 p -89.77 69.36 7.62 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 6.2 t90 -26.94 126.04 0.21 Allowed Pre-proline 0 N--CA 1.465 0.275 0 CA-C-N 113.872 -1.513 . . . . 0.0 113.518 -176.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 74.8 Cg_endo -99.9 29.35 13.24 Favored 'Cis proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.07 -1.221 . . . . 0.0 113.7 0.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.6 143.56 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.031 -0.418 . . . . 0.0 111.813 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 60.9 m -89.09 127.22 35.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.624 HG22 ' HB3' ' A' ' 3' ' ' PRO . 31.0 p -127.18 130.15 49.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.098 0.475 . . . . 0.0 111.347 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.592 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.3 ttm180 -91.34 116.85 29.16 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.1 m120 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.888 -179.544 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.472 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.674 HG12 HG23 ' A' ' 4' ' ' ILE . 3.0 t -80.91 124.64 81.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.044 0.45 . . . . 0.0 110.813 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 27' ' ' THR . 96.4 Cg_endo -80.81 50.77 3.68 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.727 2.284 . . . . 0.0 113.982 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -92.55 16.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.214 0.53 . . . . 0.0 110.69 178.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.85 ' HB3' HG21 ' A' ' 16' ' ' THR . 8.9 m -89.34 -37.07 15.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.889 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.71 37.28 84.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.163 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -133.72 147.04 51.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.855 0.359 . . . . 0.0 110.613 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 p -102.39 130.83 49.25 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.475 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 11.1 t -95.61 40.61 1.11 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.115 0.483 . . . . 0.0 109.881 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.6 p -59.13 -42.58 90.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.58 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.7 mt -85.65 10.29 13.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.237 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.23 36.3 92.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.701 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -157.85 128.79 6.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.673 0.273 . . . . 0.0 110.58 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -107.63 140.04 41.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -88.38 -31.29 18.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.85 HG21 ' HB3' ' A' ' 5' ' ' CYS . 3.5 t -70.49 97.81 1.35 Allowed 'General case' 0 C--O 1.242 0.695 0 CA-C-O 122.04 0.924 . . . . 0.0 111.065 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.76 123.65 16.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.116 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.48 -22.6 14.92 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.041 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 85.8 m -88.37 139.27 30.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.088 0.471 . . . . 0.0 111.275 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.6 m -88.53 151.87 22.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.849 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.5 t -88.85 112.47 23.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 111.534 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.3 m -117.91 68.93 0.77 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 12.1 t90 -31.75 126.56 0.33 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.847 -177.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.4 Cg_endo -99.56 32.24 10.23 Favored 'Cis proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.077 -1.218 . . . . 0.0 113.984 0.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.78 142.38 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 121.799 -0.563 . . . . 0.0 111.862 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 77.5 m -89.54 124.73 34.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 3' ' ' PRO . 53.0 p -129.71 130.67 45.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.908 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.689 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 49.7 ttt180 -91.8 118.39 30.65 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.896 -178.979 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 120.371 -0.127 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.719 HG12 HG23 ' A' ' 4' ' ' ILE . 3.5 t -80.65 121.17 80.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.071 0.462 . . . . 0.0 110.709 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.25 52.16 4.21 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.691 2.261 . . . . 0.0 114.248 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.719 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -92.08 12.3 2.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.781 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -88.73 -36.66 16.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.164 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.75 33.06 83.07 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.147 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.33 144.87 48.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.798 0.332 . . . . 0.0 111.342 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -105.82 126.88 52.69 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.688 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 31.7 p -106.31 54.71 0.68 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.232 0.539 . . . . 0.0 111.104 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 p -57.05 -39.16 74.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.812 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -95.45 19.73 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.018 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.3 51.12 57.28 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.054 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.0 t -155.52 146.05 22.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.832 0.349 . . . . 0.0 111.329 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.2 m -140.82 139.65 34.55 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.46 -26.96 21.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.735 0.302 . . . . 0.0 110.326 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 m -73.83 106.31 5.5 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.176 0.512 . . . . 0.0 110.629 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.42 123.98 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.764 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.0 -17.57 32.09 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.11 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -88.13 130.11 35.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.112 0.482 . . . . 0.0 110.69 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.4 m -89.02 152.18 21.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.703 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.0 t -87.89 91.61 8.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.37 0.605 . . . . 0.0 111.407 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -89.66 64.07 6.42 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 6.6 t90 -25.42 124.28 0.2 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 114.017 -1.447 . . . . 0.0 113.543 -176.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.3 Cg_endo -99.25 30.38 12.52 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.085 -1.215 . . . . 0.0 113.819 0.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.14 140.25 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 O-C-N 122.015 -0.428 . . . . 0.0 111.952 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 62.9 m -87.82 126.61 35.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.2 p -129.18 132.57 47.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.088 0.471 . . . . 0.0 111.093 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HB3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -89.31 106.99 18.8 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.744 -177.847 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.713 HG12 HG23 ' A' ' 4' ' ' ILE . 3.0 t -82.21 121.01 78.39 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.058 0.456 . . . . 0.0 110.562 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HB3' HG22 ' A' ' 27' ' ' THR . 89.9 Cg_endo -80.12 50.69 3.62 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.687 2.258 . . . . 0.0 114.308 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -93.67 18.94 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.33 0.586 . . . . 0.0 110.322 178.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.7 m -89.74 -34.65 16.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.184 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.13 38.18 93.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.734 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.54 152.79 49.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.96 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -107.91 130.06 55.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.045 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 16.6 t -100.04 34.29 2.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.298 0.57 . . . . 0.0 109.871 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.405 HG23 ' HG ' ' A' ' 11' ' ' LEU . 8.1 t -62.02 -30.07 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.439 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.405 ' HG ' HG23 ' A' ' 10' ' ' THR . 94.4 mt -96.37 15.87 20.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.946 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.16 36.76 93.87 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.535 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.2 m -157.22 135.29 11.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.5 m -112.66 133.77 54.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.587 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -88.17 -26.59 22.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.447 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.74 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -72.85 113.46 9.92 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.228 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.16 134.3 56.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.421 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.22 -4.27 77.43 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.353 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.74 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 88.4 m -92.04 135.01 34.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.342 0.571 . . . . 0.0 111.376 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 m -89.28 158.36 17.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.012 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -89.07 131.44 35.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.293 0.568 . . . . 0.0 111.518 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.0 m -140.91 63.41 1.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.4 t90 -29.18 126.63 0.24 Allowed Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 114.51 -1.223 . . . . 0.0 113.182 -177.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.4 Cg_endo -97.6 26.78 18.46 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.871 -1.304 . . . . 0.0 113.824 0.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -125.05 147.23 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 121.997 -0.439 . . . . 0.0 111.972 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 77.8 m -94.51 128.46 41.11 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.513 HG22 ' HB3' ' A' ' 3' ' ' PRO . 80.5 p -126.15 132.57 51.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 0.0 111.25 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -89.87 112.5 23.87 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.171 -178.951 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 120.099 -0.278 . . . . 0.0 113.496 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.13 118.71 67.85 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 117.599 0.7 . . . . 0.0 111.171 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 72.5 Cg_endo -75.45 50.86 2.77 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.102 2.535 . . . . 0.0 114.616 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -93.54 29.35 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.468 0.652 . . . . 0.0 110.563 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.88 ' HB3' HG21 ' A' ' 16' ' ' THR . 18.1 m -88.95 -31.57 18.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.73 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.05 32.81 56.01 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.202 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -134.1 142.82 47.66 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.047 0.451 . . . . 0.0 110.639 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.6 p -92.95 137.48 32.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 43.7 t -88.91 13.07 13.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.777 0.799 . . . . 0.0 109.572 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -62.9 -31.07 72.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.954 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -77.97 -7.41 56.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.882 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.39 32.25 62.55 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.884 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 t -175.85 149.64 0.95 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -122.52 138.69 54.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -88.67 -31.02 18.72 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.88 HG21 ' HB3' ' A' ' 5' ' ' CYS . 4.8 t -69.97 101.53 1.8 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.008 0.908 . . . . 0.0 111.027 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.29 135.37 44.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.316 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.95 -21.92 43.55 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.697 ' HB2' HG23 ' A' ' 16' ' ' THR . 71.0 m -89.3 135.59 33.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.178 0.513 . . . . 0.0 111.304 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 14.8 m -88.64 151.21 22.61 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.426 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.38 84.69 7.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.215 0.531 . . . . 0.0 110.157 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 m -94.49 75.46 3.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.509 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 12.3 t90 -35.22 127.39 0.55 Allowed Pre-proline 0 N--CA 1.464 0.267 0 O-C-N 124.042 0.839 . . . . 0.0 112.345 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 79.5 Cg_endo -100.0 37.04 6.25 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.174 -1.178 . . . . 0.0 114.369 1.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.92 149.23 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.445 0.641 . . . . 0.0 112.445 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 20' ' ' SER . 64.6 m -88.84 126.26 35.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 44.0 p -112.07 131.59 55.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.13 0.491 . . . . 0.0 112.147 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -89.67 102.53 15.22 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.123 -179.492 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 120.31 -0.161 . . . . 0.0 112.97 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.661 HG12 HG23 ' A' ' 4' ' ' ILE . 3.6 t -85.61 121.19 73.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.088 0.444 . . . . 0.0 110.556 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.9 Cg_exo -77.93 53.52 4.46 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.019 2.479 . . . . 0.0 114.451 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.683 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -99.39 25.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.522 . . . . 0.0 110.832 178.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.843 ' HB3' HG21 ' A' ' 16' ' ' THR . 11.2 m -88.85 -34.66 16.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.89 32.57 63.54 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.565 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.436 ' OE1' HG22 ' A' ' 16' ' ' THR . 86.0 mt-10 -131.36 141.97 49.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 120.924 0.392 . . . . 0.0 111.012 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -103.13 128.6 50.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.617 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 32.1 p -103.61 53.74 0.75 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.367 0.604 . . . . 0.0 110.824 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -56.43 -39.29 72.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.363 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.54 22.64 2.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.171 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.36 44.81 97.18 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.089 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.6 t -161.75 145.7 12.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 61.8 m -125.69 141.67 51.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.837 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.53 -31.71 18.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.843 HG21 ' HB3' ' A' ' 5' ' ' CYS . 4.5 t -71.12 100.13 1.99 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.027 0.918 . . . . 0.0 110.681 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 125.32 21.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.394 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.56 -24.42 17.6 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.318 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.674 ' HB2' HG23 ' A' ' 16' ' ' THR . 76.7 m -88.47 135.75 33.32 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 111.216 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 18.3 t -88.99 154.72 19.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.49 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -88.33 92.54 9.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.294 0.569 . . . . 0.0 112.002 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -92.39 64.07 4.29 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 176.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.7 t90 -24.6 123.73 0.19 Allowed Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.63 -176.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 84.5 Cg_endo -99.47 28.17 15.13 Favored 'Cis proline' 0 CA--C 1.537 0.631 0 C-N-CA 124.069 -1.221 . . . . 0.0 113.95 0.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.09 141.74 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 121.92 -0.488 . . . . 0.0 111.778 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 61.1 m -87.92 128.57 35.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.299 . . . . 0.0 110.224 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.3 p -116.11 132.65 56.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.142 0.496 . . . . 0.0 111.65 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.503 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 13.1 tpt180 -90.91 106.46 18.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.36 -179.055 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.626 -0.19 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 4' ' ' ILE . 5.8 t -74.55 114.75 37.09 Favored Pre-proline 0 C--O 1.236 0.346 0 CA-C-O 121.312 0.577 . . . . 0.0 111.091 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.6 60.17 7.15 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.955 2.437 . . . . 0.0 113.656 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -87.94 -12.9 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.87 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 62.8 m -88.16 -43.34 11.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.339 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.35 21.62 70.51 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.6 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -89.61 146.99 24.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.717 0.258 . . . . 0.0 110.506 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -94.8 127.53 40.87 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 10.2 t -98.41 38.33 1.36 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.115 0.484 . . . . 0.0 110.395 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p -61.54 -37.87 85.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.989 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.44 7.48 28.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.114 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.52 94.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.792 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.5 m -157.65 132.59 8.7 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.827 -0.22 . . . . 0.0 110.693 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -119.25 134.74 55.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.9 -27.05 21.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.002 0.43 . . . . 0.0 110.609 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.52 ' HB ' ' SG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -77.78 104.6 8.42 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.363 0.602 . . . . 0.0 112.192 -179.244 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.66 131.91 50.36 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.529 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.32 -27.15 20.45 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.09 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.5 130.65 35.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.205 0.526 . . . . 0.0 110.648 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 16.0 t -88.68 162.46 16.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.849 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.0 t -87.59 83.29 7.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.288 0.566 . . . . 0.0 111.595 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.3 m -89.8 65.11 6.65 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.3 t90 -30.7 126.06 0.29 Allowed Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 114.662 -1.154 . . . . 0.0 112.867 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 87.1 Cg_endo -98.6 33.85 9.07 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.888 -1.297 . . . . 0.0 114.005 0.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.56 140.62 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 112.1 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 20' ' ' SER . 62.5 m -89.46 120.68 31.0 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.8 p -132.44 138.69 47.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.849 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -88.61 99.37 12.27 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.167 -178.688 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 120.046 -0.308 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.828 HG13 HD12 ' A' ' 4' ' ' ILE . 14.7 p -89.68 125.97 59.4 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 117.654 0.727 . . . . 0.0 111.461 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.579 ' HB3' HG22 ' A' ' 27' ' ' THR . 83.6 Cg_endo -79.48 54.64 5.28 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.909 2.406 . . . . 0.0 114.508 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.828 HD12 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -88.27 15.0 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.416 0.627 . . . . 0.0 110.209 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.3 m -89.3 -36.61 15.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.428 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.54 34.56 73.62 Favored Glycine 0 C--O 1.227 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.223 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -130.47 143.06 50.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.825 0.345 . . . . 0.0 110.795 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . 20.9 p -92.31 129.94 38.13 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.638 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.439 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 14.9 t -95.75 34.49 1.5 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.346 0.593 . . . . 0.0 110.109 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -63.43 -27.38 69.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.175 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.4 mt -95.9 13.31 27.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.082 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.44 45.17 96.45 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.583 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -167.33 151.77 6.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.696 0.284 . . . . 0.0 110.38 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -137.17 138.0 39.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -89.04 -28.14 20.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.133 0.492 . . . . 0.0 109.803 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.506 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -68.1 105.55 2.1 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.634 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.07 136.26 56.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.067 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.72 -11.48 66.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.848 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.506 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 95.1 m -88.94 132.1 34.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.107 0.48 . . . . 0.0 111.02 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 m -89.44 154.89 19.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.855 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.3 t -88.82 123.73 33.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.215 0.531 . . . . 0.0 111.028 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.9 t -131.38 67.47 1.51 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 21.5 t90 -31.33 128.18 0.29 Allowed Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.906 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 79.4 Cg_endo -97.93 32.69 10.39 Favored 'Cis proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.921 -1.283 . . . . 0.0 114.146 0.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 14.5 p -135.67 146.91 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 121.66 -0.65 . . . . 0.0 112.139 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 64.6 m -89.35 127.97 35.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 3' ' ' PRO . 33.2 p -129.26 130.36 46.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.158 0.504 . . . . 0.0 111.142 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.9 ttm180 -91.86 116.44 28.91 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.646 -179.188 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.5 t -85.97 117.53 68.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 117.125 0.462 . . . . 0.0 110.635 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.7 Cg_exo -75.16 51.14 2.76 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.138 2.558 . . . . 0.0 113.568 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 28' ' ' ARG . 1.9 pp -94.88 24.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.002 0.429 . . . . 0.0 111.391 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 20.5 m -88.69 -34.11 17.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.83 -5.59 46.55 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.887 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.602 ' OE1' HG22 ' A' ' 16' ' ' THR . 40.2 mt-10 -89.79 142.21 27.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.321 0.561 . . . . 0.0 110.726 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p -97.2 127.13 42.88 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 28.2 p -105.58 48.26 0.84 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.461 0.648 . . . . 0.0 110.73 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -61.25 -26.27 67.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.595 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -97.14 17.25 17.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.653 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.57 45.92 94.84 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.05 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -164.54 151.88 11.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.825 0.312 . . . . 0.0 111.031 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.6 m -132.61 142.15 49.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -88.28 -31.33 19.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.131 0.491 . . . . 0.0 109.705 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.604 HG21 ' HB3' ' A' ' 5' ' ' CYS . 5.4 t -73.98 100.11 3.47 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.902 0.858 . . . . 0.0 110.482 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.47 125.08 18.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.103 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.46 -25.32 11.27 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.131 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.602 ' HB2' HG23 ' A' ' 16' ' ' THR . 96.7 m -87.84 132.64 34.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.175 0.512 . . . . 0.0 110.984 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.5 m -89.53 156.38 18.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.286 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.4 t -88.56 124.74 34.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.552 0.691 . . . . 0.0 111.331 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.8 m -128.68 67.25 1.4 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 4.0 t90 -24.32 122.93 0.19 Allowed Pre-proline 0 N--CA 1.463 0.194 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.581 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 68.1 Cg_endo -100.86 26.6 15.32 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.084 -1.215 . . . . 0.0 114.165 0.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.9 t -125.99 147.84 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.765 -0.584 . . . . 0.0 111.768 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 75.9 m -88.26 131.07 34.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.79 0.329 . . . . 0.0 110.243 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 30.7 p -110.09 136.94 48.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.153 0.501 . . . . 0.0 111.599 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.646 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 8.0 tpt180 -105.15 108.87 20.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.424 -179.202 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 120.233 -0.204 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.72 HG12 HG23 ' A' ' 4' ' ' ILE . 10.6 t -74.54 116.43 53.2 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 121.221 0.534 . . . . 0.0 110.825 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.96 57.78 6.42 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.789 2.326 . . . . 0.0 113.992 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.747 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -88.91 33.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.356 0.598 . . . . 0.0 110.778 178.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' SG ' HG21 ' A' ' 16' ' ' THR . 91.1 m -141.48 -49.91 0.41 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.698 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.89 22.8 77.12 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.942 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.627 ' OE1' HG22 ' A' ' 16' ' ' THR . 42.7 mt-10 -89.06 145.53 25.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.004 0.402 . . . . 0.0 109.971 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.4 p -89.08 125.64 35.1 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 10.3 t -102.81 34.6 2.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.141 0.496 . . . . 0.0 109.953 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -34.56 75.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.096 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.12 11.25 23.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.857 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.18 41.08 98.49 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.777 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.8 m -157.0 131.6 8.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.689 0.28 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.3 m -113.79 141.54 47.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -88.45 -31.36 18.83 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.627 HG22 ' OE1' ' A' ' 7' ' ' GLU . 3.4 t -71.9 99.08 2.14 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.985 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.16 64.32 0.1 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.989 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.52 -32.43 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.162 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.568 ' HB2' HG23 ' A' ' 16' ' ' THR . 2.1 m -89.42 145.98 24.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.861 0.362 . . . . 0.0 110.995 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -89.03 156.43 18.86 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.8 t -88.57 128.61 35.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.342 0.591 . . . . 0.0 111.168 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 m -137.3 72.5 1.42 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.7 t90 -30.93 125.5 0.31 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.871 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.4 Cg_endo -100.41 33.43 8.68 Favored 'Cis proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.15 -1.187 . . . . 0.0 113.961 0.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.5 t -135.74 141.39 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 121.866 -0.521 . . . . 0.0 112.206 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 62.0 m -89.66 121.94 32.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.9 p -140.48 150.39 43.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.817 0.341 . . . . 0.0 110.407 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.568 ' HB3' HD11 ' A' ' 4' ' ' ILE . 8.9 tpt85 -96.18 101.51 13.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.351 -178.848 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 CA-C-O 120.368 -0.129 . . . . 0.0 112.817 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.624 HG12 HG23 ' A' ' 4' ' ' ILE . 4.4 t -80.42 124.21 82.47 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.028 0.442 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 27' ' ' THR . 88.7 Cg_endo -79.75 52.67 4.4 Favored 'Trans proline' 0 CA--C 1.527 0.158 0 C-N-CA 122.709 2.272 . . . . 0.0 114.181 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -89.96 8.06 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.994 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 3.7 m -88.81 -36.01 16.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.109 0.481 . . . . 0.0 109.78 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.59 29.57 74.08 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.027 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 35.2 mt-10 -113.36 144.81 42.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.614 0.245 . . . . 0.0 110.604 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.4 p -91.22 129.19 37.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.332 -0.394 . . . . 0.0 109.939 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.454 ' O ' ' HD1' ' A' ' 23' ' ' TRP . 44.5 t -89.76 20.35 4.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.541 0.686 . . . . 0.0 109.661 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -58.93 -39.25 81.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.275 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.26 6.83 47.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.892 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.58 46.02 95.13 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.892 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.3 m -156.72 133.99 10.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.852 0.326 . . . . 0.0 111.152 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.8 m -126.4 136.77 53.1 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -88.34 -27.22 21.79 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.697 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.4 m -77.21 103.24 7.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.126 0.488 . . . . 0.0 110.753 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.35 122.93 13.73 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.334 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 112.94 -17.2 22.66 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.79 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 96.1 m -87.92 135.95 33.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.86 0.362 . . . . 0.0 110.378 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -88.28 143.6 26.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.826 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 t -87.61 81.54 7.69 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.8 m -89.97 76.5 7.03 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 26.9 t90 -34.89 127.07 0.52 Allowed Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 124.066 0.854 . . . . 0.0 112.382 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.1 Cg_endo -99.96 35.67 7.2 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.19 -1.171 . . . . 0.0 114.082 0.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.5 t -137.89 141.14 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.468 0.651 . . . . 0.0 112.445 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 93.0 m -88.52 116.16 26.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 3' ' ' PRO . 23.1 p -121.98 132.61 54.62 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.003 0.43 . . . . 0.0 111.253 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.663 ' HB3' HD11 ' A' ' 4' ' ' ILE . 32.0 ttt85 -89.11 112.94 24.03 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 C--N 1.328 -0.368 0 O-C-N 123.564 0.54 . . . . 0.0 110.014 -178.82 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.505 0 N-CA-C 112.783 -0.127 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.711 HG12 HG23 ' A' ' 4' ' ' ILE . 3.3 t -81.59 119.15 74.79 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.94 0.4 . . . . 0.0 110.599 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.6 Cg_exo -79.33 51.49 3.89 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.118 2.545 . . . . 0.0 114.134 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.711 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.29 17.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.153 0.501 . . . . 0.0 110.617 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.2 m -89.45 -34.77 16.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.192 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.65 34.96 79.57 Favored Glycine 0 C--N 1.33 0.238 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.394 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -128.71 143.02 50.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.881 0.372 . . . . 0.0 111.34 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.4 p -97.19 127.11 42.86 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 7.6 t -99.74 35.66 1.96 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.977 0.418 . . . . 0.0 110.701 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.1 -34.84 74.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.8 mt -98.44 14.23 28.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.41 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 63.44 49.33 70.88 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.918 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.2 m -155.68 134.96 12.29 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.667 -0.313 . . . . 0.0 111.062 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.5 m -137.45 135.02 36.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.87 -26.2 21.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.913 0.387 . . . . 0.0 110.306 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 m -73.25 97.33 2.42 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.23 0.538 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.84 127.92 30.76 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.14 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.407 ' HA3' HH12 ' A' ' 28' ' ' ARG . . . 106.94 -16.11 39.74 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.075 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.2 m -88.63 134.96 33.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.077 0.465 . . . . 0.0 110.808 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -88.49 155.31 19.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.099 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.0 t -87.99 84.63 6.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.071 0.462 . . . . 0.0 111.692 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 m -90.5 67.25 6.51 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 14.2 t90 -32.31 125.97 0.37 Allowed Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 124.461 1.101 . . . . 0.0 112.734 -177.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.6 Cg_endo -99.44 36.33 6.87 Favored 'Cis proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.102 -1.207 . . . . 0.0 113.937 0.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.0 t -133.58 142.74 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 121.754 -0.591 . . . . 0.0 112.152 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 53.9 m -88.84 123.4 33.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.9 p -125.87 133.66 51.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.981 0.42 . . . . 0.0 111.201 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HB3' HD11 ' A' ' 4' ' ' ILE . 51.7 ttm-85 -88.8 107.97 19.25 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.331 -179.019 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 112.758 -0.137 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.692 HG12 HG23 ' A' ' 4' ' ' ILE . 3.7 t -86.0 120.69 72.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.028 0.414 . . . . 0.0 110.391 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.2 Cg_exo -78.41 52.29 4.07 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.946 2.431 . . . . 0.0 114.202 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.703 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -92.46 20.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.049 0.452 . . . . 0.0 110.911 178.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 10.9 m -89.11 -29.66 19.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.006 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.79 32.5 74.12 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.355 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -126.64 143.81 51.11 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.845 0.355 . . . . 0.0 110.997 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -97.93 129.2 44.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 8.8 t -98.5 34.39 2.03 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.036 0.446 . . . . 0.0 110.419 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -34.94 75.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.859 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.5 mt -96.95 11.99 34.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.887 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.46 ' HA2' ' SG ' ' A' ' 9' ' ' CYS . . . 62.97 46.58 93.25 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.912 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m -156.39 135.57 12.08 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.659 -0.318 . . . . 0.0 111.079 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 m -132.35 135.87 46.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -88.76 -25.51 22.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.75 0.31 . . . . 0.0 110.444 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -72.86 97.63 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.147 0.498 . . . . 0.0 110.672 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.7 126.35 23.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.794 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.77 -16.81 33.46 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.94 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.2 m -88.96 132.25 34.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.022 0.439 . . . . 0.0 110.738 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -89.2 157.73 18.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.776 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.7 t -89.05 129.8 35.61 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.292 0.568 . . . . 0.0 111.424 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 m -138.53 68.63 1.39 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.2 t90 -31.68 126.03 0.33 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.931 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 80.2 Cg_endo -99.94 34.23 8.28 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.144 -1.19 . . . . 0.0 113.883 0.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.46 146.22 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.743 -0.598 . . . . 0.0 111.936 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.5 m -89.26 126.09 35.36 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 77.2 p -117.97 131.22 56.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.206 0.527 . . . . 0.0 111.596 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.561 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 35.4 ttt85 -92.56 108.21 19.8 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.926 -178.506 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 112.688 -0.165 . . . . 0.0 112.688 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.4 t -90.13 117.94 68.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 117.023 0.412 . . . . 0.0 110.764 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 70.1 Cg_endo -74.9 51.57 2.78 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.854 2.37 . . . . 0.0 113.637 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -91.83 26.58 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.023 0.44 . . . . 0.0 111.61 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.7 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 22.1 m -89.0 -26.19 21.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.781 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.61 33.8 67.24 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.256 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -131.03 142.55 50.33 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.149 0.499 . . . . 0.0 110.965 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.4 p -94.49 132.6 38.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.082 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 52.6 t -89.12 21.72 3.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.575 0.702 . . . . 0.0 109.428 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -60.47 -38.64 84.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.07 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.6 mt -92.4 5.22 51.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.08 41.1 99.68 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.263 -0.494 . . . . 0.0 112.876 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -158.31 134.12 9.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.738 0.304 . . . . 0.0 110.909 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 m -125.02 136.6 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.33 -25.59 22.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.816 0.341 . . . . 0.0 110.27 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -71.56 101.63 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.091 0.472 . . . . 0.0 110.365 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.1 24.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.905 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.5 -16.68 40.8 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.286 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.9 m -87.76 136.5 32.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.137 0.494 . . . . 0.0 110.846 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -88.28 141.89 28.19 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.96 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.09 87.29 7.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.431 . . . . 0.0 110.187 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.3 p -100.45 85.22 2.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 21.5 t90 -37.03 127.59 0.78 Allowed Pre-proline 0 N--CA 1.462 0.152 0 O-C-N 123.998 0.811 . . . . 0.0 112.261 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 70.7 Cg_endo -102.23 33.81 7.59 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.372 -1.095 . . . . 0.0 114.148 0.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 t -139.43 147.43 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 121.767 -0.583 . . . . 0.0 112.217 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.9 m -88.96 120.41 30.35 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 9.4 p -106.93 138.79 42.43 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.7 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 10.7 tpt180 -111.04 110.58 21.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.701 -178.978 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 CA-C-O 120.327 -0.152 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.706 HG12 HG23 ' A' ' 4' ' ' ILE . 3.8 t -84.18 120.94 75.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 117.055 0.427 . . . . 0.0 110.505 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.7 Cg_exo -78.88 52.23 4.15 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 123.018 2.479 . . . . 0.0 114.019 -178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.706 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.53 18.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.744 178.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.9 m -88.95 -37.96 14.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.762 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.73 42.82 95.06 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.4 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 26' ' ' CYS . 8.7 pt-20 -144.95 142.96 30.28 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.126 0.489 . . . . 0.0 110.957 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.3 p -98.57 131.23 44.95 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.697 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.797 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 28.5 p -103.3 56.47 0.75 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.237 0.541 . . . . 0.0 110.374 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 p -54.76 -41.0 69.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.572 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -93.15 22.68 4.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.226 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.27 45.58 96.19 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.955 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.5 m -149.11 132.28 16.38 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.525 -0.397 . . . . 0.0 111.058 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -110.07 140.29 44.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.032 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -89.56 -32.93 16.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.822 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.1 m -82.33 114.53 20.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.188 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.51 125.7 24.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.638 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.87 -17.26 38.81 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.827 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 72.4 m -88.83 129.78 35.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.135 0.493 . . . . 0.0 110.688 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 20.7 t -89.28 153.05 21.2 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.2 t -87.8 91.65 8.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.461 0.648 . . . . 0.0 111.915 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.5 m -89.94 63.94 6.15 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 t90 -25.46 124.65 0.2 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 114.076 -1.42 . . . . 0.0 113.412 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 76.6 Cg_endo -98.51 28.27 15.82 Favored 'Cis proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.928 -1.28 . . . . 0.0 114.083 0.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.1 141.01 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 121.853 -0.529 . . . . 0.0 111.797 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.797 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 98.3 m -88.65 131.46 34.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.816 0.341 . . . . 0.0 110.782 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.6 p -124.5 131.19 53.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.579 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.474 ' HB3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -89.19 109.23 20.13 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.443 -178.704 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 112.643 -0.183 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 t -81.12 125.72 78.85 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.121 0.486 . . . . 0.0 111.336 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.7 71.72 4.68 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.928 2.419 . . . . 0.0 112.925 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.611 HD12 ' HB3' ' A' ' 28' ' ' ARG . 3.3 mt -87.27 -30.26 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.827 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.0 m -87.45 -39.56 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.421 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.37 31.53 79.21 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.606 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 34.1 mt-10 -89.07 153.06 21.29 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.0 p -89.95 129.57 36.27 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.166 0.507 . . . . 0.0 109.977 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 52.6 t -91.39 14.91 13.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.475 0.655 . . . . 0.0 109.764 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -61.21 -35.63 77.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.813 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.2 mt -84.84 -6.88 59.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.532 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.54 35.27 80.87 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.881 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.3 m -159.97 124.81 3.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.765 0.317 . . . . 0.0 111.027 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.5 m -99.73 138.29 37.03 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -89.02 -28.06 20.44 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.019 0.438 . . . . 0.0 110.316 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -86.68 103.85 15.53 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.483 0.658 . . . . 0.0 111.433 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.36 126.52 21.52 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.659 ' HA3' ' NH1' ' A' ' 28' ' ' ARG . . . 116.05 -27.37 8.23 Favored Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 120.734 -0.745 . . . . 0.0 111.8 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 1.7 m -88.42 134.23 33.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.105 0.479 . . . . 0.0 110.455 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 13.7 m -88.03 148.82 24.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.706 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 t -86.56 80.75 8.51 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.251 0.548 . . . . 0.0 110.087 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.5 m -89.94 74.65 7.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.578 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 19.6 t90 -33.63 126.97 0.44 Allowed Pre-proline 0 N--CA 1.464 0.258 0 O-C-N 124.122 0.889 . . . . 0.0 112.692 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.7 Cg_endo -99.46 33.97 8.68 Favored 'Cis proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.055 -1.227 . . . . 0.0 114.085 0.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.53 140.63 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.474 0.654 . . . . 0.0 112.498 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 7' ' ' GLU . 99.2 m -88.91 116.14 26.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.8 p -124.05 135.57 53.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.143 0.497 . . . . 0.0 111.384 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.659 ' NH1' ' HA3' ' A' ' 18' ' ' GLY . 61.3 ttm-85 -88.59 109.22 19.91 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.404 0.621 . . . . 0.0 109.546 -178.196 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 CA-C-O 120.377 -0.124 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.589 HG12 HG23 ' A' ' 4' ' ' ILE . 5.6 t -85.04 125.3 70.81 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.868 0.366 . . . . 0.0 110.316 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 3.0 Cg_exo -76.26 50.44 2.89 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.997 2.465 . . . . 0.0 114.598 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.637 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -94.68 32.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.309 0.576 . . . . 0.0 110.459 178.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.6 m -92.9 -39.54 11.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.369 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.9 36.09 53.05 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.293 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.643 ' OE2' HG22 ' A' ' 16' ' ' THR . 10.3 pt-20 -150.42 142.87 24.39 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.269 0.557 . . . . 0.0 110.442 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -89.62 133.16 34.76 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.676 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 11.9 t -91.78 41.66 1.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.185 0.517 . . . . 0.0 109.755 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.0 p -61.83 -37.79 85.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.022 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.94 -1.43 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.153 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.84 34.21 62.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.58 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.1 m -159.42 126.27 4.59 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.0 m -95.93 137.4 35.05 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -88.58 -28.59 20.62 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.991 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.643 HG22 ' OE2' ' A' ' 7' ' ' GLU . 10.8 t -84.59 111.91 19.96 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 122.344 1.069 . . . . 0.0 111.257 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.16 135.41 43.84 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.028 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.2 -22.44 37.88 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.399 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 65.3 m -88.85 132.78 34.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.407 0.622 . . . . 0.0 111.865 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 m -89.32 151.57 22.02 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.247 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.3 t -88.78 110.73 21.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.263 0.554 . . . . 0.0 111.765 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.8 p -117.93 71.33 0.82 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 t90 -32.28 128.95 0.33 Allowed Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 114.265 -1.334 . . . . 0.0 112.796 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.4 Cg_endo -99.45 30.83 11.8 Favored 'Cis proline' 0 CA--C 1.536 0.619 0 C-N-CA 124.037 -1.235 . . . . 0.0 114.102 0.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.4 t -132.44 147.41 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.838 -0.539 . . . . 0.0 111.433 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 88.3 m -90.53 133.64 34.93 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.108 -0.37 . . . . 0.0 110.211 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.4 p -123.79 131.55 53.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.101 0.477 . . . . 0.0 111.415 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.58 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 50.2 ttm-85 -93.0 109.96 21.42 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.4 m120 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.426 -179.239 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-O 120.332 -0.149 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.588 HG12 HG23 ' A' ' 4' ' ' ILE . 10.5 t -90.99 123.41 64.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 117.181 0.491 . . . . 0.0 110.467 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 3.8 Cg_exo -74.29 53.07 2.91 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.002 2.468 . . . . 0.0 114.199 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.588 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -91.41 25.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.992 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 7.8 m -88.96 -32.8 17.48 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.48 42.22 95.9 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.713 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -150.23 147.12 27.31 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.113 0.483 . . . . 0.0 111.072 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.6 p -89.71 134.03 34.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.394 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.858 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 22.0 p -96.19 49.36 1.13 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.388 0.613 . . . . 0.0 111.284 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -60.54 136.3 58.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt 72.64 9.03 5.65 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.613 0.57 . . . . 0.0 111.133 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.19 56.44 5.21 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.125 -0.559 . . . . 0.0 113.718 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 10.0 t -150.41 142.48 24.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.065 0.459 . . . . 0.0 111.294 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.5 m -133.24 140.13 47.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.402 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -87.64 -31.61 19.69 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.034 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.545 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 8.4 m -78.65 112.92 16.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.623 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.31 125.86 25.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.646 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.76 52.04 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.37 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 90.0 m -88.16 128.48 35.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.148 0.499 . . . . 0.0 110.779 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 15.6 m -88.82 153.91 20.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.653 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.3 t -88.01 91.17 8.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.335 0.588 . . . . 0.0 112.086 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 m -93.96 62.93 3.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.8 t90 -27.88 127.96 0.21 Allowed Pre-proline 0 C--O 1.231 0.107 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.572 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 71.2 Cg_endo -96.48 26.34 19.96 Favored 'Cis proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.5 -1.458 . . . . 0.0 114.203 0.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.19 144.83 32.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 121.793 -0.567 . . . . 0.0 112.377 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.858 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 70.9 m -87.71 130.76 34.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 110.206 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 24.3 p -112.67 130.49 56.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.108 0.48 . . . . 0.0 111.208 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.485 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 14.5 tpt180 -94.54 108.48 20.43 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.589 -179.311 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.513 0 N-CA-C 112.917 -0.073 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.726 HG12 HG23 ' A' ' 4' ' ' ILE . 3.4 t -82.05 118.71 73.02 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 0.0 110.545 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 4.8 Cg_exo -79.52 51.71 3.99 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 123.075 2.517 . . . . 0.0 114.165 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.726 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -90.75 18.24 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.154 0.502 . . . . 0.0 110.659 178.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.2 m -89.52 -37.23 14.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.228 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.47 36.19 88.23 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.645 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 15' ' ' TYR . 48.1 mt-10 -131.81 145.63 51.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.685 0.279 . . . . 0.0 111.208 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 p -89.56 132.4 35.1 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.724 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.3 p -101.09 53.65 0.84 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.581 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.6 p -61.88 122.12 14.62 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 67.02 27.2 8.82 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.649 0.593 . . . . 0.0 110.828 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.32 44.87 89.71 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.585 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 26.9 m -118.88 128.5 54.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.987 0.394 . . . . 0.0 111.493 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.9 m -145.08 134.95 23.64 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.458 ' HB2' ' OE2' ' A' ' 7' ' ' GLU . 5.9 m-85 -89.64 -29.66 18.66 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.7 m -72.81 99.77 2.72 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.749 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.21 129.58 38.82 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.102 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA3' HH12 ' A' ' 28' ' ' ARG . . . 104.16 -16.51 49.62 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.245 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.04 128.88 35.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.002 0.429 . . . . 0.0 110.85 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -89.41 159.51 17.27 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.552 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.6 t -88.91 120.84 30.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.649 0.738 . . . . 0.0 111.756 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -123.98 63.84 1.06 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 11.9 t90 -26.1 125.99 0.2 Allowed Pre-proline 0 N--CA 1.462 0.166 0 CA-C-N 113.741 -1.572 . . . . 0.0 113.567 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 76.1 Cg_endo -98.04 29.41 14.61 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.7 -1.375 . . . . 0.0 114.328 0.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.69 147.82 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.724 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 55.5 m -87.97 130.98 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.2 p -125.96 132.33 52.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.172 0.511 . . . . 0.0 111.101 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.425 HH12 ' HA3' ' A' ' 18' ' ' GLY . 52.0 ttm-85 -90.35 107.77 19.35 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 121.24 0.543 . . . . 0.0 110.047 -178.6 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 120.171 -0.238 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.747 HG12 HG23 ' A' ' 4' ' ' ILE . 3.4 t -81.17 116.77 64.79 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 117.247 0.523 . . . . 0.0 110.476 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 6.3 Cg_exo -78.86 52.44 4.24 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.021 2.481 . . . . 0.0 114.376 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.747 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -95.33 16.99 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.79 178.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.0 m -88.75 -33.74 17.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.124 0.487 . . . . 0.0 109.783 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.29 31.03 73.8 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.666 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 26' ' ' CYS . 99.3 mt-10 -120.2 144.19 47.85 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.843 0.354 . . . . 0.0 110.815 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -94.78 133.6 38.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.468 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 44.2 t -89.36 20.14 4.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.525 0.679 . . . . 0.0 109.845 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -62.6 -30.39 71.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.277 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.64 5.65 50.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.737 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.14 37.34 93.78 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.853 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.3 m -158.52 130.02 6.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.721 0.296 . . . . 0.0 110.791 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.8 m -109.36 139.47 44.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -89.42 -30.5 18.29 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.041 0.448 . . . . 0.0 109.846 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 74.1 m -78.82 108.56 12.35 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.43 0.633 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.28 137.87 46.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.79 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.71 -17.62 58.24 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.492 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -87.96 133.67 33.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.17 0.509 . . . . 0.0 110.349 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 12.7 m -88.01 147.81 24.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.87 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.35 82.27 7.62 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.178 0.513 . . . . 0.0 110.011 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.4 m -91.36 73.92 6.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 37.9 t90 -34.45 127.58 0.48 Allowed Pre-proline 0 N--CA 1.464 0.272 0 O-C-N 123.975 0.797 . . . . 0.0 112.474 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 91.5 Cg_endo -98.69 33.35 9.49 Favored 'Cis proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.079 -1.217 . . . . 0.0 114.287 0.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.8 t -137.44 141.98 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.392 0.615 . . . . 0.0 112.569 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 20' ' ' SER . 87.5 m -88.81 123.9 33.65 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 66.9 p -123.06 139.22 54.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.151 0.5 . . . . 0.0 112.128 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HB3' HD11 ' A' ' 4' ' ' ILE . 16.0 tpp85 -88.22 98.91 11.83 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.438 -178.834 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.508 0 CA-C-O 120.188 -0.229 . . . . 0.0 113.55 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.838 HG13 HD12 ' A' ' 4' ' ' ILE . 13.3 p -91.62 126.17 55.05 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 117.61 0.705 . . . . 0.0 111.319 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.624 ' HB3' HG22 ' A' ' 27' ' ' THR . 73.2 Cg_endo -78.83 54.08 4.95 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 123.027 2.485 . . . . 0.0 114.601 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.838 HD12 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -88.38 16.15 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.488 0.661 . . . . 0.0 110.09 178.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.0 m -89.06 -37.2 15.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.273 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.57 35.04 80.22 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.943 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -129.83 143.53 50.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.791 0.329 . . . . 0.0 110.671 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 p -104.21 130.93 51.99 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.603 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 29.3 p -107.1 58.95 0.63 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.366 0.603 . . . . 0.0 111.019 -179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -56.89 -39.49 74.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.139 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.62 20.41 9.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.859 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.76 48.01 84.55 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.989 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.2 m -149.2 135.94 19.59 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.575 -0.367 . . . . 0.0 110.722 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 59.9 m -130.0 137.53 50.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -89.64 -29.02 19.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.304 0.573 . . . . 0.0 109.738 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.539 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -69.74 107.15 3.36 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.713 -179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.57 135.84 56.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.06 -14.38 62.23 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.562 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 82.0 m -89.71 128.03 36.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.045 0.45 . . . . 0.0 111.015 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.6 t -89.44 153.4 20.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.329 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.7 t -88.67 88.69 7.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.248 0.547 . . . . 0.0 111.759 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 p -89.77 69.36 7.62 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 176.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 6.2 t90 -26.94 126.04 0.21 Allowed Pre-proline 0 N--CA 1.465 0.275 0 CA-C-N 113.872 -1.513 . . . . 0.0 113.518 -176.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 74.8 Cg_endo -99.9 29.35 13.24 Favored 'Cis proline' 0 CA--C 1.536 0.58 0 C-N-CA 124.07 -1.221 . . . . 0.0 113.7 0.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.6 143.56 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.031 -0.418 . . . . 0.0 111.813 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 60.9 m -89.09 127.22 35.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.624 HG22 ' HB3' ' A' ' 3' ' ' PRO . 31.0 p -127.18 130.15 49.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.098 0.475 . . . . 0.0 111.347 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.592 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 43.3 ttm180 -91.34 116.85 29.16 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.1 m120 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.888 -179.544 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.472 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.674 HG12 HG23 ' A' ' 4' ' ' ILE . 3.0 t -80.91 124.64 81.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.044 0.45 . . . . 0.0 110.813 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HB3' HG22 ' A' ' 27' ' ' THR . 96.4 Cg_endo -80.81 50.77 3.68 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.727 2.284 . . . . 0.0 113.982 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -92.55 16.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.214 0.53 . . . . 0.0 110.69 178.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.85 ' HB3' HG21 ' A' ' 16' ' ' THR . 8.9 m -89.34 -37.07 15.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.889 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 68.71 37.28 84.33 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.163 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -133.72 147.04 51.31 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.855 0.359 . . . . 0.0 110.613 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 p -102.39 130.83 49.25 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.475 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 11.1 t -95.61 40.61 1.11 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.115 0.483 . . . . 0.0 109.881 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.6 p -59.13 -42.58 90.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.58 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.7 mt -85.65 10.29 13.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.237 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.23 36.3 92.65 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.701 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.7 m -157.85 128.79 6.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.673 0.273 . . . . 0.0 110.58 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -107.63 140.04 41.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -88.38 -31.29 18.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.85 HG21 ' HB3' ' A' ' 5' ' ' CYS . 3.5 t -70.49 97.81 1.35 Allowed 'General case' 0 C--O 1.242 0.695 0 CA-C-O 122.04 0.924 . . . . 0.0 111.065 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.76 123.65 16.42 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.116 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.48 -22.6 14.92 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.041 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 85.8 m -88.37 139.27 30.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.088 0.471 . . . . 0.0 111.275 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.6 m -88.53 151.87 22.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.849 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.5 t -88.85 112.47 23.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 111.534 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.3 m -117.91 68.93 0.77 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 12.1 t90 -31.75 126.56 0.33 Allowed Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.847 -177.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.4 Cg_endo -99.56 32.24 10.23 Favored 'Cis proline' 0 CA--C 1.537 0.65 0 C-N-CA 124.077 -1.218 . . . . 0.0 113.984 0.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.78 142.38 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 121.799 -0.563 . . . . 0.0 111.862 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 77.5 m -89.54 124.73 34.79 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.436 HG22 ' HB3' ' A' ' 3' ' ' PRO . 53.0 p -129.71 130.67 45.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.908 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.689 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 49.7 ttt180 -91.8 118.39 30.65 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.896 -178.979 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 120.371 -0.127 . . . . 0.0 112.913 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.719 HG12 HG23 ' A' ' 4' ' ' ILE . 3.5 t -80.65 121.17 80.94 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.071 0.462 . . . . 0.0 110.709 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.25 52.16 4.21 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.691 2.261 . . . . 0.0 114.248 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.719 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -92.08 12.3 2.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.781 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.7 m -88.73 -36.66 16.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.164 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.75 33.06 83.07 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.147 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.33 144.87 48.4 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.798 0.332 . . . . 0.0 111.342 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -105.82 126.88 52.69 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.688 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 31.7 p -106.31 54.71 0.68 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.232 0.539 . . . . 0.0 111.104 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 p -57.05 -39.16 74.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.812 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -95.45 19.73 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.018 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.3 51.12 57.28 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.054 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.0 t -155.52 146.05 22.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.832 0.349 . . . . 0.0 111.329 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.2 m -140.82 139.65 34.55 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.46 -26.96 21.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.735 0.302 . . . . 0.0 110.326 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 m -73.83 106.31 5.5 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.176 0.512 . . . . 0.0 110.629 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.42 123.98 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.764 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.0 -17.57 32.09 Favored Glycine 0 N--CA 1.442 -0.967 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.11 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -88.13 130.11 35.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.112 0.482 . . . . 0.0 110.69 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.4 m -89.02 152.18 21.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.703 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.0 t -87.89 91.61 8.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.37 0.605 . . . . 0.0 111.407 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -89.66 64.07 6.42 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 6.6 t90 -25.42 124.28 0.2 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 114.017 -1.447 . . . . 0.0 113.543 -176.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 73.3 Cg_endo -99.25 30.38 12.52 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 C-N-CA 124.085 -1.215 . . . . 0.0 113.819 0.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.6 t -125.14 140.25 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 O-C-N 122.015 -0.428 . . . . 0.0 111.952 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 62.9 m -87.82 126.61 35.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.2 p -129.18 132.57 47.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.088 0.471 . . . . 0.0 111.093 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HB3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -89.31 106.99 18.8 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.744 -177.847 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 112.778 -0.129 . . . . 0.0 112.778 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.713 HG12 HG23 ' A' ' 4' ' ' ILE . 3.0 t -82.21 121.01 78.39 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.058 0.456 . . . . 0.0 110.562 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HB3' HG22 ' A' ' 27' ' ' THR . 89.9 Cg_endo -80.12 50.69 3.62 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.687 2.258 . . . . 0.0 114.308 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.714 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -93.67 18.94 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.33 0.586 . . . . 0.0 110.322 178.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.7 m -89.74 -34.65 16.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.184 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.13 38.18 93.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.734 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.54 152.79 49.53 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.96 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -107.91 130.06 55.05 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.045 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 16.6 t -100.04 34.29 2.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.298 0.57 . . . . 0.0 109.871 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.405 HG23 ' HG ' ' A' ' 11' ' ' LEU . 8.1 t -62.02 -30.07 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.439 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.405 ' HG ' HG23 ' A' ' 10' ' ' THR . 94.4 mt -96.37 15.87 20.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.946 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.16 36.76 93.87 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.535 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.2 m -157.22 135.29 11.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.5 m -112.66 133.77 54.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.587 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -88.17 -26.59 22.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.447 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.74 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -72.85 113.46 9.92 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.228 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.16 134.3 56.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.421 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.22 -4.27 77.43 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.353 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.74 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 88.4 m -92.04 135.01 34.3 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.342 0.571 . . . . 0.0 111.376 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.9 m -89.28 158.36 17.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.012 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.1 t -89.07 131.44 35.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.293 0.568 . . . . 0.0 111.518 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.0 m -140.91 63.41 1.45 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.4 t90 -29.18 126.63 0.24 Allowed Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 114.51 -1.223 . . . . 0.0 113.182 -177.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 82.4 Cg_endo -97.6 26.78 18.46 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.871 -1.304 . . . . 0.0 113.824 0.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.4 t -125.05 147.23 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 O-C-N 121.997 -0.439 . . . . 0.0 111.972 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 77.8 m -94.51 128.46 41.11 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.513 HG22 ' HB3' ' A' ' 3' ' ' PRO . 80.5 p -126.15 132.57 51.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.047 0.451 . . . . 0.0 111.25 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -89.87 112.5 23.87 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.171 -178.951 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 120.099 -0.278 . . . . 0.0 113.496 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.13 118.71 67.85 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 117.599 0.7 . . . . 0.0 111.171 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 72.5 Cg_endo -75.45 50.86 2.77 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.102 2.535 . . . . 0.0 114.616 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -93.54 29.35 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.468 0.652 . . . . 0.0 110.563 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.88 ' HB3' HG21 ' A' ' 16' ' ' THR . 18.1 m -88.95 -31.57 18.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.73 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.05 32.81 56.01 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.202 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -134.1 142.82 47.66 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.047 0.451 . . . . 0.0 110.639 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.6 p -92.95 137.48 32.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.912 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 23' ' ' TRP . 43.7 t -88.91 13.07 13.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.777 0.799 . . . . 0.0 109.572 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -62.9 -31.07 72.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.954 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 mp -77.97 -7.41 56.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.882 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.39 32.25 62.55 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.884 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.5 t -175.85 149.64 0.95 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -122.52 138.69 54.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -88.67 -31.02 18.72 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.88 HG21 ' HB3' ' A' ' 5' ' ' CYS . 4.8 t -69.97 101.53 1.8 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.008 0.908 . . . . 0.0 111.027 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.29 135.37 44.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.316 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.95 -21.92 43.55 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.697 ' HB2' HG23 ' A' ' 16' ' ' THR . 71.0 m -89.3 135.59 33.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.178 0.513 . . . . 0.0 111.304 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 14.8 m -88.64 151.21 22.61 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.426 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.38 84.69 7.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.215 0.531 . . . . 0.0 110.157 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.1 m -94.49 75.46 3.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.509 ' HA ' ' HB3' ' A' ' 9' ' ' CYS . 12.3 t90 -35.22 127.39 0.55 Allowed Pre-proline 0 N--CA 1.464 0.267 0 O-C-N 124.042 0.839 . . . . 0.0 112.345 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 79.5 Cg_endo -100.0 37.04 6.25 Favored 'Cis proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.174 -1.178 . . . . 0.0 114.369 1.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.92 149.23 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.445 0.641 . . . . 0.0 112.445 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 20' ' ' SER . 64.6 m -88.84 126.26 35.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 44.0 p -112.07 131.59 55.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.13 0.491 . . . . 0.0 112.147 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -89.67 102.53 15.22 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.7 m120 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.123 -179.492 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 120.31 -0.161 . . . . 0.0 112.97 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.661 HG12 HG23 ' A' ' 4' ' ' ILE . 3.6 t -85.61 121.19 73.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.088 0.444 . . . . 0.0 110.556 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 2' ' ' VAL . 5.9 Cg_exo -77.93 53.52 4.46 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.019 2.479 . . . . 0.0 114.451 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.683 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -99.39 25.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.522 . . . . 0.0 110.832 178.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.843 ' HB3' HG21 ' A' ' 16' ' ' THR . 11.2 m -88.85 -34.66 16.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.406 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.89 32.57 63.54 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.963 -0.636 . . . . 0.0 112.565 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.436 ' OE1' HG22 ' A' ' 16' ' ' THR . 86.0 mt-10 -131.36 141.97 49.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 120.924 0.392 . . . . 0.0 111.012 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -103.13 128.6 50.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.617 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 32.1 p -103.61 53.74 0.75 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.367 0.604 . . . . 0.0 110.824 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -56.43 -39.29 72.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.363 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.54 22.64 2.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.171 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.36 44.81 97.18 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.38 -0.438 . . . . 0.0 113.089 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.6 t -161.75 145.7 12.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 61.8 m -125.69 141.67 51.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.837 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.53 -31.71 18.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.843 HG21 ' HB3' ' A' ' 5' ' ' CYS . 4.5 t -71.12 100.13 1.99 Allowed 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.027 0.918 . . . . 0.0 110.681 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 125.32 21.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.394 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.56 -24.42 17.6 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.318 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.674 ' HB2' HG23 ' A' ' 16' ' ' THR . 76.7 m -88.47 135.75 33.32 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.03 0.443 . . . . 0.0 111.216 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 18.3 t -88.99 154.72 19.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.49 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -88.33 92.54 9.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.294 0.569 . . . . 0.0 112.002 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -92.39 64.07 4.29 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 176.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 5.7 t90 -24.6 123.73 0.19 Allowed Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.63 -176.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 84.5 Cg_endo -99.47 28.17 15.13 Favored 'Cis proline' 0 CA--C 1.537 0.631 0 C-N-CA 124.069 -1.221 . . . . 0.0 113.95 0.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.1 t -124.09 141.74 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 121.92 -0.488 . . . . 0.0 111.778 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 61.1 m -87.92 128.57 35.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.727 0.299 . . . . 0.0 110.224 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.3 p -116.11 132.65 56.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.142 0.496 . . . . 0.0 111.65 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 13.1 tpt180 -90.91 106.46 18.53 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.36 -179.055 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.61 0 N-CA-C 112.626 -0.19 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 4' ' ' ILE . 5.8 t -74.55 114.75 37.09 Favored Pre-proline 0 C--O 1.236 0.346 0 CA-C-O 121.312 0.577 . . . . 0.0 111.091 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.6 60.17 7.15 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.955 2.437 . . . . 0.0 113.656 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -87.94 -12.9 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.87 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.52 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 62.8 m -88.16 -43.34 11.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.339 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.35 21.62 70.51 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.6 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -89.61 146.99 24.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.717 0.258 . . . . 0.0 110.506 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.1 p -94.8 127.53 40.87 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 10.2 t -98.41 38.33 1.36 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.115 0.484 . . . . 0.0 110.395 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p -61.54 -37.87 85.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.989 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.44 7.48 28.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.114 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.16 42.52 94.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.792 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.5 m -157.65 132.59 8.7 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 122.827 -0.22 . . . . 0.0 110.693 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -119.25 134.74 55.04 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -88.9 -27.05 21.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.002 0.43 . . . . 0.0 110.609 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.52 ' HB ' ' SG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -77.78 104.6 8.42 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.363 0.602 . . . . 0.0 112.192 -179.244 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.66 131.91 50.36 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.529 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.32 -27.15 20.45 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.09 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.5 130.65 35.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.205 0.526 . . . . 0.0 110.648 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 16.0 t -88.68 162.46 16.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.849 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.0 t -87.59 83.29 7.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.288 0.566 . . . . 0.0 111.595 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.3 m -89.8 65.11 6.65 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.3 t90 -30.7 126.06 0.29 Allowed Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 114.662 -1.154 . . . . 0.0 112.867 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 87.1 Cg_endo -98.6 33.85 9.07 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.888 -1.297 . . . . 0.0 114.005 0.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.56 140.62 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.184 0.516 . . . . 0.0 112.1 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 20' ' ' SER . 62.5 m -89.46 120.68 31.0 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.8 p -132.44 138.69 47.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.849 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -88.61 99.37 12.27 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.167 -178.688 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 120.046 -0.308 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.828 HG13 HD12 ' A' ' 4' ' ' ILE . 14.7 p -89.68 125.97 59.4 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 117.654 0.727 . . . . 0.0 111.461 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.579 ' HB3' HG22 ' A' ' 27' ' ' THR . 83.6 Cg_endo -79.48 54.64 5.28 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.909 2.406 . . . . 0.0 114.508 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.828 HD12 HG13 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -88.27 15.0 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.416 0.627 . . . . 0.0 110.209 178.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.3 m -89.3 -36.61 15.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.428 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.54 34.56 73.62 Favored Glycine 0 C--O 1.227 -0.332 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.223 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -130.47 143.06 50.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.825 0.345 . . . . 0.0 110.795 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . 20.9 p -92.31 129.94 38.13 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.638 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.439 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 14.9 t -95.75 34.49 1.5 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.346 0.593 . . . . 0.0 110.109 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -63.43 -27.38 69.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.175 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.4 mt -95.9 13.31 27.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.082 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.44 45.17 96.45 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.583 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.7 t -167.33 151.77 6.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.696 0.284 . . . . 0.0 110.38 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.0 m -137.17 138.0 39.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -89.04 -28.14 20.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.133 0.492 . . . . 0.0 109.803 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.506 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 0.9 OUTLIER -68.1 105.55 2.1 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.634 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.07 136.26 56.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.067 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.72 -11.48 66.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.848 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.506 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 95.1 m -88.94 132.1 34.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.107 0.48 . . . . 0.0 111.02 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 m -89.44 154.89 19.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.855 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.3 t -88.82 123.73 33.49 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.215 0.531 . . . . 0.0 111.028 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.9 t -131.38 67.47 1.51 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 21.5 t90 -31.33 128.18 0.29 Allowed Pre-proline 0 N--CA 1.466 0.333 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.906 -177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 79.4 Cg_endo -97.93 32.69 10.39 Favored 'Cis proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.921 -1.283 . . . . 0.0 114.146 0.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 14.5 p -135.67 146.91 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 121.66 -0.65 . . . . 0.0 112.139 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 64.6 m -89.35 127.97 35.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 3' ' ' PRO . 33.2 p -129.26 130.36 46.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.158 0.504 . . . . 0.0 111.142 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 42.9 ttm180 -91.86 116.44 28.91 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.646 -179.188 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.569 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 14.5 t -85.97 117.53 68.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 117.125 0.462 . . . . 0.0 110.635 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' THR . 2.7 Cg_exo -75.16 51.14 2.76 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.138 2.558 . . . . 0.0 113.568 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 28' ' ' ARG . 1.9 pp -94.88 24.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.002 0.429 . . . . 0.0 111.391 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 28' ' ' ARG . 20.5 m -88.69 -34.11 17.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.83 -5.59 46.55 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.887 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.602 ' OE1' HG22 ' A' ' 16' ' ' THR . 40.2 mt-10 -89.79 142.21 27.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 117.321 0.561 . . . . 0.0 110.726 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 p -97.2 127.13 42.88 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 28.2 p -105.58 48.26 0.84 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.461 0.648 . . . . 0.0 110.73 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -61.25 -26.27 67.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.595 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -97.14 17.25 17.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.653 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.57 45.92 94.84 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.05 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -164.54 151.88 11.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.825 0.312 . . . . 0.0 111.031 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.6 m -132.61 142.15 49.0 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -88.28 -31.33 19.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.131 0.491 . . . . 0.0 109.705 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.604 HG21 ' HB3' ' A' ' 5' ' ' CYS . 5.4 t -73.98 100.11 3.47 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.902 0.858 . . . . 0.0 110.482 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.47 125.08 18.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.103 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 113.46 -25.32 11.27 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.131 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.602 ' HB2' HG23 ' A' ' 16' ' ' THR . 96.7 m -87.84 132.64 34.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.175 0.512 . . . . 0.0 110.984 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.5 m -89.53 156.38 18.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.286 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.4 t -88.56 124.74 34.32 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.552 0.691 . . . . 0.0 111.331 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.8 m -128.68 67.25 1.4 Allowed 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 4.0 t90 -24.32 122.93 0.19 Allowed Pre-proline 0 N--CA 1.463 0.194 0 CA-C-N 113.611 -1.631 . . . . 0.0 113.581 -176.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 68.1 Cg_endo -100.86 26.6 15.32 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.084 -1.215 . . . . 0.0 114.165 0.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.9 t -125.99 147.84 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.765 -0.584 . . . . 0.0 111.768 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 75.9 m -88.26 131.07 34.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.79 0.329 . . . . 0.0 110.243 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 30.7 p -110.09 136.94 48.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.153 0.501 . . . . 0.0 111.599 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.646 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 8.0 tpt180 -105.15 108.87 20.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.424 -179.202 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.641 0 CA-C-O 120.233 -0.204 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.72 HG12 HG23 ' A' ' 4' ' ' ILE . 10.6 t -74.54 116.43 53.2 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 121.221 0.534 . . . . 0.0 110.825 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.96 57.78 6.42 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.789 2.326 . . . . 0.0 113.992 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.747 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -88.91 33.56 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.356 0.598 . . . . 0.0 110.778 178.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' SG ' HG21 ' A' ' 16' ' ' THR . 91.1 m -141.48 -49.91 0.41 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.698 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.89 22.8 77.12 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 113.942 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.627 ' OE1' HG22 ' A' ' 16' ' ' THR . 42.7 mt-10 -89.06 145.53 25.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.004 0.402 . . . . 0.0 109.971 178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.4 p -89.08 125.64 35.1 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.643 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 10.3 t -102.81 34.6 2.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.141 0.496 . . . . 0.0 109.953 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.13 -34.56 75.18 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.096 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.12 11.25 23.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.857 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.18 41.08 98.49 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.777 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.8 m -157.0 131.6 8.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.689 0.28 . . . . 0.0 110.88 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.3 m -113.79 141.54 47.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -88.45 -31.36 18.83 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.627 HG22 ' OE1' ' A' ' 7' ' ' GLU . 3.4 t -71.9 99.08 2.14 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.985 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.16 64.32 0.1 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.989 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.52 -32.43 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.162 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.568 ' HB2' HG23 ' A' ' 16' ' ' THR . 2.1 m -89.42 145.98 24.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.861 0.362 . . . . 0.0 110.995 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -89.03 156.43 18.86 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.8 t -88.57 128.61 35.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.342 0.591 . . . . 0.0 111.168 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.7 m -137.3 72.5 1.42 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 10.7 t90 -30.93 125.5 0.31 Allowed Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.871 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' TRP . 77.4 Cg_endo -100.41 33.43 8.68 Favored 'Cis proline' 0 CA--C 1.539 0.73 0 C-N-CA 124.15 -1.187 . . . . 0.0 113.961 0.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.5 t -135.74 141.39 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 121.866 -0.521 . . . . 0.0 112.206 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 62.0 m -89.66 121.94 32.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.9 p -140.48 150.39 43.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.817 0.341 . . . . 0.0 110.407 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.568 ' HB3' HD11 ' A' ' 4' ' ' ILE . 8.9 tpt85 -96.18 101.51 13.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.351 -178.848 . . . . . . . . 0 0 . 1 stop_ save_